Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40411,0.146990917731684,0.00277657816057646,0.141548824536954,0.152433010926413,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40332,0.138231190010125,0.00277612049415858,0.132789993841574,0.143672386178676,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,37998,-0.14617386566362,0.00382070516973946,-0.153662447796309,-0.13868528353093,3.38620955510879e-304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40422,0.092147059491752,0.00250277796385967,0.0872416146825871,0.097052504300917,6.68853080879665e-285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,40332,-0.139231523299069,0.00385405812413181,-0.146785477222368,-0.131677569375771,1.02238314556921e-274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,39980,-0.394768424893059,0.0114174329632415,-0.417146593501013,-0.372390256285106,1.94348286482484e-252
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,40293,-0.12740707178831,0.0037034458841883,-0.134665825721319,-0.120148317855301,3.39158342323115e-250
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,37990,-0.247345887262753,0.00726398671537837,-0.261583301224894,-0.233108473300611,6.52863057978448e-244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,37987,0.0681938261334335,0.00222634007164665,0.0638301995930061,0.0725574526738609,2.80438568773553e-199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40228,-0.0823590265829302,0.00271174909827551,-0.0876740548155502,-0.0770439983503102,5.88550035872491e-197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,40372,0.073769513859988,0.00248066231842526,0.0689074157158745,0.0786316120041016,3.5656667364087e-189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,38013,0.181513891484326,0.00613563960874606,0.169488037851184,0.193539745117469,1.90813714840077e-186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40500,0.314269187676362,0.010879368177879,0.292945626047719,0.335592749305005,6.4347713735945e-179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,40471,-0.35353857386455,0.012251032926278,-0.377550598400055,-0.329526549329045,1.44826392422153e-178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,37562,-0.248774669087742,0.0087782452385111,-0.265980029755224,-0.231569308420261,1.56143397632115e-171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,40305,-0.22943348423669,0.00856601280242866,-0.24622286932945,-0.21264409914393,1.33466620930003e-154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,40356,-0.128654001306416,0.00487780436575782,-0.138214497863301,-0.119093504749531,4.35501575708004e-150
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37900,-0.133496197687175,0.00506185314870072,-0.143417429858628,-0.123574965515721,1.71310484902101e-149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,40332,-0.103347285034503,0.00396338176309169,-0.111115513290162,-0.095579056778843,8.35537036532155e-147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,40489,-0.160865025911399,0.00620429187246558,-0.173025437981432,-0.148704613841367,3.11389904274459e-145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,40471,0.052396253023983,0.002033239703992,0.0484111032041587,0.0563814028438073,1.59893676973988e-143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,40489,0.082390848603127,0.00321760887729655,0.0760843352036258,0.0886973620026283,9.04311588416559e-142
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,40516,-0.125293695436224,0.00498182687992383,-0.135058076120875,-0.115529314751573,6.19650788260842e-137
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,40359,0.106577184145647,0.00428000229063496,0.0981883796560028,0.114965988635292,2.66047849673073e-134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,40461,0.0793806077171042,0.00319289090521864,0.0731225415428756,0.0856386738913327,6.62041088670153e-134
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40403,0.0781144707955848,0.00318070615099744,0.0718802867396298,0.0843486548515398,9.22480020053142e-131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,40042,-0.153577269414112,0.00627299506030681,-0.165872339732313,-0.141282199095911,6.39697116716795e-130
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,40400,-0.077791948880429,0.00318896032856927,-0.0840423111244248,-0.0715415866364333,4.52506626673709e-129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40359,0.0611019671574624,0.00251218558869194,0.0561780834036262,0.0660258509112986,2.4895196325772e-128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,40341,-0.119103936051694,0.00500085995198132,-0.128905621557578,-0.109302250545811,3.20710366966511e-123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,40126,0.118694323356313,0.00499197171257508,0.108910058799666,0.12847858791296,8.53402834157366e-123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37790,-0.0564971743458281,0.00242180596909408,-0.0612439140452525,-0.0517504346464037,5.16743600941354e-118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,40309,0.0676500105275185,0.00291533012623875,0.0619359634800906,0.0733640575749465,3.60848487314976e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,37987,0.105541102254104,0.00455092988490236,0.0966212796796952,0.114460924828512,1.04033223547928e-116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37671,0.0660321666898664,0.00284883165980048,0.0604484566366574,0.0716158767430753,1.5503293179072e-116
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,40338,0.0980971770946705,0.00426032619036058,0.0897469377615637,0.106447416427777,1.98296960616409e-115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40228,-0.0685902158703026,0.00299672822296169,-0.0744638031873076,-0.0627166285532977,4.34578764862312e-114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,40375,0.0429522525259933,0.00188449647333567,0.0392586394382554,0.0466458656137312,3.50372101192423e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,40453,-0.249243832482759,0.0109449200201706,-0.270695875722293,-0.227791789243224,5.32961564219981e-113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,40489,-0.0709652494100626,0.00316853570365601,-0.0771755793892284,-0.0647549194308968,2.00051043873061e-109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,40357,-0.109602262112707,0.00495382289146411,-0.119311754979977,-0.0998927692454372,7.42621187972426e-107
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,40415,-0.070424185026514,0.00320466715751191,-0.0767053326552374,-0.0641430373977907,1.79945276109146e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,40352,-0.156214172092955,0.00713071597761164,-0.170190375409074,-0.142237968776836,7.83580193492756e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,40332,0.0759826803223903,0.00353143700336215,0.0690610637958004,0.0829042968489801,3.05770998274103e-101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40372,0.0595181102023229,0.00278691280713366,0.0540557611003409,0.0649804593043049,8.52794512019901e-100
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40313,-0.108591926251499,0.00516846093850047,-0.11872210969096,-0.0984617428120377,1.08768397532292e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,40411,-0.0660890392393986,0.00315706005830987,-0.072276876953686,-0.0599012015251113,5.13515777437632e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40536,0.0674032852811448,0.00324942176566932,0.0610344186204329,0.0737721519418566,2.42019308801e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,37981,0.070578490379124,0.00340065025467826,0.0639132158799546,0.0772437648782933,3.26263303461851e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40424,-0.087687280139354,0.004334099932342,-0.0961821160067443,-0.0791924442719636,6.83875292935286e-90
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,37671,-0.0546781116235114,0.00270647711012291,-0.0599828067593523,-0.0493734164876705,2.06272628966618e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,40536,-0.100080172552031,0.00497156553634515,-0.109824441003268,-0.0903359041007949,4.97103821678106e-89
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40044,-0.1051553967956,0.00523485325701981,-0.115415709179359,-0.0948950844118409,1.25036370149204e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37370,-0.0602682754307493,0.00299878772489039,-0.0661458993715345,-0.0543906514899642,1.73555580501888e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,37345,0.0840515406790047,0.00418225396855648,0.0758543229006339,0.0922487584573754,1.75812942672447e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,40359,-0.111671713580045,0.00558727926316724,-0.122622780935853,-0.100720646224237,8.56449397732046e-88
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,40332,0.0502762258524257,0.00252937740770389,0.0453186461333261,0.0552338055715254,7.32158641632627e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,40470,-0.0372510888295574,0.00187852194594778,-0.0409329918436151,-0.0335691858154998,1.78435522042929e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,40424,0.0524342192442544,0.0026498457535995,0.0472405215671994,0.0576279169213094,4.08237336690042e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,40372,-0.0334576417492657,0.00169083280364231,-0.0367716740444047,-0.0301436094541268,4.11199606747306e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,37987,0.0998836292853937,0.00506732270279441,0.0899516767879166,0.109815581782871,2.69746500589903e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40497,0.116029572017855,0.00597503734181534,0.104318498827897,0.127740645207813,4.77430208103713e-83
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,40044,-0.138446107963534,0.00720953820557292,-0.152576802846457,-0.124315413080611,3.01292193703984e-81
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,40502,0.0972010438305055,0.00509787791172985,0.087209203123515,0.107192884537496,3.65141338075796e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40332,0.0477896456500715,0.00254076370514878,0.0428097487879799,0.0527695425121632,4.4772669472508e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40063,-0.0738593244136174,0.00398980670277246,-0.0816793455510514,-0.0660393032761834,1.06617308614085e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37671,-0.065300079969132,0.0035408569386727,-0.0722401595689305,-0.0583600003693335,5.27201316920852e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,40353,0.0937180068736679,0.00508815027041637,0.0837452323436518,0.103690781403684,5.57920012241279e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,37671,-0.0721151009603817,0.00392829454097991,-0.0798145582607023,-0.0644156436600611,2.39078661232076e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40411,-0.0594576402097276,0.00324836798783102,-0.0658244414658764,-0.0530908389535788,4.41258128266776e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,40422,0.0763560682432988,0.00417724723081557,0.0681686636709003,0.0845434728156973,6.88329069673408e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,40280,-0.134055642302379,0.00733972828908274,-0.148441509748981,-0.119669774855777,9.09212611136172e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,40419,-0.099591642858258,0.00550105859921122,-0.110373717712712,-0.088809568003804,1.57090671552111e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,37628,-0.0878013208461625,0.00486560885936767,-0.0973379142105231,-0.0782647274818019,6.29485388603197e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,37998,0.102249187069878,0.00568736663314784,0.0911019484689085,0.113396425670848,1.94562154849572e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,37990,-0.154136597845237,0.00858490326890576,-0.170963008252293,-0.137310187438182,2.96767438886798e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,37642,-0.0610811179994623,0.00340722663384441,-0.0677592822017973,-0.0544029537971273,5.04951615805948e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,40536,0.0464534594118187,0.00260438730052294,0.0413488603027937,0.0515580585208436,1.75227383507364e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,40516,-0.0570739731577501,0.00322560032567591,-0.0633961497960749,-0.0507517965194253,2.12082951164599e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40379,0.0527839890986548,0.00299035365932631,0.0469228959263753,0.0586450822709344,4.50927152615821e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,37572,-0.130507737980807,0.00742475034888453,-0.14506024866462,-0.115955227296993,2.22633955257138e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,40337,-0.164861407646511,0.00950173577779079,-0.183484809770981,-0.146238005522041,8.04997527647001e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,39243,-0.0651608632402368,0.00376236187403913,-0.0725350925133535,-0.0577866339671201,1.52794766217982e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40516,-0.0618564818500589,0.0035964390363529,-0.0689055023613106,-0.0548074613388072,1.04014263492341e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,39961,-0.0800569795506771,0.00473722705204098,-0.0893419445726775,-0.0707720145286768,1.67696361602743e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,40536,0.0259809498515414,0.00154537183852942,0.0229520210480237,0.029009878655059,6.84934633074657e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40305,-0.125138202779392,0.00745934185280026,-0.139758512810881,-0.110517892747904,1.2668668225961e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39961,-0.0865404693539682,0.00516255029365464,-0.0966590679295313,-0.0764218707784051,1.61164732298424e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39980,-0.0924889258517274,0.00552122036351068,-0.103310517764208,-0.0816673339392465,1.94861252845707e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,40309,-0.0481488671507673,0.00287657802290221,-0.0537869600756556,-0.042510774225879,2.36487278852897e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,40224,0.0448548937344061,0.00268033743080746,0.0396014323700235,0.0501083550987888,2.51995240338249e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,38013,-0.0293556990983433,0.00175813668028922,-0.0328016469917102,-0.0259097512049764,5.71799116574993e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,37959,-0.0720477617787468,0.00434171660542647,-0.0805575263253827,-0.063537997232111,3.09129789852825e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40305,-0.0856513219453125,0.00516703139202776,-0.0957787034736869,-0.0755239404169381,3.37277435091719e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40042,-0.131514172839342,0.00793792591171792,-0.147072507626309,-0.115955838052374,3.96443537829573e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,40068,0.0466019234823055,0.00282300714496191,0.0410688294781801,0.0521350174864308,1.05158218326711e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40403,0.0430971047720356,0.00261206896663127,0.0379774495974383,0.0482167599466328,1.18183261254764e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37969,0.0752861668708826,0.00456300292672709,0.0663426811344975,0.0842296526072677,1.45067596345558e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40411,-0.0538309816880567,0.00327724929090126,-0.0602543902982232,-0.0474075730778903,3.90259200351751e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,40332,-0.0873109383651944,0.00532561167562531,-0.09774913724942,-0.0768727394809688,6.49666401216251e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,40489,0.0253166163230411,0.00154432906587081,0.0222897313539343,0.0283435012921479,6.55802107726683e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40453,-0.0646469809214458,0.00395364776049291,-0.0723961305320119,-0.0568978313108797,1.29729985403237e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40042,-0.075404677730194,0.00461590221369729,-0.0844518460690407,-0.0663575093913473,1.71133909803676e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37942,-0.115321620100664,0.00709665808902649,-0.129231069955156,-0.101412170246172,8.05938164339954e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40319,0.0375855312978754,0.00232094695100564,0.0330364752739044,0.0421345873218465,1.63570749884205e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40341,0.0590613314217944,0.00365681991041305,0.0518939643973848,0.066228698446204,3.24788925129959e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,40333,-0.125768566000852,0.00780248900938173,-0.14106144445924,-0.110475687542463,5.40924108898106e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40359,-0.0453650225419442,0.00281930309347166,-0.0508908566051487,-0.0398391884787398,8.45249782008456e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,37990,0.041342995854499,0.00257423159832769,0.0362975019217767,0.0463884897872212,1.64371746191171e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40305,-0.0628012598463276,0.00391847376857046,-0.0704814684327257,-0.0551210512599295,2.33719453985129e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,40392,-0.0487026651139577,0.00303995530460555,-0.0546609775109846,-0.0427443527169308,2.56060016062181e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,40516,-0.0453211756449028,0.00283843868489811,-0.0508845154673031,-0.0397578358225025,5.95595073933012e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40160,-0.0691608421225279,0.00433578824754287,-0.0776589870877119,-0.0606626971573439,7.81310353974503e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40054,-0.111907807193142,0.00703115476567262,-0.12568887053386,-0.0981267438524234,1.36835814883665e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,40332,-0.0354885135214768,0.00223209950103093,-0.0398634285434974,-0.0311135984994562,1.75138116689795e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,37901,-0.165808618762055,0.0104314264477627,-0.186254214599669,-0.14536302292444,2.23243444757533e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40403,0.0563492556504576,0.0035485421450334,0.0493941130461922,0.0633043982547231,2.37252987457333e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,40536,-0.0643057726165659,0.00406548757280376,-0.0722741282592612,-0.0563374169738705,6.22290496071379e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40305,-0.100717233397295,0.00637303716294784,-0.113208386236673,-0.0882260805579172,7.833493121326e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,39963,-0.0885832340769479,0.00561235303524174,-0.0995834460260217,-0.0775830221278741,1.09396496148934e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40411,0.0361327018692613,0.00229900918744013,0.0316266438618786,0.040638759876644,3.0191889130933e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,40516,-0.038942224831948,0.00247881344033715,-0.0438006991750088,-0.0340837504888872,3.32539942357953e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,40372,-0.0501002236453559,0.00319409417691473,-0.0563606482321088,-0.043839799058603,4.92499765754692e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,40309,-0.0792407854372316,0.0050522598998661,-0.0891432148409691,-0.069338356033494,5.02395124186034e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40141,-0.218715843309715,0.0139828393578545,-0.24612220845111,-0.19130947816832,9.79888968220764e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39980,-0.0904938363464953,0.00581397854869691,-0.101889234301941,-0.0790984383910493,3.2382229519677e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37942,0.0539960540326336,0.00346978815444688,0.0471952692499177,0.0607968388153495,3.90945103539871e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,40345,-0.0454617535755034,0.00293702438844485,-0.0512183213768553,-0.0397051857741515,1.18737160562366e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,40305,-0.0808747375370656,0.0052249477138857,-0.0911156350562816,-0.0706338400178496,1.19505665262161e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,37998,0.0552688803046739,0.00357012926958324,0.0482714269362908,0.062266333673057,1.3424515608247e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40516,-0.0544465804359754,0.00352513853160837,-0.0613558519579278,-0.047537308914023,1.96702086779695e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,40398,-0.0931604327995793,0.00605137798151742,-0.105021133643353,-0.0812997319558052,4.26615920959168e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40305,-0.0446940013457146,0.00290608654752814,-0.0503899309788698,-0.0389980717125595,5.42643472786116e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,40330,-0.0419779531929252,0.00273119978882145,-0.0473311047790152,-0.0366248016068351,6.27693134909552e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,39980,-0.109712635396169,0.0071397075900951,-0.123706462272755,-0.0957188085195822,6.72422284665614e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,40376,-0.0432514024439847,0.00282926316421161,-0.0487967582458395,-0.03770604664213,2.19269215762208e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40379,0.0494963699026276,0.00324524442250547,0.0431356908345169,0.0558570489707383,3.73156930798955e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40305,-0.110728210139419,0.00727587918234818,-0.124988933336821,-0.0964674869420163,6.20252802738453e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,40228,0.0481712444219194,0.00316993095885686,0.0419581797425599,0.0543843091012788,8.70232269565252e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,40367,0.0531288710800943,0.00349874734134739,0.0462713262910534,0.0599864158691351,1.02229515147335e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40261,0.0883008683642336,0.00582327160341221,0.0768872560215456,0.0997144807069215,1.42336883477682e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40305,-0.150046746989752,0.00990130149082133,-0.169453297911761,-0.130640196067742,1.63039065605332e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40536,0.0450377611588666,0.00298728377578558,0.0391826849583269,0.0508928373594064,5.15940567674479e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40489,-0.0468655917213531,0.00311144161773428,-0.0529640172921123,-0.0407671661505939,6.38760489989429e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,37901,-0.0970252818594864,0.00645774744753706,-0.109682466856659,-0.0843680968623138,1.30302555745273e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40489,-0.0523887793385097,0.00349323350099188,-0.0592355170004538,-0.0455420416765656,1.68405660822714e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,37819,-0.0383083406845829,0.00255922611470563,-0.0433244238694059,-0.0332922574997599,3.00018527487481e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40443,-0.0434898293988263,0.00291465737826809,-0.0492025578602318,-0.0377771009374209,5.21573455177685e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40044,-0.0618445813317778,0.00414735363389692,-0.0699733944542158,-0.0537157682093398,6.09890535132328e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,40305,-0.0695823380818152,0.00468548260011358,-0.0787658839780378,-0.0603987921855926,1.48396329269842e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,40341,0.0477975310829379,0.00321984035925139,0.0414866439788052,0.0541084181870706,1.61653127210882e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40042,-0.0762166517091453,0.00514873632405176,-0.0863081749042867,-0.0661251285140038,3.02593662730454e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40516,0.0361839196037957,0.00244739849237407,0.0313870185587425,0.0409808206488489,3.87110656779831e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37920,-0.115331623515759,0.0078499433051122,-0.130717512393779,-0.0999457346377391,1.71977447575676e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40305,0.0329341706949999,0.00224814214409361,0.0285278120925764,0.0373405292974234,2.80611416281193e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,40465,-0.0365043946748481,0.00249752048437654,-0.0413995348242261,-0.0316092545254701,4.51301965327653e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,40359,-0.0985785010135472,0.00674539739090523,-0.111799479899721,-0.0853575221273729,4.67216803545177e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,37990,-0.0389812400496028,0.00266944933412411,-0.044213360744486,-0.0337491193547195,6.24266097133651e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,40382,0.0536312658778106,0.00367749837958224,0.0464233690538294,0.0608391627017918,7.26374554143211e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,40536,-0.0611880010385742,0.0042088874573168,-0.0694374204549151,-0.0529385816222333,1.39810430997547e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40305,0.0568680818439105,0.00396899673786815,0.0490888482376889,0.0646473154501321,2.84223757942735e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,40471,0.0502790801682688,0.00352318804189692,0.0433736316061509,0.0571845287303868,6.35260758700286e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,40434,-0.0641804549328243,0.00449794093258111,-0.0729964191606833,-0.0553644907049653,6.54964088072327e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40471,-0.0700541690160636,0.00492577417431782,-0.0797086863977265,-0.0603996516344007,1.26894282288292e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37628,-0.0767884523556135,0.00540696213848638,-0.0873860981470468,-0.0661908065641802,1.93230767394146e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40391,-0.0309361863164923,0.00219019031292981,-0.0352289593298348,-0.0266434133031499,4.98702741995573e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,40536,-0.0749181950774355,0.0053294157916161,-0.0853638500290031,-0.064472540125868,1.27312191792589e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39980,-0.106353514459893,0.00759336098512475,-0.121236501990737,-0.091470526929048,2.66023696924477e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40411,0.0561633774878406,0.00401827110148342,0.0482875661289331,0.0640391888467481,3.92079036649489e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,40333,0.0289784715280166,0.00207364424121466,0.0249141288152359,0.0330428142407974,4.06210380191617e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,40422,-0.0539898937664865,0.00387502806112636,-0.0615849487662942,-0.0463948387666788,7.23342190071784e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37998,-0.0405579374589839,0.00291769627396773,-0.0462766221559607,-0.0348392527620072,1.25063417336962e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,37871,-0.0335510107971828,0.00241558396538105,-0.0382855553693297,-0.0288164662250359,1.47007083295618e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40471,-0.0455848415575393,0.00328468325241199,-0.0520228207322669,-0.0391468623828118,1.53839062785006e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,37928,0.0250381660145074,0.00180381680133602,0.0215026850838888,0.028573646945126,1.65312503723716e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37990,-0.0949015029939301,0.00685896796852757,-0.108345080212244,-0.0814579257756161,3.0382571707507e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40379,-0.0386446738243621,0.00281477502587014,-0.0441616328750675,-0.0331277147736566,1.18700162891797e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,40305,-0.105521700591844,0.00769498895117817,-0.120603878936153,-0.0904395222475345,1.48378937225691e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40305,-0.113484280217423,0.00830328031549554,-0.129758709635794,-0.0972098507990516,2.76033742498403e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,40305,-0.046535777762672,0.00341872466879255,-0.0532364781135054,-0.0398350774118386,5.84658228029724e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40422,-0.0366201777623117,0.00269500946047485,-0.0419023963048424,-0.031337959219781,8.04245235512863e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,37628,-0.0698779330677846,0.00514798637578752,-0.0799679863643282,-0.0597878797712411,1.09118218599397e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40228,-0.0704114324017949,0.00519869229366097,-0.0806008692973704,-0.0602219955062193,1.46658037932493e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,40456,-0.0751121247923874,0.00555259986444082,-0.0859952205266914,-0.0642290290580834,1.82191359763197e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39839,-0.129566645374322,0.00959564106618775,-0.14837410186405,-0.110759188884594,2.59286730121826e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38484,0.0400626343973992,0.00297087358472891,0.0342397221713306,0.0458855466234679,3.45315572750433e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40309,-0.049607640870564,0.00368992191793122,-0.0568398878297091,-0.0423753939114188,5.59147250391621e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40305,0.0336463661139313,0.00250269443854242,0.0287410850143882,0.0385516472134745,5.59465015546393e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,40359,0.06613130071808,0.0049238882239315,0.0564804797991743,0.0757821216369858,6.67528189008036e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40411,-0.0269238104664989,0.00202130163243185,-0.0308855616660653,-0.0229620592669325,2.90408104280679e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,40489,-0.0568773948545551,0.00427289462377636,-0.0652522683171567,-0.0485025213919534,3.25639953428925e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,37981,-0.0344886463763825,0.0025898875206039,-0.0395648259167662,-0.0294124668359989,3.31651874098904e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,40360,0.0478042937337904,0.00361555154273743,0.040717812710025,0.0548907747575557,1.06294807238634e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40042,-0.114835006250423,0.0086887224680851,-0.13186490228787,-0.0978051102129761,1.15076713653401e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40228,-0.0467519551761059,0.00354986112546051,-0.0537096829820085,-0.0397942273702033,2.10567031265991e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40312,-0.0252533397542591,0.0019244736087294,-0.0290253080273687,-0.0214813714811495,3.9284653227409e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,40332,0.0364471987120133,0.00277950201889504,0.030999374754979,0.0418950226690476,4.43598219590365e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,40332,0.0360508817137497,0.00274944354672705,0.0306619723621647,0.0414397910653347,4.48178290910689e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,40469,-0.0763617916299777,0.00583448068198389,-0.0877973737666662,-0.0649262094932893,6.10747100248917e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,40516,-0.0402490147662622,0.00307959397247876,-0.0462850189523206,-0.0342130105802039,7.75320009815904e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,40341,0.0526988796644478,0.00404206104660466,0.0447764400131027,0.060621319315793,1.18016840541682e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40471,-0.0803751972626855,0.00619791419888612,-0.0925231090925023,-0.0682272854328687,2.89141273008292e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40332,-0.0354574459065711,0.00273692212606986,-0.040821813273668,-0.0300930785394742,3.42719414275245e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40341,-0.0750165537205369,0.00579449575388861,-0.0863737653981586,-0.0636593420429152,3.85040403151003e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,40341,-0.0525249320546435,0.00407810865231584,-0.0605180250131826,-0.0445318390961045,9.04593378675429e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,40042,0.0288153564423369,0.002238823458342,0.0244272624639865,0.0332034504206872,1.02323798201064e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40332,0.0494684464459577,0.00384395084484505,0.0419343027900614,0.057002590101854,1.03597411418937e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,40536,-0.0607727408248801,0.00473223533094114,-0.0700479220735247,-0.0514975595762354,1.453429722901e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37628,0.0773080648013123,0.00602035393808949,0.0655081710826569,0.0891079585199677,1.61920442948884e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,40330,-0.0360302220520077,0.00281024654756741,-0.0415383052852398,-0.0305221388187756,1.91780472959735e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,40341,0.0579397289153685,0.0045223656462187,0.0490758922487799,0.0668035655819571,2.15606859254193e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,40359,-0.0773001915930617,0.00605006534808315,-0.0891583196753046,-0.0654420635108187,3.3688012488978e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,37942,-0.157210931894438,0.012315624564409,-0.18134955604068,-0.133072307748196,4.20619589778609e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40341,-0.0455156096300298,0.00357072452123077,-0.0525142296916421,-0.0385169895684175,4.92656889570397e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37942,-0.103796129605066,0.00815791585143113,-0.119785644673871,-0.0878066145362612,7.14277749961224e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40280,-0.0308267363909881,0.00242423481056068,-0.0355782366196871,-0.0260752361622892,7.29325456611081e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40341,-0.0635488110165364,0.00502574905594505,-0.0733992791661887,-0.0536983428668841,1.79480831973093e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,40470,-0.0399497048468904,0.00315969066951334,-0.0461426985591366,-0.0337567111346443,1.81386366002319e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40357,0.0457989532930817,0.00362241145673628,0.0386990268378786,0.0528988797482848,1.82651435876774e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,40228,0.0301391866698697,0.00238378238121302,0.0254669732026922,0.0348114001370473,1.82772025600705e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40536,0.0290047867992533,0.00229476884294822,0.0245070398670748,0.0335025337314318,1.90506444176948e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37562,-0.0811588921325601,0.00643632844591491,-0.0937740958865533,-0.0685436883785669,3.03770903376196e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40341,-0.0328940883503966,0.00261712938353084,-0.0380236619421171,-0.0277645147586762,4.65472721512156e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,40516,-0.032323294638996,0.00257817239512529,-0.0373765125334416,-0.0272700767445505,6.87127844845578e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40192,-0.0869412027165776,0.00693880338180257,-0.100541257344911,-0.0733411480882445,7.61332932936885e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,37959,-0.0515465235085107,0.00412629677749339,-0.0596340651923977,-0.0434589818246236,1.29535144821703e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,37598,-0.0529584251909776,0.00424488066701512,-0.0612783912983273,-0.044638459083628,1.60692937348552e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,40341,-0.0564890657042111,0.00453742099507258,-0.0653824108545533,-0.0475957205538688,2.05604016029207e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,37671,0.0338891878100792,0.0027231081949033,0.0285518957480687,0.0392264798720897,2.34775635775336e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,40268,-0.085367005724668,0.00686628508028769,-0.0988249244820318,-0.0719090869673041,2.53720365461938e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,37901,-0.110587206333368,0.00889175039913606,-0.128015037115675,-0.0931593755510616,2.57158759801014e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40332,0.0618834674135826,0.00499014165393769,0.0521027897718647,0.0716641450553005,3.74739587338745e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40359,-0.0396829702725683,0.00320743848134658,-0.0459695496960076,-0.033396390849129,5.35590198482513e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,40203,-0.0345137280762861,0.0027905500853618,-0.0399832062435952,-0.029044249908977,5.65389352042538e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40502,-0.0442157992638694,0.00358613619215771,-0.0512446262004986,-0.0371869723272403,9.01150303383449e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40489,-0.040447246950967,0.00328162288071354,-0.0468792277971655,-0.0340152661047684,9.49977458111392e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,40359,-0.030144740198622,0.00244849615176597,-0.0349437926560833,-0.0253456877411607,1.12939556154555e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,37973,0.0857404114363509,0.00696821446050663,0.0720827110937579,0.0993981117789439,1.31191271915422e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40305,-0.069060916958478,0.0056211057201499,-0.0800782841699718,-0.0580435497469842,1.54645961977077e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37959,-0.0665556309210814,0.00542537941886663,-0.07718937458206,-0.0559218872601028,2.06457975546675e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,38013,-0.0232972317487408,0.00190364127873661,-0.0270283686550645,-0.019566094842417,2.9435804258531e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,37628,-0.0746660198398754,0.00610232718325888,-0.0866265811190628,-0.062705458560688,3.07454748105901e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37990,0.0381657349762091,0.0031268050265862,0.0320371971241001,0.0442942728283181,4.36190899714427e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40536,-0.0566664607145582,0.00464842705273412,-0.065777377737917,-0.0475555436911993,4.93783128903856e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,37671,0.0250684832130787,0.0020557213325371,0.021039269401306,0.0290976970248514,5.06486213352633e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37900,-0.0588879741647442,0.00483163657566564,-0.0683579818530488,-0.0494179664764395,5.44164593870352e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,40359,0.0409390819063641,0.00338493722113632,0.0343046049529369,0.0475735588597913,1.58489968272041e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,40332,0.0327073439015736,0.00271227582637643,0.0273912832818758,0.0380234045212714,2.43172284327623e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,40228,-0.0412083086316549,0.00342138595465498,-0.0479142251027787,-0.0345023921605312,2.90720141942176e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,37998,0.0456649477172603,0.00379021314990952,0.0382361299434376,0.053093765491083,2.93482586707414e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39980,-0.0409598861507332,0.0034064314904977,-0.0476364918721087,-0.0342832804293577,3.71818517328556e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,40305,-0.0781210375073835,0.00650104363449192,-0.0908630830309876,-0.0653789919837793,4.04440124947824e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,40489,-0.0306282901837982,0.00254898508563071,-0.0356243009516343,-0.025632279415962,4.0687208684748e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,40359,-0.0676320122253881,0.0056314945420353,-0.0786697415277773,-0.0565942829229989,4.39816848273646e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,40403,-0.05697923186801,0.00475887644946422,-0.0663066297089599,-0.0476518340270602,6.78855940850477e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40359,-0.0475786185374191,0.00398482339674341,-0.0553888723950361,-0.039768364679802,1.0108933625318e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37671,-0.0549641996350721,0.0046024675394084,-0.0639850360123126,-0.0459433632578316,1.04872293189884e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40332,-0.0308102628587282,0.00258834416342516,-0.0358834174190415,-0.0257371082984149,1.56136478733763e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,40216,-0.0424963398328802,0.00357005553999814,-0.0494936486912765,-0.0354990309744838,1.56339226244141e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40332,-0.0488632620632647,0.00410609746731063,-0.0569112130991936,-0.0408153110273359,1.62365970361468e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,40516,-0.0873599833636412,0.00735657256721915,-0.101778865595391,-0.0729411011318916,2.17850563001763e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40359,-0.0397101302973336,0.00334538382645819,-0.0462670825971916,-0.0331531779974756,2.31764899327491e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,40414,-0.0666673917886956,0.00562072281119801,-0.0776840084986437,-0.0556507750787475,2.57945659726911e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,40536,-0.0639406678304023,0.00542233223587277,-0.0745684390127129,-0.0533128966480917,5.80531094823326e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,40341,-0.0445783656334382,0.00378294197359685,-0.051992931901688,-0.0371637993651884,6.40585205104164e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40355,0.0405752613236352,0.00344346463865311,0.0338260706318751,0.0473244520153953,6.46320872250547e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,40350,-0.0356314936313137,0.00304606220892241,-0.0416017755608016,-0.0296612117018257,1.76536650910245e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,40471,-0.0700485289872422,0.00599786434336622,-0.08180434310024,-0.0582927148742444,2.18977901414044e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,40411,-0.0450259975699042,0.00385550943520636,-0.0525827960629086,-0.0374691990768997,2.20653136469387e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37835,-0.0364490957592504,0.00312042096507549,-0.0425651208507984,-0.0303330706677024,2.26780941205021e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,40516,-0.0388560603925029,0.00333423287443377,-0.0453911568263931,-0.0323209639586127,2.93605443475154e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,40447,-0.0409359333307754,0.003512941774474,-0.0478212992087445,-0.0340505674528064,2.96653449648083e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40310,-0.0750769308187591,0.00644432327494183,-0.0877078044376451,-0.0624460571998731,3.07262690738251e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,40341,-0.0583012717801357,0.00502493716385033,-0.0681501486212823,-0.048452394938989,5.34339150767315e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40536,-0.0741649636963248,0.00639823011055335,-0.0867054947130093,-0.0616244326796402,6.04209305624788e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,40471,0.0255579783375056,0.0022052727400171,0.0212356437670721,0.0298803129079391,6.19033831460412e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40044,0.0422748777297972,0.00365776184690735,0.0351056645098588,0.0494440909497356,9.02083410482871e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40305,-0.0478911370019933,0.00415564334134347,-0.0560361979510265,-0.0397460760529601,1.31682375970422e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,40490,-0.0534946156763255,0.00464251097527237,-0.0625939371878594,-0.0443952941647917,1.33676824926733e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37815,-0.0337755557400631,0.00293459867871789,-0.0395273691503502,-0.0280237423297761,1.64665983526574e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,37917,-0.0321769834807639,0.00279900279831074,-0.037663028965453,-0.0266909379960749,1.91901275596305e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,40483,0.0362499414450447,0.00315651773209614,0.0300631666901363,0.0424367161999532,2.08400006722518e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,40411,0.0448815677010634,0.00390826285661403,0.0372213725020999,0.0525417629000268,2.09596832242083e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40341,0.037294910613366,0.00326001515614204,0.0309052809073276,0.0436845403194044,3.46001050613522e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40341,-0.0671413087052186,0.0058718958075112,-0.0786502244879406,-0.0556323929224967,3.69520244792477e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,40228,-0.0442005578042539,0.00386643963734058,-0.0517787794934414,-0.0366223361150663,3.80960639669713e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,40372,-0.0304404677608433,0.00266378580398819,-0.0356614879366602,-0.0252194475850265,3.99289032108643e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,40332,-0.0376968694525162,0.00330932801829368,-0.0441831523683718,-0.0312105865366606,6.05284275968224e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,40332,0.0273055607835388,0.00241458660594725,0.0225729710358821,0.0320381505311954,1.54337277049398e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,40332,0.0260417931434812,0.0023037710079247,0.0215264019679488,0.0305571843190137,1.6257572563391e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40490,-0.0224365628781762,0.00198680664114656,-0.0263307038948234,-0.0185424218615289,1.84050483645993e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,40489,-0.138845802580403,0.0123404726900992,-0.163033129052997,-0.114658476107809,2.93881433516995e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37990,-0.0695405319635811,0.00617866107711581,-0.081650707674728,-0.0574303562524341,2.95287200363938e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,40192,-0.058649982122024,0.00521350059041201,-0.0688684432792315,-0.0484315209648164,3.00703750145107e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37598,0.0343782872912823,0.00305570452306457,0.0283891064260757,0.0403674681564888,3.13094765810341e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40332,0.0458620548625125,0.00408302140552174,0.0378593329076899,0.0538647768173351,3.64232299611583e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,40346,0.029421886044099,0.00262104849655101,0.024284630990859,0.034559141097339,3.9457363870788e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,37987,-0.0274734123366422,0.0024610985286623,-0.0322971654528203,-0.0226496592204641,8.25883461712271e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40403,0.0469282724811852,0.00420702424553262,0.0386825049599412,0.0551740400024291,8.67600122269585e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,39757,-0.0986054154842048,0.00884203990534957,-0.11593581369869,-0.0812750172697196,9.04957940619618e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,40228,-0.09378919909993,0.00844419681545954,-0.110339824858231,-0.0772385733416293,1.48111927213501e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37663,-0.0479168670766878,0.00431433931461256,-0.0563729721333284,-0.0394607620200472,1.56145515805294e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40422,-0.0284949307599735,0.00256756665325748,-0.0335273614003581,-0.0234625001195888,1.63039209244447e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,40411,-0.0269517198422085,0.00243784787538258,-0.0317299016779584,-0.0221735380064587,2.61120361626177e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40228,-0.0602762492346682,0.00545458416682886,-0.0709672342016527,-0.0495852642676836,2.76627324928604e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,40152,-0.0388024496705254,0.00351242320137445,-0.0456867991452193,-0.0319181001958315,2.87439255265029e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,38013,-0.0228726610703056,0.00207055131309612,-0.026930941643974,-0.0188143804966372,3.00268740647724e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,40341,-0.0818548981854695,0.00742422337964691,-0.0964063760095775,-0.0673034203613616,3.64704947638097e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37998,0.027001155292708,0.00245265524966169,0.0221939510033711,0.0318083595820449,4.55051970436267e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,38013,-0.0182827833700438,0.00166213226875522,-0.021540562616804,-0.0150250041232835,5.04186522952528e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40357,-0.0965245830668903,0.00881837534038403,-0.113808598734043,-0.0792405673997376,8.74007276329234e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40411,0.0292818601619425,0.00268367733530852,0.0240218525847378,0.0345418677391472,1.27713936941833e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37901,-0.0596743476888185,0.00547051707911945,-0.0703965611638926,-0.0489521342137444,1.37186790254997e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,40516,-0.0559577773479289,0.00514433490563188,-0.0660406737629674,-0.0458748809328904,1.83842473102136e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,40516,0.00892097275369866,0.000820186587637197,0.00731340704192975,0.0105285384654676,1.85437070413208e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,40305,-0.0808392615274307,0.00743723814276743,-0.0954162482872549,-0.0662622747676065,2.01209669506348e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,40489,0.0472869464686675,0.00435506667071689,0.0387510157940624,0.0558228771432726,2.2770939252978e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,40228,-0.0531401095012533,0.00489539105538018,-0.0627350759697984,-0.0435451430327081,2.35554249794008e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,40044,-0.0490210735402819,0.00451832883468925,-0.0578769980562728,-0.0401651490242909,2.51387517377657e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40411,-0.0935895190327402,0.00863294890671176,-0.110510098889895,-0.0766689391755852,2.74017683089704e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,39806,-0.0412399682946779,0.00380548301477885,-0.0486987150036444,-0.0337812215857113,2.88575884728698e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,37628,-0.0625891892392096,0.00578130701417551,-0.0739205509869936,-0.0512578274914256,3.36910038863845e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,40042,-0.055041595109572,0.00508928037637164,-0.0650165846472604,-0.0450666055718836,3.6415588702806e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40408,0.0248371773812174,0.00229736498255705,0.0203343420154056,0.0293400127470292,3.78524748109312e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37998,0.0337738990045521,0.00312460607594396,0.027649671095702,0.0398981269134023,4.02552432381664e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,39961,-0.0529254421025028,0.00490840672147842,-0.0625459192766005,-0.0433049649284051,5.18529974435491e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,40422,-0.0338273565257893,0.00314604664990541,-0.0399936079596038,-0.0276611050919747,7.14102743977542e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37562,-0.057315619142896,0.00532998157429053,-0.0677623830285054,-0.0468688552572865,7.38896787154796e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,40311,-0.0928971138393584,0.00864883884684507,-0.109848837979175,-0.0759453896995421,8.08010828177401e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,40422,-0.0431728412443309,0.00403322113311096,-0.0510779546652284,-0.0352677278234334,1.19630145064127e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37942,-0.047236397485114,0.00441447827792888,-0.0558887749098546,-0.0385840200603734,1.29667190671305e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37628,-0.0707970641703735,0.00664520782782141,-0.0838216715129035,-0.0577724568278436,2.14236630462548e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,40489,0.0345242891445019,0.003244773675419,0.0281645327406807,0.0408840455483232,2.37751012771179e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40471,-0.096940466583834,0.00911610173396787,-0.114808025982411,-0.079072907185257,2.53464501441673e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,40370,0.0285435687498272,0.00268712652221477,0.0232768007662862,0.0338103367333682,2.87277115315041e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40434,-0.0727027437428503,0.00684961655083802,-0.0861279921824928,-0.0592774953032078,3.13222127464063e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40471,0.0454642060211683,0.00428626914743923,0.0370631184921874,0.0538652935501492,3.37947053820927e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40305,-0.0976166056668938,0.00921535254913568,-0.1156786966632,-0.0795545146705879,3.93415922964849e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39961,-0.0268598158969697,0.00253708058539859,-0.0318324938443509,-0.0218871379495885,4.20794889775923e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37598,-0.0792230136809705,0.00748076004696046,-0.093885303373013,-0.064560723988928,4.21351288748498e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40357,-0.0281345079721042,0.00266145726380884,-0.0333509642091695,-0.0229180517350389,4.95011286071383e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,40341,-0.0616076172158971,0.00583263424467163,-0.0730395803354535,-0.0501756540963407,5.41836858108024e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,37998,-0.112038969560542,0.0106240006594829,-0.132862010853128,-0.0912159282679554,6.69033622771215e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40341,-0.065154768866921,0.00619716691052074,-0.0773012160115416,-0.0530083217223003,9.08310476166595e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37900,-0.0674489997337238,0.00642597039511574,-0.0800439017081506,-0.0548540977592969,1.12875852425443e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,40341,-0.0721658362657667,0.00687889553232257,-0.0856484715091189,-0.0586832010224144,1.15378652627658e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,40293,-0.0310763257819186,0.00296837687917743,-0.0368943444651063,-0.0252583070987308,1.45103454012381e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,40516,-0.0440787914772012,0.00422567935042196,-0.0523611230040282,-0.0357964599503741,2.15362817416933e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,37598,0.0299792654427497,0.00287547323438435,0.0243433379033564,0.035615192982143,2.37237803357533e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,40516,-0.0745022586139585,0.00715888578828219,-0.0885336747589916,-0.0604708424689254,2.77311888623379e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,37598,-0.0821446622905699,0.00789423987793065,-0.097617372451314,-0.0666719521298258,2.92867685940893e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40167,-0.0277310885543986,0.00266851650268275,-0.0329613808996568,-0.0225007962091404,3.25612213032974e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39886,-0.0540507766416428,0.00520907292897882,-0.0642605595824413,-0.0438409937008443,3.84605069413702e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,40359,0.0301307454790026,0.00290888503954032,0.0244293308015035,0.0358321601565016,4.61582432890529e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40305,-0.0667352797044137,0.00644295641694978,-0.0793634742816353,-0.0541070851271922,4.63362041387544e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,40332,0.038743161868364,0.00374126555698011,0.031410281376683,0.046076042360045,4.74096450318174e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,37671,-0.0445361983938814,0.00430122851958686,-0.0529666062922716,-0.0361057904954912,4.98690285312029e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,40374,-0.0459129826009644,0.00443641162633519,-0.0546083493885814,-0.0372176158133474,5.06955884428883e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40341,-0.053682338528687,0.00519483329535677,-0.0638642117875863,-0.0435004652697877,5.94511171786957e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37598,-0.119032358045973,0.0115161422958694,-0.141603996945877,-0.0964607191460688,6.02643142326913e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37900,-0.0562399299233106,0.00545768938150379,-0.066937001111058,-0.0455428587355632,8.29701439151651e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,37598,-0.045364922507427,0.0044036173175487,-0.0539960124498224,-0.0367338325650315,8.59711290985615e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,37628,-0.0317151884881976,0.00308311188210889,-0.0377580877771311,-0.0256722891992642,1.00289843136232e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37628,-0.0822811267281748,0.00800608031770291,-0.0979730441508725,-0.0665892093054771,1.10498699127153e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37987,0.0252863357570097,0.00246092286186062,0.0204629269477628,0.0301097445662565,1.12374929503009e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40255,-0.0435726796354943,0.00424592445223344,-0.0518946915618719,-0.0352506677091168,1.24575403073499e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40234,-0.0287610741767595,0.0028067014856449,-0.0342622090886235,-0.0232599392648955,1.45308606180222e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,40489,-0.0637600886614414,0.00622567346742458,-0.0759624086575935,-0.0515577686652892,1.53813360230074e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40357,-0.0373196007798543,0.00364472180101009,-0.0444632555098341,-0.0301759460498746,1.57426970519751e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39980,-0.0653574997555485,0.00638292753519959,-0.0778680377245397,-0.0528469617865573,1.57984044301994e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40228,-0.0717837795565703,0.00701309060460905,-0.0855294371416041,-0.0580381219715366,1.63706151099344e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37901,-0.0261402507113685,0.00255422773806626,-0.0311465370779784,-0.0211339643447587,1.71498297913751e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37942,-0.0375158510231697,0.00366687650860817,-0.0447029289800417,-0.0303287730662977,1.76925740419852e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,40471,-0.0356125036310431,0.00348247972931474,-0.0424381639005,-0.0287868433615862,1.79972209029829e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,40292,-0.0457551052147714,0.00449107033834882,-0.0545576030779351,-0.0369526073516077,2.66530914888546e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,40305,-0.0492958559883727,0.00483989127833996,-0.058782042893919,-0.0398096690828264,2.73932377125328e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40350,-0.0476824145529246,0.00468411811162951,-0.0568632860517184,-0.0385015430541307,2.90300075490834e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,40332,0.086417439885755,0.00849693696124974,0.0697634434417055,0.103071436329805,3.18839739082612e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40414,-0.0560801216782834,0.00551557386118353,-0.0668906464462031,-0.0452695969103636,3.27881899058555e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,40330,0.168709659212931,0.0166042729463779,0.136165284238031,0.201254034187832,3.5237096737814e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,40332,-0.0429039934748832,0.00422328932599294,-0.0511816405538294,-0.0346263463959371,3.58566161864294e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,40403,0.0293378327021298,0.00288917377251076,0.0236750521080087,0.0350006132962509,3.75112605238263e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,37301,-0.0223542140235399,0.00220102319696683,-0.0266682194895949,-0.0180402085574849,3.83260780607302e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,40341,0.0250385278096103,0.00246799604906244,0.0202012555534479,0.0298758000657727,4.11859927014955e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,37901,-0.100920017627606,0.00995459560804284,-0.12043102501937,-0.0814090102358418,4.57111836441342e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,40432,-0.0663123359042063,0.00654696955897466,-0.0791443962397967,-0.053480275568616,4.87024918836705e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40379,-0.0318048476549766,0.003142395798982,-0.0379639434209813,-0.0256457518889719,5.25847922988229e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,37959,-0.0516700823841335,0.0051053215538059,-0.0616765126295931,-0.041663652138674,5.43859509556789e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,37671,0.0517218756976076,0.00511083412818745,0.0417046408063602,0.061739110588855,5.50536279366511e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,40471,0.0288232336493811,0.00285052807234995,0.0232361986275752,0.034410268671187,5.79504737030479e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,40359,-0.0611563682612225,0.00605639311018754,-0.0730268987571901,-0.049285837765255,6.66758113533706e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39980,-0.10389896638343,0.0102984839275948,-0.124083994881516,-0.0837139378853443,7.33737319350092e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39980,-0.0601648697091874,0.00596853216857042,-0.0718631927595855,-0.0484665466587894,7.98948263982106e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,40097,-0.0399785306713844,0.00396806615863983,-0.0477559403423185,-0.0322011210004503,8.41690383386564e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37998,0.0202214568661569,0.0020076307308956,0.0162865006336016,0.0241564130987123,8.88137340681716e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,40305,-0.0511365219398417,0.00507843349038742,-0.0610902515810011,-0.0411827922986824,8.89801568860332e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,40305,-0.108204374152529,0.0107634861055671,-0.12930080691944,-0.0871079413856172,1.05039991890858e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37598,-0.0802415605511159,0.00798193662379716,-0.0958861563337583,-0.0645969647684734,1.08638645577753e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,40192,-0.076339566216847,0.00760913675203729,-0.0912534742508401,-0.0614256581828539,1.29021737000525e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40359,-0.0826033173274681,0.00824175560983044,-0.0987571583227358,-0.0664494763322005,1.42549623784673e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,40417,-0.0634259091886441,0.00632848356918982,-0.0758297369842561,-0.051022081393032,1.42821219645678e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,40198,0.0322201511614282,0.00321620472172126,0.0259163899068545,0.0385239124160019,1.49351455658597e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39980,-0.0470703256231133,0.0047002320775592,-0.0562827804951294,-0.0378578707510973,1.55201738581719e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40333,-0.0580121590870714,0.00580239955785808,-0.0693848622204733,-0.0466394559536696,1.82517284031179e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40396,-0.0490540338254282,0.00491231365432322,-0.0586821685879017,-0.0394258990629547,2.05782110176033e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,37990,-0.0237511065054408,0.00237792255481208,-0.0284118347128725,-0.0190903782980091,2.06929876929417e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40357,0.032089431856858,0.0032151953740538,0.0257876489237125,0.0383912147900034,2.17259017880199e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37959,0.0252214139528934,0.00253164297308829,0.0202593937256404,0.0301834341801465,2.67700114083581e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40277,-0.0984727826214559,0.0098889980712028,-0.117855218841013,-0.0790903464018985,2.72985538610228e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40305,-0.0803965093319414,0.00809253529809963,-0.0962578785162167,-0.0645351401476661,3.4390009875265e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,37931,-0.102151803420822,0.0102928671613736,-0.122325823057114,-0.0819777837845295,3.90928267759915e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,40341,-0.0834000234332117,0.00841105473074226,-0.0998856907054665,-0.0669143561609568,4.1593498129793e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,37575,-0.0257407527312879,0.00259681470536028,-0.030830509553794,-0.0206509959087817,4.43042909885452e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,40411,-0.0296393421116465,0.00299393505092113,-0.0355074548114519,-0.0237712294118411,4.86044172580054e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,37990,-0.0745921877555474,0.00753548615403697,-0.0893617406174599,-0.059822634893635,5.04462694622076e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,40116,0.025806066536622,0.00260820402563343,0.0206939866463805,0.0309181464268635,5.15347690859223e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,38013,0.0259189940431738,0.00262074246800287,0.0207823388058881,0.0310556492804594,5.50571753381077e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,37990,-0.0521692180826132,0.00528232697903668,-0.0625225789615251,-0.0418158572037013,6.31218516903211e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40042,-0.0457516927142972,0.00464109487937469,-0.0548482386778716,-0.0366551467507228,7.38640903621008e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,37781,-0.0224225163775932,0.00227544741207788,-0.0268823933052659,-0.0179626394499206,7.87401818134628e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37987,-0.020768062610449,0.00210987129620667,-0.024903410351014,-0.0166327148698839,8.73913720486325e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,39960,-0.0367944243119904,0.00374056868058455,-0.0441259389259361,-0.0294629096980446,9.13088774709792e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,40516,0.0364433911744575,0.00370520780243301,0.0291811838816888,0.0437055984672261,9.16060295784549e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40305,-0.114006981453796,0.0115970536485923,-0.136737206605037,-0.0912767563025555,9.6465076111991e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40203,-0.0826817190417122,0.00842871789089191,-0.0992020061078603,-0.066161431975564,1.18958489572181e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,37967,-0.0525806850141307,0.00535902908946815,-0.0630843820294883,-0.0420769879987732,1.19449469187778e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,37998,-0.0230929502185699,0.00235742037006449,-0.0277134941438963,-0.0184724062932436,1.3940560822939e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37628,-0.0281884132893838,0.00287795742399194,-0.033829209840408,-0.0225476167383596,1.41832622834517e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40303,-0.0448213217057931,0.00458949754086976,-0.0538167368858978,-0.0358259065256883,1.82181600839277e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,40011,-0.0285650944169825,0.0029279009528563,-0.0343037802845808,-0.0228264085493842,2.01283170818931e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37562,-0.0686125819039349,0.00703139268814685,-0.0823941115727027,-0.0548310522351671,2.03151761653656e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40332,-0.0335132307132384,0.00344339944602114,-0.0402622936274398,-0.0267641677990369,2.52744266705014e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37563,-0.0454723399206955,0.00468937290666679,-0.0546635108177624,-0.0362811690236286,3.68917353864607e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37594,-0.0355002485098051,0.00366752822047346,-0.0426886038219331,-0.0283118931976772,4.36212622687034e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,40489,-0.0516133284390403,0.00534404482639868,-0.0620876562987817,-0.0411390005792989,5.21413169672585e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,40283,-0.0379591075933005,0.00393355229710609,-0.0456688700956284,-0.0302493450909726,5.64588398735295e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,37562,-0.0396550147480641,0.00411319319116706,-0.0477168734027516,-0.0315931560933767,6.34890700871205e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37598,-0.0394899770264856,0.00409827232886079,-0.0475225907910528,-0.0314573632619185,6.67136977143902e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40359,0.0235695710422866,0.00244708828116498,0.0187732780112033,0.02836586407337,6.7430832074508e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40536,-0.0313505194091139,0.00325746659368391,-0.0377351539327344,-0.0249658848854935,7.23796821482948e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40159,0.0345241768215492,0.00359063015347336,0.0274865417207414,0.041561811922357,7.93120756744209e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40341,-0.0866402549978018,0.00902821200687811,-0.104335550531283,-0.0689449594643207,9.46323521642885e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40405,-0.0464642108434224,0.00484460164745262,-0.0559596300724296,-0.0369687916144153,9.99119010872911e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,37628,-0.0515814023023727,0.00538819341805652,-0.0621422614017634,-0.0410205432029819,1.22068580014869e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,37977,0.0304675392376917,0.0031851676133363,0.0242246107155526,0.0367104677598309,1.30767443391603e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39961,-0.0501437815620959,0.00525040898202556,-0.060434583166866,-0.0398529799573258,1.48017200654536e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40536,0.023514854879573,0.0024677310726586,0.0186781019771622,0.0283516077819839,1.81046743376812e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40422,-0.0378991404312145,0.00398152560275937,-0.0457029306126229,-0.0300953502498061,1.99779624370823e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,40379,-0.0438878343556493,0.00462021034960581,-0.0529434466408767,-0.0348322220704219,2.41138248141514e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39980,-0.0548175988040212,0.00577124914105066,-0.0661292471204805,-0.0435059504875619,2.43575795763477e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40536,-0.0352134559128226,0.00371196766387833,-0.0424889125340242,-0.0279379992916211,2.71686760236232e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,37681,0.0190217512666091,0.00200535845543611,0.0150912486939543,0.0229522538392639,2.81957485922607e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,40332,0.041216479303601,0.00435039322795692,0.0326897085768054,0.0497432500303966,3.05887908080154e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37628,0.018454796728667,0.00194794211560552,0.0146368301820802,0.0222727632752538,3.14664965454277e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40044,-0.0759818614454875,0.00804211358174668,-0.091744404065711,-0.060219318825264,3.93371065374792e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,40228,-0.0599964312907782,0.00635078428423621,-0.0724439684878811,-0.0475488940936752,3.96172817703598e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37860,-0.097034556062186,0.010273718454192,-0.117171044232402,-0.0768980678919697,4.13617866596799e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,37987,-0.0216796025990208,0.00229724030488054,-0.0261821935965866,-0.0171770116014549,4.44289870445889e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40044,-0.0624027771235763,0.00661414967692275,-0.0753665104903448,-0.0494390437568077,4.46114623382477e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40379,0.0214520856889667,0.00227628673830784,0.0169905636818833,0.02591360769605,4.91852024096866e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37671,-0.0743386525109868,0.00788825659078356,-0.0897996354289225,-0.058877669593051,5.05591142035166e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,38013,-0.0282840993242227,0.00301616908952956,-0.0341957907397007,-0.0223724079087448,7.8115819224914e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40154,-0.0312682326998118,0.00333572810485856,-0.0378062597853346,-0.024730205614289,7.93509084223775e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39980,-0.0731178839638891,0.00780744668946773,-0.0884204794752458,-0.0578152884525323,8.61584914115728e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39961,-0.0433231302562696,0.00464083226040552,-0.0524191614866644,-0.0342270990258748,1.14186040725113e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39865,-0.0335294251966187,0.00359170370829098,-0.040569164464869,-0.0264896859283684,1.14236470633156e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,40341,-0.0722690229925083,0.00774541005646097,-0.0874500267031718,-0.0570880192818448,1.18921461929562e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,40203,-0.0461431709551768,0.00494646375137261,-0.0558382399078671,-0.0364481020024865,1.21353164447426e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,40145,-0.0317978063819443,0.00341192195870018,-0.0384851734209967,-0.025110439342892,1.31974634383108e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40335,0.0156517568902724,0.00168044790727315,0.012358078992017,0.0189454347885278,1.38853984928078e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,40516,-0.0355904419195206,0.00382786331979897,-0.0430930540263265,-0.0280878298127146,1.61534694250538e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37628,-0.0638050099520387,0.00686603678762646,-0.0772624420557865,-0.0503475778482908,1.73508969888916e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40341,0.0464796489800118,0.0050098901773511,0.0366602642324036,0.0562990337276199,1.95251285421009e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37922,-0.0737007494994737,0.00794679321436126,-0.0892764641996218,-0.0581250347993257,2.05681289501235e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40305,-0.0398919536490316,0.00431448761086989,-0.0483483493663366,-0.0314355579317267,2.61998049586347e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,40341,-0.0805820075090144,0.00871794714949307,-0.0976691839220208,-0.063494831096008,2.68875782324659e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,37598,-0.0798913101174788,0.00866817927997874,-0.0968809415062372,-0.0629016787287205,3.52633886412831e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,38013,-0.0258926664121124,0.00281464693128999,-0.0314093743974408,-0.020375958426784,4.12344998819211e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,37990,-0.0375888734153474,0.00408990319857431,-0.0456050836845531,-0.0295726631461418,4.46596845990149e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40332,-0.0230567857711914,0.00251137206388865,-0.0279790750164132,-0.0181344965259696,4.78937782493596e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39980,-0.0608982545766178,0.00663500595188057,-0.0739028662423037,-0.0478936429109319,4.9195613558319e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,37810,0.0930490256798626,0.0101479934081142,0.0731589585999588,0.112939092759766,5.45320062769885e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37901,-0.0441803492427387,0.00483060161951956,-0.0536483284169971,-0.0347123700684804,6.7501790305624e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39980,-0.0457750339348242,0.00501081016470455,-0.0555962218576451,-0.0359538460120033,7.31601401272018e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,40228,0.0367377244211717,0.0040319783427703,0.0288350468693419,0.0446404019730015,9.0756790970569e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40341,-0.0467708109996863,0.0051350474469239,-0.0568355039956572,-0.0367061180037155,9.35844061315702e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39961,-0.0735319994662333,0.00807597335241509,-0.0893609072369669,-0.0577030916954997,9.65619350880287e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,37671,-0.0228215255360743,0.00250971878416811,-0.0277405743530438,-0.0179024767191048,1.09661140112628e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,37990,-0.078950599836768,0.00868667014405905,-0.0959764733191237,-0.0619247263544123,1.13969060197548e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37608,-0.0694441738450493,0.00764106948147072,-0.0844206700287319,-0.0544676776613667,1.14841361839515e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37900,-0.0332521871470322,0.00365898842649805,-0.0404238044629684,-0.0260805698310961,1.1500701656425e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37572,-0.102589842506314,0.01128910550028,-0.124716489286863,-0.0804631957257654,1.15694894074245e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,39956,0.1045399621681,0.0115328483211535,0.0819355794586391,0.127144344877561,1.39836248136622e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37562,-0.0546831867218611,0.00603205024458341,-0.0665060052012446,-0.0428603682424776,1.41524882673816e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,39980,-0.0530244768611082,0.0058817698772868,-0.0645527458205903,-0.041496207901626,2.19337923979734e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40516,-0.0377763637073446,0.00419219635355654,-0.0459930685603155,-0.0295596588543738,2.26502748165922e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,40341,-0.0802607461962915,0.00891101676557624,-0.0977263390568209,-0.062795153335762,2.35575416770358e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37990,-0.0508982939270326,0.00565855153964681,-0.0619890549447403,-0.0398075329093248,2.67412245049432e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40536,-0.0267234337412586,0.00297268965867462,-0.0325499054722609,-0.0208969620102563,2.75114696058561e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40341,-0.0902737259647995,0.0100509896889853,-0.109973665755211,-0.0705737861743884,2.96336585063861e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40471,-0.0697206811150975,0.00778067842157771,-0.0849708108213898,-0.0544705514088052,3.57395063915152e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,37900,-0.0377221610556737,0.00421469214731804,-0.045982957664417,-0.0294613644469303,4.00941153988121e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,39980,-0.0624518007571518,0.00698053349025288,-0.0761336463980475,-0.0487699551162562,4.0745512137206e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,37990,-0.0587574809582072,0.00656711478883768,-0.0716290259443291,-0.0458859359720854,4.11324314427908e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,40312,-0.0518834801318174,0.00580118603078902,-0.0632538047521639,-0.040513155511471,4.17573474090822e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,39961,-0.0508787826308419,0.00569219399198591,-0.0620354828551343,-0.0397220824065495,4.38826897980448e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,40471,-0.0493445400785759,0.00552779871038679,-0.060179025550934,-0.0385100546062178,4.86030789969492e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,40359,-0.0912467019726747,0.0102297036698163,-0.111296921165515,-0.0711964827798346,5.17200902310815e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37671,-0.0243806989488628,0.0027343908784098,-0.029740105070546,-0.0190212928271796,5.44614475901303e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40451,-0.0361751185977869,0.00406231376406446,-0.0441372535753532,-0.0282129836202205,5.89961122526017e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,40471,-0.0503139323915341,0.00565243702798581,-0.0613927089663863,-0.0392351558166819,6.10180983934763e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37959,-0.0439316697625956,0.00493744712039552,-0.0536090661185708,-0.0342542734066203,6.42160196861328e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,37628,0.0589246380228324,0.00664197792204844,0.0459063612956174,0.0719429147500473,8.13339600123312e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37990,-0.0648094293746749,0.00730858012082129,-0.0791342464114846,-0.0504846123378652,8.39981792771185e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,37671,-0.0426523495177132,0.00481231879538461,-0.0520844943566671,-0.0332202046787594,8.76237260436625e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39961,-0.0422742738134114,0.00477223840955317,-0.0516278610961356,-0.0329206865306872,8.98573973974949e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40305,0.0528859357394885,0.00598277152864397,0.0411597035433463,0.0646121679356307,1.05897438097493e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,40305,-0.0788446821303293,0.00893356644397165,-0.0963544723605137,-0.0613348919001448,1.19989138132643e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,40309,-0.0559788912108851,0.00635244041609707,-0.0684296744264353,-0.0435281079953348,1.35254947809144e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39980,-0.0535494204138105,0.00608495360691527,-0.0654759294833644,-0.0416229113442566,1.50607483768822e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,40411,-0.0686767177054206,0.00782397338161844,-0.0840117055333928,-0.0533417298774485,1.83449420802635e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37901,0.0243024095352459,0.00277671955663466,0.018860039204242,0.0297447798662499,2.33905804754568e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40332,-0.0285766013950823,0.0032667049659866,-0.0349793431284161,-0.0221738596617486,2.38985105730484e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37628,-0.0620929136577479,0.00710641546928645,-0.0760214879775494,-0.0481643393379465,2.66645041912269e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39887,-0.0152970594364911,0.00175238443655497,-0.0187317329321388,-0.0118623859408434,2.82169012268147e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,40341,-0.0271600577225544,0.00311367936565963,-0.0332628692792473,-0.0210572461658615,2.97862285784007e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37959,-0.0510657935818662,0.00585504989643697,-0.0625416913788826,-0.0395898957848497,3.05855795943088e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40291,-0.0240248680485094,0.00275673784481611,-0.0294280742243489,-0.0186216618726698,3.19244555015497e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,40305,0.0373028678160263,0.00428502267180257,0.0289042233792932,0.0457015122527593,3.47156055589434e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39961,-0.0651976919709115,0.00749117967632643,-0.0798804041365113,-0.0505149798053117,3.54480635609038e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,40042,-0.0489267586251475,0.00562871384678497,-0.059959037764846,-0.0378944794854489,3.89869600325357e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40332,-0.0435330775551433,0.00500833724019768,-0.0533494185459308,-0.0337167365643559,3.89989089052313e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,40536,-0.0461626803094494,0.00531125926268648,-0.056572748464315,-0.0357526121545839,3.9174816071684e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,37671,-0.0425976414590683,0.00490209699317785,-0.0522057515656969,-0.0329895313524397,4.05837630088977e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40396,0.0375515773874986,0.00433498005948421,0.0290550164709096,0.0460481383040877,5.0535983358127e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,40228,-0.0306341219337809,0.00354151681015704,-0.0375754948816887,-0.0236927489858731,5.63936240898379e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40341,-0.0696110543927686,0.00807657988206583,-0.0854411509616176,-0.0537809578239196,7.38976812423854e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40305,-0.0282602251392969,0.00327972168345716,-0.0346884796388729,-0.0218319706397209,7.53551240684278e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,40471,-0.0337679252354396,0.00392477833615757,-0.0414604907743084,-0.0260753596965707,8.41907160902003e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39961,-0.0499808126639099,0.00581000753836862,-0.0613684274391124,-0.0385931978887074,8.53462712568416e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,40305,-0.0627236359341295,0.00729574982206271,-0.0770233055853724,-0.0484239662828866,8.91507215226736e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40042,-0.0468678095346615,0.00545291268712174,-0.0575555184014201,-0.0361801006679029,9.10650287301191e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,37998,-0.0606366354796778,0.00705700379990665,-0.0744683629274948,-0.0468049080318607,9.44012785664993e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40422,0.0168079721008477,0.0019574879488415,0.0129712957211184,0.0206446484805771,9.78196516214863e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37628,0.0296622653367717,0.0034537150887889,0.0228929837627454,0.0364315469107979,9.79200508131352e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,40411,0.0223792797997974,0.00260683601226902,0.0172698812157502,0.0274886783838447,9.92394242463343e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,37987,-0.0590220334503288,0.00688074904746369,-0.0725083015833576,-0.0455357653173,1.07078412843349e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37900,-0.0647106677121245,0.00755398910530528,-0.0795164863585228,-0.0499048490657261,1.1826556309777e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,40403,-0.0814521130637035,0.00951693900547498,-0.100105313514434,-0.0627989126129726,1.24471002985672e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40280,-0.0614905524438661,0.00718679116637657,-0.0755766631299642,-0.047404441757768,1.27375352100272e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40305,-0.0617761476451111,0.00722719258605312,-0.0759414451137752,-0.047610850176447,1.36826293365306e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37942,-0.0617855908399563,0.00724041282966199,-0.0759767999860938,-0.0475943816938188,1.57099889397657e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40330,-0.0834124424260797,0.00978356993573395,-0.102588239500118,-0.0642366453520411,1.65301525101372e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,40359,-0.031451232443052,0.00369500524911275,-0.038693442731313,-0.024209022154791,1.86317114237049e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,40411,-0.0465643838954246,0.00547527765772493,-0.0572959281045655,-0.0358328396862838,1.98386735347275e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40341,-0.041369766726781,0.00486466356711715,-0.0509045073183306,-0.0318350261352313,1.99042647827779e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37900,-0.0582347903318718,0.00685476732437636,-0.0716701342876494,-0.0447994463760941,2.17593976427439e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,40305,-0.0266436071196473,0.00313747766189101,-0.0327930633369537,-0.0204941509023409,2.20824737228015e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40042,-0.0777829127159589,0.00916407878301984,-0.0957445071306778,-0.0598213183012401,2.29319095004888e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37900,-0.046172774418827,0.00544867633819687,-0.0568521800416928,-0.0354933687959611,2.61280760622791e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40411,0.0360002023140213,0.0042577905841026,0.0276549327691802,0.0443454718588623,3.02594653862714e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40305,-0.0258693090043428,0.00307001487923514,-0.0318865381676437,-0.019852079841042,3.86581058802548e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,37942,-0.0512536546563995,0.00608375935779712,-0.0631778229976818,-0.0393294863151171,3.98080793598879e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,40305,-0.0438996068744278,0.00521602650138007,-0.0541230188171328,-0.0336761949317229,4.21414377867233e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40536,-0.017243734763559,0.00205575159218794,-0.0212730078842474,-0.0132144616428707,5.348725650184e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40228,-0.0752926064199962,0.00898492603661763,-0.0929030614517668,-0.0576821513882257,5.74009783912206e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,40295,0.0506586563937844,0.00605353404790767,0.0387937296598853,0.0625235831276834,6.3206158288601e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,37900,-0.0779954596225248,0.00932133386741927,-0.0962652740026665,-0.059725645242383,6.46619473380758e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,37671,-0.0245212217889341,0.00293291279036017,-0.03026973085804,-0.0187727127198282,6.85368579026576e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,40536,0.0233894444350739,0.00279876415709616,0.0179038666871654,0.0288750221829824,6.94984974857667e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,40536,0.0232397804408705,0.00278347071867536,0.0177841778322668,0.0286953830494742,7.42562039297363e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,37748,-0.0224080396944188,0.00268817478982257,-0.027676862282471,-0.0171392171063665,8.44956648142608e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,39959,0.0370462474717004,0.00445249784487309,0.0283193516957491,0.0457731432476516,9.49537599507206e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37942,-0.0543809771748715,0.00654144094983273,-0.0672022014365437,-0.0415597529131994,1.01916904519339e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37671,-0.0462658954498853,0.00556849811848582,-0.0571801517621175,-0.0353516391376531,1.06296577470086e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,37934,-0.0662461287529003,0.007975271835911,-0.0818776615512859,-0.0506145959545147,1.07957107937904e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37901,-0.0812294735728292,0.00978770211693395,-0.10041336972202,-0.0620455774236386,1.14795372866368e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,40324,-0.0654756886924274,0.00789394648646265,-0.0809478238058942,-0.0500035535789606,1.17791812277602e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37900,-0.0374734062713188,0.00452330629273236,-0.0463390866050743,-0.0286077259375634,1.29732010462073e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40536,-0.0321969272017273,0.00389584249847664,-0.0398327784987415,-0.024561075904713,1.51203596009398e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39853,-0.0697323054592692,0.00843843388061473,-0.0862716358652741,-0.0531929750532644,1.52689441920028e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40228,-0.0353101680380977,0.00427542807955069,-0.043690007074017,-0.0269303290021783,1.58627146814814e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40332,-0.0408702970099296,0.00494893226061361,-0.0505702042407323,-0.031170389779127,1.5915080541009e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40044,-0.0540442568958828,0.00655326771187218,-0.0668886616111522,-0.0411998521806133,1.75386618380637e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,40411,-0.0313262150389837,0.00379866289614344,-0.0387715943154249,-0.0238808357625426,1.7548190674496e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,40305,-0.0801309912331161,0.00972622185927509,-0.0991943860772953,-0.0610675963889369,1.87639651005056e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,40341,-0.047437980294306,0.0057725920270067,-0.0587522606672391,-0.0361236999213728,2.23122884412115e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40422,-0.0213974369822175,0.00260422145181628,-0.0265017110277774,-0.0162931629366576,2.25557711222853e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,40358,-0.0449202007690408,0.00546916888578703,-0.0556397717851834,-0.0342006297528982,2.31488809499426e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,40263,-0.0662149807620995,0.0080673034526352,-0.0820268955292645,-0.0504030659949345,2.42459028275127e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,40403,-0.0449264980249371,0.00547784382254948,-0.0556630719171341,-0.0341899241327401,2.55349477540051e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,38013,-0.0160865426911178,0.00196350733644613,-0.0199350170705522,-0.0122380683116834,2.7801990646833e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,40489,-0.0221759098213203,0.00270914866942733,-0.0274858412133979,-0.0168659784292428,2.91225174539256e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40009,-0.0401842508973406,0.00491416212825592,-0.0498160086687222,-0.030552493125959,3.12672669328986e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,39980,-0.042677364860719,0.00521937702799623,-0.0529073438355916,-0.0324473858858464,3.14054507760231e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,40341,-0.0640112831934484,0.00783081425125708,-0.0793596791259123,-0.0486628872609845,3.19896979722478e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40516,-0.0774624436976212,0.00948641691442758,-0.0960558208498992,-0.0588690665453431,3.43347756047887e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37714,-0.0864342804043612,0.0106030585475074,-0.107216275157476,-0.0656522856512467,3.90449823309409e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39535,-0.0294628106524145,0.00361881388509915,-0.0365556858672089,-0.0223699354376202,4.20501302244839e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37562,-0.0286382556548084,0.00351769579637361,-0.0355329394157006,-0.0217435718939161,4.26534213719584e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,37714,-0.0995699518764733,0.0122320980262612,-0.123544864007945,-0.0755950397450013,4.30134622102968e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,40261,-0.0600147197522518,0.00737990376592541,-0.0744793311334656,-0.045550108371038,4.52674836101353e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40536,-0.0554909998586608,0.00682612667201758,-0.0688702081358153,-0.0421117915815063,4.63312563299517e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,37959,-0.0603876707720796,0.00743742629520984,-0.0749650263106909,-0.0458103152334683,5.08703819360176e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,40305,-0.0232125803201812,0.00285990692013029,-0.0288179978836365,-0.0176071627567258,5.14555682580823e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37900,-0.0878858781312723,0.0108306067896526,-0.109113867438991,-0.0666578888235532,5.2950884658387e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,37990,-0.0631133373882207,0.00778446991887475,-0.0783708984292152,-0.0478557763472262,5.60398191795137e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37901,-0.107209122683863,0.0132365405690491,-0.133152742199199,-0.0812655031685263,5.9919589696826e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,40341,-0.0699282541464504,0.00863621878852392,-0.0868552429719573,-0.0530012653209435,6.03394799966177e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40305,-0.0461343047801334,0.00569951043603825,-0.0573053452347684,-0.0349632643254984,6.16761229976149e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40305,0.0252305814435831,0.00311982041113391,0.0191157334377606,0.0313454294494056,6.54391180517106e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40411,-0.0203430917393357,0.00251749338814929,-0.0252773787801084,-0.0154088046985631,6.89751751424676e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,37987,-0.0186022380502766,0.00230541405767717,-0.0231208496033238,-0.0140836264972294,7.68527574105302e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,40516,-0.0718106866325858,0.00890553849907228,-0.0892655420907675,-0.0543558311744041,7.92638128297979e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,40341,-0.0407636393903146,0.005055248287753,-0.0506719260343105,-0.0308553527463187,7.93039114643898e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,37959,-0.0787274683374811,0.00978629449893093,-0.0979086055553857,-0.0595463311195765,9.36507870848036e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,39934,-0.0526646063394644,0.00655355750748035,-0.0655095790541259,-0.0398196336248029,9.94443567653767e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,40341,-0.0630400702802395,0.00784517642591736,-0.0784166160750375,-0.0476635244854415,9.96836398785756e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40332,0.0183948726325908,0.0022903632015537,0.0139057607575455,0.022883984507636,1.03061080493003e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40489,-0.0411329364750309,0.00512455960562634,-0.0511770733020585,-0.0310887996480033,1.07079503274012e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,40341,-0.0219654406322529,0.0027371217791953,-0.0273301993194756,-0.0166006819450301,1.08558570947877e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37942,-0.0674428946625864,0.00840844113968037,-0.0839234392963599,-0.0509623500288129,1.13623001524236e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,40341,-0.0509568867865569,0.00635475791135064,-0.0634122122928041,-0.0385015612803096,1.14263843946745e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,40192,0.0387023574138764,0.00482832860044092,0.0292388333570122,0.0481658814707406,1.17163651253675e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40359,0.0132983765659077,0.00166061242536283,0.0100435762121965,0.0165531769196188,1.24483511178284e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,40228,-0.0467985332790236,0.00584947989459701,-0.0582635138724337,-0.0353335526856134,1.32512243023455e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,40341,-0.064186067865398,0.00802666320218524,-0.0799183277416811,-0.0484538079891149,1.36642772431061e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,40516,-0.041377962103686,0.00517874264651482,-0.051528297690855,-0.0312276265165169,1.44077106791508e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,40309,-0.0261519276036155,0.00327645828047899,-0.0325737858333543,-0.0197300693738766,1.54065453997341e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,37990,-0.0353341236790689,0.00442670572295046,-0.0440104668960518,-0.026657780462086,1.55469547509246e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37901,-0.063042397407405,0.00790022813059558,-0.0785268445433724,-0.0475579502714377,1.5835328425795e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37598,-0.0367779936868799,0.00461332168486352,-0.0458201041892123,-0.0277358831845474,1.68779007523672e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37671,-0.031683025402093,0.00397962706773379,-0.0394830944548513,-0.0238829563493348,1.84063944179299e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40332,-0.0317989060541876,0.00399706230683667,-0.0396331481755875,-0.0239646639327877,1.90260246608452e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,37628,-0.0464541792022123,0.0058495131957833,-0.0579192250659476,-0.034989133338477,2.15788530672087e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,37598,-0.033388855686482,0.00420778347112903,-0.0416361112898949,-0.0251416000830691,2.27422718644547e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40192,-0.0839563783760081,0.0105973572280486,-0.104727198542983,-0.0631855582090329,2.48484578990371e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40305,-0.0410223378892027,0.00517846275200686,-0.0511721248831362,-0.0308725508952693,2.49702063737907e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,37900,-0.0154359095303754,0.00194861270344635,-0.0192551904291302,-0.0116166286316205,2.53037705091284e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40228,-0.0407986424855535,0.00515290733523336,-0.0508983408626109,-0.0306989441084961,2.58169699161823e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40502,-0.0285404218060571,0.00360478519573419,-0.0356058007896962,-0.0214750428224181,2.58354858896487e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40341,-0.0778408699223662,0.00983478217572791,-0.0971170429867929,-0.0585646968579395,2.63781355347331e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40422,-0.0643747142313313,0.00813620248912411,-0.0803216711100145,-0.048427757352648,2.69504707929943e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,40228,0.0256576124591167,0.00324898137726842,0.0192896089596706,0.0320256159585628,3.04100014398048e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37671,-0.0273905403360997,0.00347282833945475,-0.0341972838814311,-0.0205837967907684,3.33476443401841e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40335,-0.0336538957275353,0.00427019296692842,-0.042023473942715,-0.0252843175123556,3.45391395366077e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,37990,-0.0478974288485656,0.00609627743899951,-0.0598461326290046,-0.0359487250681265,4.23557036357447e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39939,-0.0431069902773206,0.00549148204956802,-0.0538702950944739,-0.0323436854601673,4.43872292596289e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,40359,-0.0316186860895042,0.00403164014043338,-0.0395207007647536,-0.0237166714142548,4.69038513333583e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,40471,-0.0448704437234375,0.00572910030483215,-0.0560994803209085,-0.0336414071259665,5.10008881292914e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,40516,-0.0307503540862764,0.00392943292669731,-0.0384520426226031,-0.0230486655499496,5.36342186385773e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,38013,0.0172607352008459,0.00220536965915435,0.0129382106689033,0.0215832597327884,5.37866899056959e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,37057,-0.0183157663325422,0.0023425099904254,-0.022907085913776,-0.0137244467513084,5.75277948846647e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40536,0.0215235871792565,0.00275379146797825,0.0161261559020192,0.0269210184564939,5.78931347070129e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40359,-0.0474829344120137,0.00608055509186007,-0.0594008223920594,-0.0355650464319679,6.12293877270844e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,37942,-0.0555657851268272,0.00711549423953068,-0.0695121538363074,-0.0416194164173471,6.18205064836884e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40332,-0.0169743288265997,0.00217551231853023,-0.021238332970919,-0.0127103246822805,6.44768048103815e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39980,-0.0347041640668648,0.00444948675946813,-0.0434251581154224,-0.0259831700183073,6.60404190184252e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,37848,-0.0687108728286109,0.00880833202702,-0.0859752036015701,-0.0514465420556517,6.61210102296659e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37628,-0.0572983648540192,0.00736865594356856,-0.0717409305034136,-0.0428557992046249,8.04223757707066e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,40489,-0.0285731856004939,0.00367688325806246,-0.0357798767862963,-0.0213664944146915,8.25438687140485e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,40288,-0.0220605295738469,0.00284266204820842,-0.0276321471883354,-0.0164889119593584,8.97238689714393e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,40352,-0.037310846850985,0.0048091121537296,-0.046736706672295,-0.0278849870296749,9.12324501329189e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,37671,-0.0517948984663021,0.00667541292479009,-0.0648787077988907,-0.0387110891337136,9.18228434019115e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,40536,0.0223983374321882,0.0028875353671234,0.0167387681126263,0.0280579067517501,9.22226501901372e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37942,-0.0295635443729897,0.0038141199537372,-0.0370392194823146,-0.0220878692636648,9.76142601992228e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37959,-0.070430808619344,0.00909194525578506,-0.0882510213206827,-0.0526105959180053,1.01168081837632e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,39991,-0.0365079381333148,0.00472554367517214,-0.0457700037366522,-0.0272458725299774,1.18047430951406e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,40332,-0.0389910280754293,0.00505188758383809,-0.0488927277397519,-0.0290893284111066,1.25064750761847e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,40044,-0.0373590768542741,0.00484180486073852,-0.0468490143813216,-0.0278691393272266,1.27338722475771e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,37671,-0.0457579865291194,0.0059321640867398,-0.0573850281391294,-0.0341309449191094,1.31114018416677e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37990,-0.0541896537478806,0.00703046601197124,-0.0679693671313442,-0.040409940364417,1.3686289902103e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,40536,0.0197979997135705,0.00257098418351058,0.0147588707138898,0.0248371287132512,1.43331842810592e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,40376,-0.0672952914902876,0.00874284830702295,-0.0844312741720526,-0.0501593088085226,1.47231845827291e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,37598,-0.039662998380767,0.00515197789893636,-0.0497608750626822,-0.0295651216988517,1.47372012982014e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40042,-0.0533403570848402,0.00693080844464793,-0.0669247416363502,-0.0397559725333303,1.48631399310032e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37671,-0.05776901385842,0.00750533019863458,-0.0724794610477438,-0.0430585666690963,1.49083885027548e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,40471,0.0217017960823791,0.00282200783781781,0.0161706607202562,0.027232931444502,1.55413409808455e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40042,0.0152933028291842,0.00198863126681671,0.0113955855462234,0.0191910201121449,1.55448584246721e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40411,-0.0694456861381898,0.00904291707867543,-0.0871698036123937,-0.0517215686639859,1.68852343765742e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37572,-0.052527645124746,0.00684312925671329,-0.065940178467904,-0.0391151117815879,1.75756704211546e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37942,-0.0454094933462293,0.00591628237401673,-0.0570054067993021,-0.0338135798931565,1.76284585433014e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40396,-0.0636079700435541,0.00828962233479851,-0.0798556298197592,-0.047360310267349,1.77422622665655e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,40228,-0.0253028908048447,0.0033015998960817,-0.0317740266011648,-0.0188317550085245,1.90939368569209e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,40489,-0.0265281635261214,0.00346169101074176,-0.0333130779071753,-0.0197432491450676,1.91466531167668e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,40341,-0.0283444672016874,0.00370261107082104,-0.0356015849004967,-0.0210873495028782,2.0397119341675e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,40422,-0.034334168916002,0.0044946353872246,-0.0431436542749622,-0.0255246835570418,2.31429633106623e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40489,-0.0225556104537224,0.00296095210018237,-0.0283590765700798,-0.0167521443373649,2.72631818850408e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,40359,-0.0254739244024727,0.00334728797379781,-0.0320346088311164,-0.018913239973829,2.88707880558964e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,37966,-0.032091357170729,0.00423018332773145,-0.0403825164930827,-0.0238001978483754,3.50700610991871e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40471,-0.0347817931858309,0.00458846671995116,-0.0437751879569352,-0.0257883984147267,3.63686249860755e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37959,-0.0552700194389572,0.00730162721999512,-0.0695812087901476,-0.0409588300877667,3.98756905112873e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40359,0.0226587449129366,0.00299608530969576,0.0167864177059329,0.0285310721199402,4.16037700163453e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40471,-0.0472762199909991,0.00625640300276684,-0.0595387698764221,-0.0350136701055761,4.36546226348431e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,40029,-0.0275391121824639,0.00365054120077715,-0.0346941729359871,-0.0203840514289407,4.81473899503282e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40044,-0.0415818844006005,0.0055146882303767,-0.0523906733321388,-0.0307730954690622,4.95022126898722e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40516,-0.0400121234526583,0.00530930699719405,-0.0504183651671586,-0.029605881738158,5.09514405701883e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,40471,-0.0476280494487687,0.00632416380866075,-0.0600234105137438,-0.0352326883837936,5.29827870136692e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,40471,-0.0567676706093008,0.0075417551099299,-0.0715495106247634,-0.0419858305938382,5.46271204011501e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40305,-0.0197999381686344,0.00263164411759292,-0.0249579606391165,-0.0146419156981522,5.60610456511107e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,37628,-0.0354823325864005,0.00471524174444296,-0.0447242064055087,-0.0262404587672923,5.61243721279199e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,40472,-0.0166559205407828,0.0022148990155544,-0.0209971226112694,-0.0123147184702962,5.76970662774022e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,37901,-0.0202795575535859,0.002696971536541,-0.0255656217652063,-0.0149934933419656,5.85177185939297e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,40471,-0.0168417778678248,0.00224456272004262,-0.0212411207991084,-0.0124424349365413,6.54596428964231e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37990,-0.0521583362608892,0.00695203227981344,-0.0657843195293236,-0.0385323529924549,6.64586877436651e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37942,-0.0762986754215647,0.0101832532798398,-0.0962578518500507,-0.0563394989930787,7.17393388245333e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,37900,-0.0276507079895224,0.00369328411515867,-0.0348895448552334,-0.0204118711238114,7.49866810416567e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40341,0.0242064435758173,0.00323589516256582,0.0178640890571883,0.0305487980944463,7.78461435979124e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40516,-0.0482205151742698,0.0064462569986591,-0.0608551788916417,-0.035585851456898,7.79283375263484e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40489,0.043512678914833,0.00581900992598612,0.0321074194599002,0.0549179383697658,7.95542769216266e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37990,0.0232214540841362,0.00310744842663682,0.017130855167928,0.0293120530003443,8.32935057919629e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,40516,-0.034649036872358,0.0046417452540044,-0.0437468575702066,-0.0255512161745094,8.77923034203376e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,40411,-0.0501500661038032,0.00671869168237246,-0.0633187018012532,-0.0369814304063532,8.80849666961064e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40305,-0.0976321675851243,0.0130805846241477,-0.123270113448454,-0.0719942217217948,8.83557164018901e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39980,-0.0390690251425643,0.00524018011620486,-0.0493397781703258,-0.0287982721148028,9.41322741415188e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,40422,-0.07395798385986,0.00992058167215639,-0.0934023239372865,-0.0545136437824335,9.44687000398274e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37901,-0.021133291032306,0.00284114892007901,-0.0267019429156608,-0.0155646391489511,1.08172162302562e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37901,-0.0537669074416064,0.00724733938723385,-0.0679716926405847,-0.0395621222426281,1.252216183635e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,40332,-0.0532974429931252,0.00720257659088152,-0.067414493111253,-0.0391803928749974,1.43238311923895e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37391,-0.0246578483287381,0.00333159891671548,-0.0311877822055005,-0.0181279144519758,1.43285615349884e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40396,0.059628566480216,0.00805953961154595,0.0438318688415859,0.075425264118846,1.4457815088264e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,40411,-0.0392041255851857,0.00529903466507332,-0.0495902335287294,-0.028818017641642,1.44740259621454e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,40516,-0.0264318245640769,0.00357372442449138,-0.03343632443608,-0.0194273246920738,1.47098079066722e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39980,-0.0283468127557079,0.00383333556668898,-0.0358601504664183,-0.0208334750449975,1.48830328625369e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,37970,-0.0322111778440576,0.00435560683674278,-0.0407481672440734,-0.0236741884440417,1.49349693605813e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37942,-0.0277555407568517,0.00375316335928978,-0.0351117409410597,-0.0203993405726437,1.49476261808659e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,40422,-0.0473784961979144,0.0064122212694863,-0.0599464498861075,-0.0348105425097213,1.55505643434267e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,39961,-0.0221124683160572,0.00299545910986112,-0.027983568171385,-0.0162413684607294,1.63845802228439e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,40290,-0.0306600958812185,0.00415694180518159,-0.0388077018193744,-0.0225124899430626,1.71655558001605e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,40396,0.021379995960222,0.0029016015576773,0.0156928569071745,0.0270671350132695,1.81220290177721e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,37901,-0.0724906805289188,0.00985189861443321,-0.0918004018132079,-0.0531809592446297,1.97443169877984e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37998,-0.0161325800471446,0.00219497009075647,-0.0204347214250273,-0.011830438669262,2.09879175300508e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37598,-0.0300587702514449,0.00409287436859926,-0.0380808040138995,-0.0220367364889904,2.1922668037034e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,37990,-0.0519690101725637,0.00708483970043734,-0.0658552959854209,-0.0380827243597065,2.33903009371534e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40384,0.0213383837702672,0.00290987593113135,0.0156350269452497,0.0270417405952846,2.35714588120933e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,37919,-0.0416590103761937,0.0056842505907645,-0.0528001415340921,-0.0305178792182953,2.45359547626317e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,37698,0.0215002543739485,0.00293529007794784,0.0157470858211707,0.0272534229267262,2.53184902189845e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37901,-0.0588260113449184,0.00803314725773484,-0.0745709799700787,-0.0430810427197581,2.56444317957216e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37901,-0.0451236672862959,0.00617169821754042,-0.0572201957926751,-0.0330271387799167,2.79335257173028e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,37998,-0.0283708183620301,0.00388163717565979,-0.0359788272263233,-0.0207628094977369,2.84244942188265e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,40489,-0.0283748944716306,0.00388460626374322,-0.0359887227485673,-0.0207610661946939,2.91497407032589e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40305,-0.0581925128526892,0.00797301513620063,-0.0738196225196424,-0.0425654031857359,3.04372872199447e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,37901,-0.0485870299291929,0.00666480527994355,-0.0616500482778823,-0.0355240115805036,3.27039244385483e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,40536,-0.0292824851405935,0.00402404859217873,-0.0371696203812638,-0.0213953498999232,3.57417699239246e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40332,-0.0315787740291896,0.00434354690180058,-0.0400921259567187,-0.0230654221016604,3.75473838187328e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,37900,-0.0271228681488266,0.00373157815617945,-0.0344367613349384,-0.0198089749627149,3.83634911420251e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,40359,-0.0831594090258435,0.0114573082635301,-0.105615733222362,-0.0607030848293246,4.10403995780223e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40422,-0.0711088691303673,0.00983571467003395,-0.0903868698836338,-0.0518308683771008,5.06135568568103e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40228,-0.0478980646763634,0.00664653531989931,-0.060925273903366,-0.0348708554493607,6.00199704087604e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40042,-0.0258980967921586,0.00359646362444694,-0.0329471654960746,-0.0188490280882426,6.25079002725162e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,40489,0.0306458956724811,0.00425866811588697,0.0222989061653426,0.0389928851796195,6.4691262794775e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40228,-0.0404285698573506,0.00562556871539199,-0.0514546845395189,-0.0294024551751823,6.941143454492e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,40332,-0.0244254390550142,0.00340095742645066,-0.0310913156108575,-0.0177595624991709,7.17828546718853e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39961,-0.0410578603804993,0.00571845463094718,-0.0522660314571558,-0.0298496893038429,7.29355384688908e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,38013,0.0208593395694025,0.0029080615210262,0.0151595389881912,0.0265591401506139,7.72126503217231e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,37562,-0.0461966886024614,0.00644898384751973,-0.0588366969436,-0.0335566802613227,8.28990048888329e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,37441,-0.0487872062212909,0.00681080943265507,-0.0621363927092948,-0.0354380197332869,8.3061853436423e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,37598,-0.0384136661125679,0.0053663396672135,-0.0489316918603064,-0.0278956403648294,8.60441846030489e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,37778,-0.0743012513090581,0.0103890051473606,-0.0946637013978849,-0.0539388012202312,9.00421442821238e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40228,-0.0529043324092443,0.00740766523269615,-0.0674233562653288,-0.0383853085531599,9.61134632779606e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40307,-0.0443079608549126,0.00621434138911227,-0.0564880699775726,-0.0321278517322525,1.04736211390076e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37959,-0.0427295467763533,0.00600101923829867,-0.0544915444834187,-0.0309675490692879,1.13069472858663e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37959,-0.0320097144858204,0.00449819789097523,-0.0408261823521318,-0.0231932466195089,1.16606058075324e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,40288,-0.0592052539529634,0.00834462131587635,-0.075560711732081,-0.0428497961738457,1.34812239526587e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37562,-0.0418013340143888,0.00589214682643285,-0.0533499417941972,-0.0302527262345804,1.36571283293766e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,40411,-0.0462455549650594,0.00652688769420243,-0.0590382548456961,-0.0334528550844226,1.44448136236118e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,37628,0.0285150846646532,0.00403496025741008,0.0206065625601295,0.036423606769177,1.66277300670555e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37901,-0.0687123450219943,0.00974065772343482,-0.0878040341599265,-0.049620655884062,1.82113542541441e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,37934,-0.0651146941819712,0.00924978364037831,-0.0832442701171127,-0.0469851182468298,2.02132607138513e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37714,-0.0295196812186452,0.00419721058336851,-0.0377462139620475,-0.0212931484752429,2.11794967143352e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,40514,0.0280233915120513,0.00398836219088098,0.0202062016179245,0.035840581406178,2.2061535842372e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37714,-0.0443854162736959,0.00632124618933156,-0.0567750588047857,-0.031995773742606,2.29982958274883e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,37990,-0.0668746446662627,0.00953403483302807,-0.0855613529389977,-0.0481879363935276,2.42065242845158e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,39759,-0.0205810995094298,0.00293482431594249,-0.0263333551686771,-0.0148288438501825,2.43513238167341e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,37959,-0.0366669012434932,0.00523213099754491,-0.0469218779986812,-0.0264119244883051,2.53169802763558e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,37959,-0.0364939041328975,0.00520954247740993,-0.0467046073886209,-0.026283200877174,2.58304945066723e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40305,0.0132512830617778,0.00189230617286333,0.00954236296296569,0.01696020316059,2.61129241660747e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39980,-0.040960629063009,0.00585078385951443,-0.0524281654276573,-0.0294930926983607,2.64783827020035e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40422,-0.0830847581146997,0.0118702314247381,-0.106350411707186,-0.0598191045222129,2.67246628771984e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37598,-0.0465523976708078,0.00665715593509375,-0.0596004233035916,-0.0335043720380241,2.8240510772555e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,40305,0.0188245240910521,0.00269545689240575,0.0135414285819368,0.0241076196001673,2.98721190879966e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37628,-0.0682498923951289,0.00977324758221691,-0.0874054576562741,-0.0490943271339838,3.02071462377657e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40228,0.0775182464363933,0.0111075748662208,0.0557473996986006,0.099289093174186,3.09425462577096e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40044,-0.0398131042975862,0.00571933601296976,-0.0510230028830069,-0.0286032057121654,3.50989858258176e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,39961,-0.0474917311489227,0.00682328879129329,-0.0608653771798576,-0.0341180851179878,3.53307428879463e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37598,-0.029607579402648,0.00425959196382677,-0.0379563796517485,-0.0212587791535476,3.80351954713491e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,40214,-0.015177361495923,0.00218635581638463,-0.0194626188960369,-0.0108921040958091,4.02085989886419e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,39961,-0.0410067330799202,0.00590900618027077,-0.0525883851932509,-0.0294250809665895,4.08496323104254e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,40360,0.0414234496079324,0.00596988721083402,0.0297224706746977,0.053124428541167,4.10896804917893e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,40442,-0.048216813398588,0.00695218257139324,-0.0618430912385188,-0.0345905355586573,4.20313497703826e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37901,-0.0198661091421061,0.00286560618198104,-0.025482697258789,-0.0142495210254233,4.32013071342089e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37419,-0.0353711270587921,0.00510202845567962,-0.0453711028319241,-0.02537115128566,4.32255867648763e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,40403,0.0311829407937581,0.00449931014366393,0.0223642929121768,0.0400015886753394,4.35091563397548e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,40359,-0.0352107161986901,0.00508771151526103,-0.0451826307686017,-0.0252388016287784,4.66453792010581e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,37901,-0.0540772573013603,0.00782315948911725,-0.0694106499000301,-0.0387438647026904,4.97803759077266e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37671,-0.044224500654425,0.00639883535890499,-0.0567662179578788,-0.0316827833509712,5.02125988267768e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,39961,-0.0232768177174642,0.00337056700404598,-0.0298831290453943,-0.016670506389534,5.18219363648678e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,37942,0.0267194793305347,0.00387000487340128,0.0191342697786682,0.0343046888824012,5.2727087254108e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37901,-0.0307133073159684,0.00444907282133557,-0.0394334900457861,-0.0219931245861506,5.30847808968057e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,40453,-0.0385241322900098,0.00558185149446469,-0.0494645612191606,-0.027583703360859,5.3321687335259e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,37942,-0.0534520008676358,0.00774487141368924,-0.0686319488384667,-0.0382720528968049,5.37167902557885e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37572,-0.0447776050400805,0.00648960314849304,-0.0574972272111269,-0.0320579828690341,5.44283317191361e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37671,-0.0147455062048997,0.00213884372568725,-0.0189376399072467,-0.0105533725025527,5.66485512338259e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,39961,-0.0439634916230598,0.00638782746371417,-0.0564836334519395,-0.03144334979418,6.11139213119769e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37978,-0.0159142594288761,0.00231352046640352,-0.020448759543027,-0.0113797593147252,6.30091109177587e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,38013,-0.0241105544118449,0.00350512249455043,-0.0309805945011637,-0.0172405143225261,6.30656110031994e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40359,0.0258745464528873,0.0037641748740612,0.0184967636997273,0.0332523292060472,6.47933879094112e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37687,-0.0419855873841288,0.00611590945018075,-0.0539727699064831,-0.0299984048617746,6.9465914137932e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40422,-0.068067995675621,0.00991797062361238,-0.0875072180979013,-0.0486287732533407,6.98618881812848e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40341,-0.027967744990534,0.00407588837862162,-0.0359564862126324,-0.0199790037684356,7.05328642993931e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39980,-0.0435755871577752,0.00635661216139015,-0.0560345469940999,-0.0311166273214505,7.39167617613831e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,39980,-0.063507750876676,0.00927164862119255,-0.0816801821742134,-0.0453353195791386,7.67991638714236e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,37998,-0.0227135726687676,0.00331568594675623,-0.0292123171244098,-0.0162148282131254,7.68555909322076e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37901,-0.0257485705593359,0.00376158680388737,-0.0331212806949552,-0.0183758604237167,7.97159654529845e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,37849,0.0188773948848395,0.002759872708577,0.0134680443760286,0.0242867453936505,8.26577050038117e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39980,-0.0227802747645048,0.00333301004108903,-0.0293129744450393,-0.0162475750839703,8.52090707676755e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37541,-0.0400953420792688,0.00587316869988543,-0.0516067527310442,-0.0285839314274934,9.06159884147899e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,40303,-0.0176983985828566,0.00259340018235114,-0.0227814629402649,-0.0126153342254484,9.14934234430959e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),37735,0.114418091799218,0.0167782576979724,0.0815327067111917,0.147303476887243,9.5358015439751e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40359,-0.0372432499844759,0.00546347124773191,-0.0479516536300304,-0.0265348463389213,9.64543154120785e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,40422,-0.0438688612845537,0.00643963645864453,-0.056490548743497,-0.0312471738256104,9.94669428628924e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40305,-0.0230481244375873,0.0033836207403691,-0.0296800210887107,-0.0164162277864639,9.99383011947513e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,37628,-0.0347557703694579,0.00510235211740809,-0.0447563805195777,-0.024755160219338,1.00628385917533e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,40192,-0.041789598279664,0.00614124429894758,-0.0538264371056012,-0.0297527594537267,1.04881005683117e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,37598,-0.027059434010749,0.00397702910802026,-0.0348544110624687,-0.0192644569590293,1.06211265603107e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40042,-0.0595779583311132,0.00875858611837975,-0.0767447871231375,-0.0424111295390889,1.06755905037835e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40471,-0.0432537106577953,0.0063597576046727,-0.0557188355629538,-0.0307885857526368,1.07452605482313e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37959,-0.0511611514330648,0.00752597077259665,-0.0659120541473543,-0.0364102487187754,1.10575995484482e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37987,-0.0174832652149391,0.00257485343176149,-0.0225299779411916,-0.0124365524886865,1.16806548698886e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,37987,0.0382504837656018,0.00563393319833077,0.0272079746968735,0.0492929928343301,1.17372955701838e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37993,-0.0125206804863706,0.0018448721856531,-0.0161366299702507,-0.00890473100249057,1.19461781070185e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,40332,-0.0153024948071935,0.0022570227030219,-0.0197262593051164,-0.0108787303092706,1.24456345749801e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,37998,-0.0179661362980627,0.00265108297381992,-0.0231622589267497,-0.0127700136693757,1.27854573685934e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,40359,0.0218580263737601,0.00322846279729132,0.0155302392910691,0.0281858134564511,1.32907641081685e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,40309,-0.0736472416121309,0.0108982257234813,-0.0950077640301543,-0.0522867191941076,1.45055401956072e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,38013,-0.0120254341386654,0.00178071961728896,-0.0155156445885517,-0.00853522368877902,1.5058003691971e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40264,-0.0171060229958721,0.0025382491332963,-0.0220809912971329,-0.0121310546946114,1.64650971550549e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,37900,-0.0227586837531645,0.00337917964314169,-0.0293818758537222,-0.0161354916526068,1.70622955106486e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,37942,-0.036378142634311,0.00540268010221966,-0.0469673956346615,-0.0257888896339604,1.72508725353519e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,39980,-0.0380273029858606,0.00565432638411886,-0.0491097826987335,-0.0269448232729876,1.81290562691839e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39980,-0.0284092524416088,0.00422540152050936,-0.0366910394218071,-0.0201274654614104,1.83666810229498e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,40203,-0.0291028933606501,0.00433222713417245,-0.0375940585436281,-0.0206117281776721,1.908509891609e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40152,-0.0740991524858804,0.0110502549498704,-0.0957576521876264,-0.0524406527841344,2.0735202633213e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40403,-0.0263667410835733,0.0039352587645021,-0.0340798482619974,-0.0186536339051492,2.15204519870646e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,40177,-0.0214585455492715,0.00320521500623925,-0.0277407669615004,-0.0151763241370426,2.23147334583005e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37981,0.0118634008104549,0.00177188850151707,0.00839049934748149,0.0153363022734284,2.23654663813361e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,37878,-0.0265242773579046,0.00396200257620802,-0.0342898024072723,-0.0187587523085369,2.24757720127046e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,40497,0.0302459068178146,0.00452969077410073,0.0213677129005771,0.039124100735052,2.51446450791815e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37671,-0.0469119710176296,0.00702963144323456,-0.0606900486463693,-0.0331338933888899,2.59800101356351e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39980,-0.0415485218126593,0.00623028440324747,-0.0537598792430243,-0.0293371643822942,2.66608863542432e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,40403,-0.019356289127424,0.00290272971461286,-0.0250456393680652,-0.0136669388867828,2.67270998909919e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,40074,-0.0339179280169363,0.00509141167655701,-0.043897094902988,-0.0239387611308846,2.7954546256654e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40042,-0.0257976531252006,0.0038782479435608,-0.0333990190945797,-0.0181962871558214,2.98996574503682e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40305,0.0260177246086205,0.00391407872630108,0.0183461303050704,0.0336893189121707,3.08436116335594e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40359,-0.048427765671669,0.00730158525298857,-0.0627388727675266,-0.0341166585758114,3.40686412960149e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37628,-0.028131562737745,0.00424247251926763,-0.0364468088755096,-0.0198163165999805,3.46571613534317e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40396,-0.0482660467773576,0.00728178318934582,-0.0625383418284754,-0.0339937517262398,3.50401137143974e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37716,-0.0264796312471343,0.00401238059942694,-0.0343438972220111,-0.0186153652722575,4.2827789711357e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,37628,-0.0461782786729494,0.00699858800733973,-0.0598955111673352,-0.0324610461785635,4.3200920259645e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37572,-0.0508957546268553,0.00771481903443038,-0.0660167999343388,-0.0357747093193717,4.35243849707614e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,40376,-0.0423005572631097,0.00642648246502711,-0.0548964628945628,-0.0297046516316566,4.77936071628752e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,39980,-0.0185536225460492,0.00282032697163978,-0.0240814634104632,-0.0130257816816352,4.90294922513218e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,40516,-0.02856589323039,0.00434346354900113,-0.0370790817864322,-0.0200527046743478,4.9566710996556e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37671,-0.0249016031917501,0.00378744999544857,-0.0323250051828292,-0.0174782012006709,5.0559895331939e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40333,-0.0605530040874247,0.009219504301744,-0.0786232325188429,-0.0424827756560065,5.26060911671578e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,40489,0.0283994869819151,0.00432458869625953,0.0199232931372464,0.0368756808265838,5.29239763449273e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37959,-0.0407462972741271,0.00623695211824973,-0.0529707234258966,-0.0285218711223576,6.67545670694291e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40341,-0.0446961699202473,0.00684494908356541,-0.0581122701240355,-0.0312800697164591,6.7853728459273e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,37671,-0.026327468669353,0.00403246921692406,-0.0342311083345242,-0.0184238290041819,6.86886635966402e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39980,-0.0281885006539524,0.00431820186092699,-0.0366521763013693,-0.0197248250065356,6.87972151680089e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,40305,0.0178033235596555,0.00273003244014168,0.0124524599769778,0.0231541871423332,7.18151635804894e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,40332,-0.0456332456737121,0.00700685155974964,-0.0593666747308214,-0.0318998166166028,7.60487044825734e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37714,-0.0326444443621443,0.00501379435933291,-0.0424714813064368,-0.0228174074178518,7.73790560342244e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37598,-0.0473770101345278,0.007290370333181,-0.0616661359875626,-0.0330878842814931,8.40095149022263e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37959,-0.0383331754277014,0.00590480132708751,-0.049906586028793,-0.0267597648266099,8.7742636394986e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,40516,-0.0209658998421335,0.00323162184895726,-0.0272998786660897,-0.0146319210181772,8.96852144798139e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,40309,-0.0240537252177412,0.00371094557226094,-0.0313271785393726,-0.0167802718961097,9.32903698656206e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,40332,0.0145738770181279,0.0022510794875367,0.010161761222556,0.0189859928136999,9.8129663387131e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40400,-0.0438419877922994,0.00677456826377549,-0.0571201415892993,-0.0305638339952994,9.9828577624588e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,40332,0.0194790574797607,0.00301020394842325,0.0135790577408512,0.0253790572186703,1.00200911933182e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37959,-0.0465567050220995,0.00719940526907231,-0.0606675393494812,-0.0324458706947178,1.03583434313429e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,37562,-0.0409853527596134,0.00633995961202886,-0.05341167359919,-0.0285590319200368,1.05159397464193e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,37671,0.0199715057624945,0.00309005686686865,0.013914994303432,0.0260280172215571,1.06143256957704e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,40471,-0.0209239152222809,0.00323856268954762,-0.0272714980937943,-0.0145763323507676,1.07109113296731e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,39980,-0.0374395785673834,0.00580341574965596,-0.0488142734367091,-0.0260648836980578,1.14176026228505e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,40228,-0.0591676722881543,0.00918033750370398,-0.0771611337954141,-0.0411742107808945,1.18919999957307e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,39980,-0.0255238902055372,0.00396161976680776,-0.0332886649484804,-0.017759115462594,1.20748715993991e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39980,-0.047917115827563,0.00744023948507188,-0.0624999852183039,-0.0333342464368221,1.22770338118304e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,39809,-0.0476002723040731,0.00739599139644663,-0.0620964154411085,-0.0331041291670377,1.26336292349108e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40044,-0.0232991150807561,0.0036211245824385,-0.0303965192623355,-0.0162017108991766,1.2772750331291e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37942,-0.0555714711549469,0.00864321709495925,-0.072512176661067,-0.0386307656488267,1.32344743249006e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37901,-0.047027422716327,0.00731478443053901,-0.0613644002001835,-0.0326904452324706,1.32703236193192e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37598,-0.0221084770168481,0.0034408779071077,-0.0288525977147792,-0.015364356318917,1.36198156212381e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,40471,-0.0216229305524408,0.00336694214243529,-0.0282221371516139,-0.0150237239532676,1.38167827374079e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,40044,-0.0268429803742308,0.00417971673100781,-0.0350352251670062,-0.0186507355814555,1.38206002252454e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40359,-0.0188837666816834,0.00294639833615044,-0.0246587074205382,-0.0131088259428285,1.50498228572475e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,39925,-0.0271970191234395,0.0042447432213502,-0.0355167158372859,-0.0188773224095931,1.52476584541458e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,37628,-0.0251899443940416,0.00393531693552528,-0.0329031655876712,-0.0174767232004121,1.59598252428354e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,37936,-0.0459316774384937,0.00717992944030521,-0.0600043391414919,-0.0318590157354955,1.63443180219895e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,40228,-0.0319238635280922,0.00499271314893723,-0.0417095813000092,-0.0221381457561752,1.66045117602421e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,37628,-0.0543796350783295,0.00850439765009852,-0.0710482544725226,-0.0377110156841364,1.66731392600258e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,40324,-0.0623126466776872,0.0097692751550729,-0.0814604259816301,-0.0431648673737443,1.83861933090737e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40422,-0.0156705762810331,0.00245770922521443,-0.0204876863624533,-0.0108534661996128,1.86653838271748e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,40411,-0.0316347511700569,0.0049619474927988,-0.0413601682559425,-0.0219093340841713,1.87411722154786e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37562,-0.0406245198315848,0.00637699685107562,-0.053123433659693,-0.0281256060034766,1.94736923534896e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39961,-0.0402521265701313,0.00632527113348341,-0.0526496579917588,-0.0278545951485038,2.02478764935866e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,40357,-0.0154598094615914,0.00243058608043423,-0.0202237581792424,-0.0106958607439403,2.06552353214996e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,37942,-0.0376543321063726,0.00592070176380512,-0.0492589075634306,-0.0260497566493145,2.08564871000693e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39708,0.0226068611909958,0.00355971463949626,0.0156298204975831,0.0295839018844085,2.20332030923208e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37901,-0.0387515330058408,0.00610507616952036,-0.0507174822981007,-0.0267855837135809,2.25971904888231e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,37959,-0.0398970024733743,0.00628726648993921,-0.0522200447936552,-0.0275739601530935,2.28509601437169e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39961,-0.0407067611453498,0.00642451638575805,-0.0532988132614356,-0.028114709029264,2.42061842603927e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40422,0.0170081726567427,0.00268738911713894,0.0117408899871504,0.022275455326335,2.5352549762649e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,39934,-0.0536997561986011,0.00850053768412568,-0.0703608100594874,-0.0370387023377147,2.73586191593123e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37942,-0.0180491261886032,0.00286527192610094,-0.023665059163761,-0.0124331932134453,3.08332529872926e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,37900,-0.0490775225163778,0.00779367282416812,-0.0643531212517473,-0.0338019237810083,3.12702312269689e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40305,-0.0264534705485778,0.00420387395371343,-0.0346930634978561,-0.0182138775992995,3.20304615078386e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40516,0.0173811503369565,0.00276439259751435,0.0119629408458284,0.0227993598280847,3.30926457659225e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,40228,-0.0786375750496775,0.012510126076969,-0.103157422160537,-0.0541177279388182,3.34494968533884e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40332,-0.0349010817072341,0.00555266619991363,-0.0457843074590648,-0.0240178559554034,3.35406498387651e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40424,0.0125402512297785,0.00199976572826577,0.00862071040237758,0.0164597920571794,3.68288895421014e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37598,-0.0534134565108475,0.00852699035960817,-0.0701263576156795,-0.0367005554060154,3.8680875546743e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,40374,-0.0633776332260944,0.0101221928280261,-0.0832171311690255,-0.0435381352831633,3.9167929373189e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,37567,-0.0255088002775326,0.00407934414215716,-0.0335043147961606,-0.0175132857589046,4.1470606944528e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,37882,-0.0213496685031531,0.00341525093246819,-0.0280435603307908,-0.0146557766755155,4.19437370276639e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,37360,-0.0280828390345658,0.0044926042763672,-0.0368883434162456,-0.0192773346528861,4.20934210800928e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37958,0.00876452458511477,0.00140349085986299,0.00601368249978332,0.0115153666704462,4.37047619380824e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39957,0.01673775978589,0.00268401251788703,0.0114770952508315,0.0219984243209486,4.60251172122572e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,37572,-0.0773918608211381,0.0124169633647558,-0.101729109016059,-0.0530546126262168,4.7234361192985e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40341,-0.0215054591744658,0.00345102379604099,-0.0282694658147061,-0.0147414525342255,4.73281895300357e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40536,0.0091996564133819,0.00147658099665044,0.00630555765994704,0.0120937551668168,4.76890840195304e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,37628,-0.0403155363580212,0.00647848387881833,-0.0530133647605052,-0.0276177079555373,5.02550187774142e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37990,-0.0381502129019357,0.0061325684077767,-0.050170046981178,-0.0261303788226934,5.08801896343999e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,40042,0.0135045099660405,0.00217118030046352,0.00924899657713202,0.017760023354949,5.10182390430272e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40411,0.0141424449989944,0.00227467476736154,0.0096840824549658,0.0186008075430231,5.18202299319386e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37562,-0.0401583622026355,0.00645980671873623,-0.0528195833713585,-0.0274971410339125,5.23283760024183e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37987,-0.0357000565184027,0.00574567248450234,-0.0469615745880273,-0.0244385384487781,5.33760173311676e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,38013,-0.0385384898244778,0.00620826752829793,-0.0507066941799417,-0.0263702854690138,5.53650127729646e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,37562,-0.0277071669160056,0.00446683382634686,-0.0364621612156454,-0.0189521726163657,5.71114837017381e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,37671,-0.0399848289184013,0.00645367043214441,-0.0526340229654044,-0.0273356348713983,5.97591678284766e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,37987,-0.0275847409872186,0.00445694272215397,-0.0363203487226404,-0.0188491332517969,6.22303191852807e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,37942,-0.0217221925584983,0.00351135222811053,-0.0286044429255949,-0.0148399421914017,6.33826998254637e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40042,-0.0438880452166539,0.00710725552895839,-0.0578182660534124,-0.0299578243798955,6.77588188770029e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,37900,-0.0372252566753407,0.00602825575443307,-0.0490406379540295,-0.0254098753966519,6.80125990191753e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,37562,-0.0468488175563193,0.00758685334762764,-0.0617190501176695,-0.0319785849949692,6.81178089592285e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37990,-0.0275744310893954,0.00446595182125975,-0.0363276966590645,-0.0188211655197263,6.83270541101357e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39980,-0.0543670129853977,0.0088094022072016,-0.0716334413115129,-0.0371005846592826,6.93354750565168e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,40359,0.0409653398763964,0.00663823569951244,0.027954397905352,0.0539762818474408,6.94514254194847e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,40396,-0.033454656778756,0.0054235143317447,-0.0440847448689756,-0.0228245686885364,7.06284090979172e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37671,-0.0609079786598045,0.00988232036331065,-0.0802773265718933,-0.0415386307477156,7.33027041132013e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37628,-0.0295254480241708,0.00479356651102152,-0.038920838385773,-0.0201300576625686,7.51500517034641e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,37598,-0.0255355111901425,0.00414711013679189,-0.0336638470582546,-0.0174071753220304,7.6091589981602e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,40429,0.0150273538652855,0.00244262591984971,0.0102398070623801,0.0198149006681909,7.82705998972415e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,40228,-0.0203125873804287,0.00330174318418928,-0.0267840040214397,-0.0138411707394177,7.83191458449388e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38013,0.0149678288214671,0.00243525894341049,0.0101947212923825,0.0197409363505516,8.15342976605208e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,40307,-0.0401355083250175,0.00654371350934789,-0.0529611868033393,-0.0273098298466956,8.8036607165018e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,37987,-0.0397514663173161,0.00648053475176639,-0.0524533144307782,-0.027049618203854,8.80949572089043e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,37900,-0.0281392509674603,0.00458792397022518,-0.0371315819491017,-0.019146919985819,8.84702253454337e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40359,-0.0162260521691001,0.00264863692928427,-0.0214173805504972,-0.0110347237877029,9.21273192064449e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37900,-0.0204369023510572,0.00333614655048529,-0.0269757495900084,-0.013898055112106,9.26870282955008e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39980,-0.0336446983013101,0.00549547240925614,-0.0444158242234522,-0.0228735723791681,9.44783550397808e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,37628,-0.0444644056392275,0.00727697405795409,-0.0587272747928175,-0.0302015364856375,1.02254981571558e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37628,-0.0325660748807064,0.00533366268173028,-0.0430200537368978,-0.0221120960245151,1.05186891933607e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40042,-0.0199358944539035,0.00326952159763374,-0.0263441567852656,-0.0135276321225413,1.10283807062435e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40192,-0.0551965874901683,0.00905451990490938,-0.0729434465037907,-0.0374497284765459,1.11275106435411e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,40270,-0.0456625768751986,0.00749170789415143,-0.0603463243477354,-0.0309788294026618,1.11919125408476e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40359,-0.0458324651790324,0.0075320254826591,-0.0605952351250442,-0.0310696952330206,1.19152688571171e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,40341,-0.0282208410177929,0.004641029821733,-0.0373172594683896,-0.0191244225671962,1.22375864107221e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,40203,-0.0305237169386708,0.00502997061313258,-0.0403824593404106,-0.0206649745369309,1.32175346831428e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,39980,-0.0558882691441931,0.00921242825970043,-0.0739446285332059,-0.0378319097551803,1.33664858759109e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,40341,-0.0481062248054676,0.00793060777915921,-0.0636502160526196,-0.0325622335583155,1.34196065606009e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,40434,-0.0346500486774183,0.00571516779874643,-0.0458517775629613,-0.0234483197918753,1.36760968598279e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,37572,0.0180566165661004,0.00298378795879407,0.0122083921668641,0.0239048409653368,1.47345214437688e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,38013,-0.024059343306038,0.00397607098094462,-0.0318524424286895,-0.0162662441833865,1.47710025322207e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37959,-0.021559784862957,0.00356536584595977,-0.0285479019210381,-0.0145716678048758,1.51456279559268e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40471,-0.0270742200596671,0.00447951322812346,-0.035854065986789,-0.0182943741325451,1.5366245276904e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37942,-0.0205877829768222,0.00341439554370506,-0.0272799982424842,-0.0138955677111603,1.6855404718298e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37959,-0.0531103755919428,0.00882109101691658,-0.0703997139850993,-0.0358210371987863,1.78014510928191e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,40305,-0.0417946705641258,0.00694487467614706,-0.055406624929374,-0.0281827161988776,1.80407138454937e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,40192,-0.0196575083014282,0.00326792111205735,-0.0260626336810606,-0.0132523829217958,1.8353527769753e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37642,-0.0489476996478701,0.00813641477956383,-0.0648950726158152,-0.033000326679925,1.83648808054164e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39980,-0.0488980464274931,0.00813343092512597,-0.06483957104074,-0.0329565218142462,1.87372398253493e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,37572,-0.0280060372587752,0.00465902114755312,-0.0371377187079793,-0.0188743558095711,1.89110122195406e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40422,0.0237126507340817,0.00394748528644094,0.0159755795726574,0.0314497218955059,1.93056468127095e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,40489,-0.0627852146463875,0.0104589230239967,-0.083284703773421,-0.042285725519354,1.97844468032848e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40341,0.0269110694304306,0.00448462579303542,0.0181212028760812,0.03570093598478,2.00688084067154e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37628,0.0148104771265853,0.00246917797996831,0.00997088828584746,0.0196500659673232,2.0481877406208e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40502,-0.0289915959058652,0.00483503897668918,-0.038468272300176,-0.0195149195115544,2.06387955164106e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37598,-0.02025883758248,0.00337852368049476,-0.0268807439962498,-0.0136369311687103,2.07084879512324e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40489,0.0329816668376511,0.00550509003074331,0.0221916903773942,0.043771643297908,2.12854539343711e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40228,-0.0167614670554071,0.00280090284361441,-0.0222512366288914,-0.0112716974819229,2.2201451314273e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37598,-0.0554619749315044,0.00927825104727354,-0.0736473469841605,-0.0372766028788482,2.32269565401143e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37901,-0.0616750505934784,0.0103393451354753,-0.0819401670590101,-0.0414099341279468,2.50649478058674e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37671,-0.0403940869979537,0.00677882335284751,-0.0536805807695348,-0.0271075932263726,2.60460577565966e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,40536,-0.0300067080509376,0.00503945994805207,-0.0398840495491197,-0.0201293665527556,2.66541578641347e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,37901,-0.0333448930013444,0.0056003681111863,-0.0443216144992695,-0.0223681715034192,2.68101249973156e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37671,0.0151494886226331,0.00254588682463677,0.010159550446345,0.0201394267989212,2.73965483435464e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37990,-0.0268951580258839,0.00452100947216281,-0.035756336591323,-0.0180339794604448,2.76565639330867e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39980,-0.0291622575714468,0.00490395447101543,-0.0387740083346371,-0.0195505068082566,2.79502940887795e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,40396,-0.0324606217190766,0.00546302383069895,-0.0431681484272466,-0.0217530950109067,2.87642401999544e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37942,-0.0164589793733505,0.00277190926883438,-0.0218919215402659,-0.0110260372064351,2.96015142660854e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40377,0.0127425178000012,0.00214655949888194,0.00853526118219263,0.0169497744178098,2.97668766491645e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,40194,0.0161148034331614,0.00271585101936884,0.0107917354351984,0.0214378714311243,3.02560142126272e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,40516,-0.0257040102873711,0.00433450351025072,-0.0341996371674625,-0.0172083834072797,3.08970934095308e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40341,-0.0565971607792924,0.00954602567653088,-0.0753073711052929,-0.0378869504532919,3.11342527327634e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,40044,-0.0396020547898213,0.00668569489672955,-0.0527060167874112,-0.0264980927922313,3.21984225289432e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,37942,-0.0124025338029194,0.00209381103874782,-0.0165064034388651,-0.00829866416697366,3.22981456311537e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,37990,0.0145749590040512,0.00246133028055045,0.00975075165417233,0.0193991663539301,3.26594599933677e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40341,-0.0541683961947295,0.00915298023389737,-0.0721082374531683,-0.0362285549362906,3.32349271412909e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,40305,-0.0335982248054295,0.00568020217957543,-0.0447314210773973,-0.0224650285334616,3.38765407326872e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,40359,-0.0380378015332942,0.00644134475433852,-0.0506628372517977,-0.0254127658147907,3.59268207954484e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,40536,-0.0138308043814065,0.00234348397639915,-0.0184240329751489,-0.00923757578766421,3.66754462953174e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40306,-0.020187296292371,0.00342434913709445,-0.0268990206010761,-0.0134755719836659,3.81776514711408e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40284,0.0195216583414963,0.00331315030982343,0.0130278837342424,0.0260154329487502,3.88881119774955e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40490,-0.0179315573253393,0.00304534408018544,-0.0239004317225028,-0.0119626829281758,3.98252900428016e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40228,-0.0229047742556653,0.00389019927175473,-0.0305295648283046,-0.0152799836830261,3.99280180086021e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37959,-0.0326485654117369,0.00555710146464056,-0.0435404842824324,-0.0217566465410414,4.32521316912712e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,37562,-0.0374598797496449,0.00638241433478354,-0.0499694118458206,-0.0249503476534692,4.48398097891228e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,40266,-0.0215317333439339,0.00367084688040339,-0.0287265932295246,-0.0143368734583432,4.56431813274834e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40341,-0.0582373075580955,0.00993238460676087,-0.0777047813873468,-0.0387698337288442,4.62543760172578e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40328,-0.020234721138814,0.00345440949672357,-0.0270053637523922,-0.0134640785252358,4.78745607111427e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,37477,0.034584184113073,0.00590693801816107,0.0230065855974773,0.0461617826286687,4.88972398239471e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,37671,-0.0410663838098953,0.00702272424361439,-0.0548309233273795,-0.0273018442924111,5.10367504661603e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37990,-0.022255884115661,0.00380834899177107,-0.0297202481395323,-0.0147915200917897,5.21433917875836e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,40332,-0.050249917649483,0.00861435370794867,-0.0671340509170624,-0.0333657843819036,5.54058736696739e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,40274,-0.0270934097606371,0.00464496981668092,-0.0361975506013317,-0.0179892689199425,5.55519301412226e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,37901,-0.0372907448971329,0.00639831211361705,-0.0498314366398223,-0.0247500531544435,5.73069315891548e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,38013,0.041622193619993,0.00714168948430491,0.0276244822307554,0.0556199050092306,5.73497145157849e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,40471,-0.0355977800828588,0.00611430595709508,-0.0475818197587652,-0.0236137404069525,5.92430956250403e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40450,-0.0167866861690104,0.00288490528864237,-0.0224411005347494,-0.0111322718032713,6.04046258252439e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,39924,-0.037629210841894,0.00646835747123485,-0.0503071914855143,-0.0249512301982737,6.09399297977554e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37928,-0.0225324581043163,0.00387549634032092,-0.0301284309313453,-0.0149364852772873,6.23482119843466e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,40341,0.0229584253924916,0.00395426932860285,0.01520805750843,0.0307087932765532,6.52099312987528e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,37562,-0.0218006422538794,0.00375444617683428,-0.0291593567604746,-0.0144419277472842,6.52239067138949e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40330,-0.0402862773346526,0.00694373170596797,-0.0538959914783498,-0.0266765631909554,6.68482201102743e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,40147,-0.0255873570808276,0.00441081445185393,-0.0342325534064613,-0.0169421607551939,6.71696311076845e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,37959,-0.0370950575682204,0.00639673335899875,-0.0496326549518579,-0.0245574601845828,6.81785523947829e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39961,-0.035255618033687,0.0060885093387001,-0.0471890963375392,-0.0233221397298348,7.15276878108569e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,40359,0.0208635117290451,0.00360690192702868,0.0137939839520688,0.0279330395060213,7.41691433726734e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40403,0.015140589752519,0.00262076166319344,0.0100038968926599,0.0202772826123782,7.73827223308227e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40422,-0.072421285921051,0.0125385467544318,-0.0969968375597374,-0.0478457342823646,7.797044532559e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,40444,0.0232653089262533,0.00403223289436119,0.0153621324533054,0.0311684853992012,8.08181150916797e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,37572,-0.0225150869229846,0.0039031863714617,-0.0301653322110495,-0.0148648416349196,8.18400134377969e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,40305,-0.0496302385311452,0.00861529139832782,-0.0665162096718678,-0.0327442673904227,8.53117339231915e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,40305,-0.0746222105081029,0.0129700214815778,-0.100043452611995,-0.0492009684042104,8.90604485975873e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,40044,-0.0433737960911684,0.00753926050983378,-0.0581507466904426,-0.0285968454918942,8.92881368854035e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40341,-0.0204663708688099,0.00355891961434828,-0.0274418533129325,-0.0134908884246872,9.04942303407106e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,39725,0.0172751499022632,0.00300609723712669,0.0113831993174949,0.0231671004870315,9.27356601321191e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37628,-0.053255809004835,0.00928545040585727,-0.0714552918003152,-0.0350563262093547,9.94170904103273e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37959,-0.0372131843688768,0.00649174522821428,-0.0499370050161768,-0.0244893637215768,1.01145160054139e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37598,-0.0288537093213837,0.00504419728262131,-0.0387403359953215,-0.018967082647446,1.08730679290746e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37959,-0.0619491664380283,0.0108330713317174,-0.0831819862481944,-0.0407163466278622,1.09729560045539e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40330,-0.0106026913859666,0.00185629102263077,-0.0142410217903229,-0.00696436098161027,1.13815055266812e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,40291,-0.0222983764363581,0.0039050142861631,-0.0299522044372378,-0.0146445484354785,1.14873283429739e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,40228,-0.0440699620018662,0.00772174921109936,-0.0592045904556209,-0.0289353335481114,1.16878339224923e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37959,-0.0389144225988871,0.00682069570729328,-0.0522829861851819,-0.0255458590125923,1.18544241698383e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37671,-0.0381906326539839,0.00669822528865014,-0.0513191542197382,-0.0250621110882296,1.21223723841209e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39980,-0.0342687937672783,0.0060210821449551,-0.0460701147713903,-0.0224674727631663,1.28226817771012e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,37671,-0.0160403383807988,0.00281831390111626,-0.0215642336269867,-0.0105164431346109,1.28628710948506e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,40332,-0.0302435946894085,0.00532013915725367,-0.0406710674376257,-0.0198161219411913,1.33316337190708e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37942,0.0167709098532459,0.00295193842510728,0.0109851105400356,0.0225567091664561,1.36420711959581e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40332,-0.0161478492206826,0.00284349126976766,-0.0217210921094273,-0.010574606331938,1.37951814464114e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37942,-0.0171728786439632,0.00302614374566561,-0.0231041203854678,-0.0112416369024586,1.41675353739251e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,37671,-0.0292674984494356,0.00515942795767702,-0.0393799772464825,-0.0191550196523886,1.43574815623944e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40044,-0.0294442650252136,0.00520054709618462,-0.0396373373337355,-0.0192511927166918,1.52465712640388e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,40042,-0.0265191167156137,0.00468488431371661,-0.0357014899704983,-0.0173367434607291,1.53527426149907e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,37572,-0.043052983366484,0.00760635894017399,-0.057961446889225,-0.028144519843743,1.54426315230442e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37598,-0.0309170840619604,0.0054631386394399,-0.0416248357952626,-0.0202093323286582,1.55242502450428e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,37998,-0.0443755101987825,0.00785117720824673,-0.0597638175269461,-0.0289872028706189,1.61711517465209e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40332,-0.0203364455488346,0.00359984347043399,-0.0273921387508852,-0.0132807523467839,1.63905123498037e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37901,-0.0426207048144491,0.00754433877288901,-0.0574076088093116,-0.0278338008195866,1.64309469693166e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39976,-0.0418144176702296,0.00740868857367529,-0.0563354472746331,-0.027293388065826,1.69077810278079e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37942,-0.0284689513709209,0.00504924692431283,-0.038365475342574,-0.0185724273992677,1.75226002790951e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,40471,-0.0700654353135723,0.0124427718326414,-0.0944532681055495,-0.0456776025215952,1.82159346153317e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,40341,-0.0199993645957414,0.00355554467569064,-0.0269682321600951,-0.0130304970313878,1.88810664402334e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,39961,-0.0330129955654974,0.00587562790697205,-0.0445292262631626,-0.0214967648678322,1.95783697583376e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,40341,-0.0179447125778568,0.00319637647499202,-0.0242096104688412,-0.0116798146868725,2.00916252820553e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,40332,-0.0285328082347494,0.00508294591178728,-0.0384953822218524,-0.0185702342476463,2.01662134373863e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,40044,-0.0491337460250375,0.0087573021494393,-0.0662980582379385,-0.0319694338121364,2.05051492673378e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40411,-0.0176949985360643,0.00315914797624881,-0.0238869285695119,-0.0115030685026166,2.16394346050731e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,40305,0.00810384847442961,0.00144704759379467,0.00526763519059206,0.0109400617582672,2.175792143468e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,40422,-0.0490995099798963,0.00877241017400371,-0.0662934339209436,-0.031905586038849,2.21630867782595e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37653,-0.028979886856943,0.00518356193182013,-0.0391396682433104,-0.0188201054705755,2.30603866312834e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,37901,-0.0360887307751359,0.00646734267208829,-0.0487647224124289,-0.0234127391378428,2.44956869117487e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,37987,-0.0481149086135391,0.00862421457029165,-0.0650183691713107,-0.0312114480557675,2.46477371964094e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,37604,0.0182008969035036,0.00326241308656475,0.0118065672538367,0.0245952265531705,2.46727571141716e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,40483,-0.0369075379845521,0.00662198518987471,-0.0498866289567065,-0.0239284470123977,2.53715803143851e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37671,-0.0444944921574069,0.00799733878685304,-0.0601692761796389,-0.0288197081351749,2.69304796768565e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40536,0.017491737069771,0.00314455868477149,0.0113284020476189,0.0236550720919232,2.7011141259745e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37901,-0.077884954324367,0.0140060926844925,-0.105336895985972,-0.0504330126627617,2.73673335944411e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40373,-0.0141959223978921,0.00255771023401642,-0.0192090344565643,-0.00918281033921993,2.89820448997542e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37901,0.0364646327521259,0.00657684661481145,0.0235740133870954,0.0493552521171563,3.00530605704625e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40341,-0.0587975055132292,0.0106137769162861,-0.0796005082691499,-0.0379945027573085,3.07740087705824e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40228,-0.0418115059051503,0.0075517939633404,-0.0566130220732975,-0.0270099897370031,3.13262923278813e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37557,-0.0444654299760965,0.0080401760866284,-0.0602241751058882,-0.0287066848463048,3.25610384801509e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40042,0.0168570295285597,0.00305568906104865,0.0108678789689044,0.0228461800882151,3.5111331587921e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40332,-0.0405200370374842,0.00735406897025537,-0.0549340122191847,-0.0261060618557837,3.6466346779202e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,37959,-0.0252799834028388,0.00458800507938009,-0.0342724733584238,-0.0162874934472538,3.65369319108456e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,40221,0.0150395772595727,0.00273006073020032,0.0096886582283801,0.0203904962907653,3.66776255821042e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39978,-0.0257182210693954,0.0046690162603926,-0.0348694929397649,-0.0165669491990259,3.68127877805594e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37635,0.0254632870749814,0.00463109353333311,0.0163863437496485,0.0345402304003143,3.90535759126507e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,37900,-0.0365829842491837,0.00665501574196319,-0.0496268151034316,-0.0235391533949359,3.93224057541323e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,37562,-0.031109596254383,0.00566632995006521,-0.0422156029565108,-0.0200035895522552,4.08820707206387e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40305,-0.0465609117653471,0.00850837290638536,-0.0632373226618624,-0.0298845008688318,4.50808598982577e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,40260,-0.0294520483550685,0.00538300803823231,-0.0400027441100039,-0.0189013526001332,4.53539341923297e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37942,0.0341653979487117,0.00624426231042826,0.0219266438202723,0.0464041520771511,4.54235567057234e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,40379,0.0173725958245061,0.00317559385337817,0.0111484318718848,0.0235967597771273,4.55123061396987e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,39980,-0.0197406986452612,0.00361307378269473,-0.0268223232593429,-0.0126590740311795,4.73528469599255e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,39980,-0.0239790734196651,0.00438989081842858,-0.0325832594237851,-0.0153748874155451,4.77127264092285e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37959,-0.0317969135586439,0.00582087553948046,-0.0432058296160256,-0.0203879975012622,4.7760900420245e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37959,-0.055842891599432,0.0102380951427143,-0.075909558079152,-0.0357762251197119,4.99969678791415e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,37942,-0.0553570214374108,0.0101534578599483,-0.0752577988429095,-0.0354562440319121,5.06721448637368e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,40299,-0.0146953303337112,0.00269751773724669,-0.0199824650987147,-0.00940819556870768,5.17793556074961e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37628,-0.0481588542442941,0.00887351149083527,-0.0655509367663312,-0.030766771722257,5.82382637356062e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,37177,-0.0637004407284086,0.0117486994012013,-0.0867278915547631,-0.0406729899020542,6.00405652833614e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,37998,-0.0426257762644463,0.0078650633879662,-0.05804130050486,-0.0272102520240325,6.07426775596474e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,40167,-0.0200346116401191,0.0036969579129624,-0.0272806491495255,-0.0127885741307128,6.07429983878114e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,40379,0.0169621783519175,0.00313147211197758,0.0108244930124415,0.0230998636913936,6.15971816886763e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40305,-0.0287085628561009,0.00530065744938379,-0.0390978514568932,-0.0183192742553087,6.18218975980028e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39980,-0.0294552298115658,0.00543916069563164,-0.0401159847750038,-0.0187944748481278,6.20612087114686e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,40359,-0.0293144600482343,0.00541631252064271,-0.0399304325886941,-0.0186984875077746,6.31374623458997e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37671,-0.0280847522651012,0.00518989271682586,-0.0382569419900799,-0.0179125625401225,6.36128120454002e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40287,-0.0456664404315715,0.0084459335338062,-0.0622204701578317,-0.0291124107053114,6.50488714352834e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37598,-0.047442566944162,0.00877406557163921,-0.0646397354645748,-0.0302453984237491,6.51598272486774e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,40453,-0.0142826941842813,0.00264254921078961,-0.0194620906374289,-0.00910329773113362,6.577582177754e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37608,-0.0291151271228118,0.00538655792497081,-0.0396727806557546,-0.018557473589869,6.58853233354439e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,38013,0.0116327454413861,0.00215362889660056,0.007411632804049,0.0158538580787232,6.72149739796476e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,39961,0.0378062918578979,0.00700375610931648,0.0240789298836376,0.0515336538321582,6.83777262254636e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,40436,-0.0204833496089019,0.00379549069016476,-0.0279225113616249,-0.013044187856179,6.88222598994084e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,40305,0.0108996075767871,0.00202182442679701,0.00693683170026496,0.0148623834533092,7.10785909211665e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,37942,0.0188040500214732,0.00349443079908591,0.0119549656552649,0.0256531343876816,7.52491737185729e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37628,-0.0291813946375692,0.00542512875812926,-0.0398146470035026,-0.0185481422716358,7.62095772471299e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,37484,-0.0279300932478723,0.00519819506697839,-0.03811855557915,-0.0177416309165947,7.87533890499501e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,40291,-0.036044901739712,0.00671174229816651,-0.0491999166441183,-0.0228898868353056,7.96600668652567e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,37959,0.0227133197337879,0.00423555103552247,0.0144116397041639,0.031014999763412,8.34102448601958e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39980,-0.0503329817238712,0.00938882910502544,-0.0687350867697211,-0.0319308766780214,8.39718955192432e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,37987,0.0131832446827012,0.0024606400764698,0.00836039013282041,0.018006099232582,8.56926375744219e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,37671,0.0111273083784144,0.00207899305579802,0.00705248198905024,0.0152021347677785,8.83140476530991e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,40355,0.0229955392388144,0.00429786563776362,0.0145717225887977,0.0314193558888311,8.89481656024558e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,37642,-0.0521973220363283,0.00975740082367342,-0.0713218276507282,-0.0330728164219284,8.96656440163169e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40305,-0.0524483993274588,0.00980951571251813,-0.0716750501239943,-0.0332217485309233,9.08204487951007e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,40516,-0.0388935565406547,0.00727467315602812,-0.0531519159264698,-0.0246351971548396,9.09304631825107e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40305,-0.0311255735419811,0.00583318538433314,-0.042558616895274,-0.0196925301886881,9.63533275397054e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,37901,-0.0389110407258771,0.00729440215363346,-0.0532080689469987,-0.0246140125047555,9.74302472497759e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40359,0.0144323965770713,0.00270886867476962,0.00912301397452286,0.0197417791796198,1.00745798430257e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37598,-0.0448615518931248,0.00842062080205094,-0.0613659686651447,-0.028357135121105,1.0117045213891e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,40359,0.0424606268341888,0.00797676818904167,0.0268261611836672,0.0580950924847105,1.03434360211683e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37575,-0.018055547455225,0.0033916382736524,-0.0247031584715837,-0.0114079364388663,1.03439589304284e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40228,-0.0479868490106638,0.00902214594622137,-0.0656702550652576,-0.0303034429560699,1.05887995112118e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37337,-0.0250127991228431,0.00470412986032989,-0.0342328936490896,-0.0157927045965965,1.07136587103725e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40422,-0.0193643188078605,0.0036428923714047,-0.0265043878558137,-0.0122242497599073,1.07709743002009e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40208,-0.0203700646652143,0.00383369389195376,-0.0278841046934436,-0.0128560246369849,1.09044503146897e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40359,-0.0341924625857613,0.00645486295469079,-0.0468439939769552,-0.0215409311945673,1.19181825886289e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,37942,-0.0684161498855985,0.0129517960934359,-0.0938016702287329,-0.0430306295424641,1.29507621543142e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37942,0.0134049119539473,0.00254293006734751,0.00842076902194617,0.0183890548859484,1.37442583481009e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40397,-0.0551041466537109,0.0104549656602814,-0.0755958793478624,-0.0346124139595594,1.37735307769962e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,40341,-0.033145191505353,0.00629339683181733,-0.045480249295715,-0.020810133714991,1.40737949632907e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37835,-0.0293840173979198,0.00558152755161797,-0.0403238113990911,-0.0184442233967486,1.42736552379523e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37990,-0.0309053950482362,0.00587358725597941,-0.0424176260699558,-0.0193931640265165,1.44861548750132e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40359,0.0141313690971187,0.00268653959960053,0.00886575148190166,0.0193969867123357,1.45871549195949e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40228,-0.0293218175002386,0.00557479374326473,-0.0402484132370375,-0.0183952217634398,1.46164702277926e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,40209,-0.0338362083253918,0.00644058304274628,-0.0464597510891745,-0.0212126655616091,1.51101410800448e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40340,-0.0282616791628482,0.00538283327239411,-0.0388120323767406,-0.0177113259489557,1.53778123565755e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37959,-0.0246615571973865,0.00470569514614557,-0.0338847196838318,-0.0154383947109412,1.6229866583253e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37901,-0.0444894297843452,0.00849378349026432,-0.0611372454252632,-0.0278416141434271,1.64881552870948e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,40228,-0.0241813788240785,0.00461710573548258,-0.0332309060656243,-0.0151318515825326,1.64995282232942e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,37901,-0.0510850182322261,0.0097562552161722,-0.0702072784559236,-0.0319627580085286,1.66449925835414e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,37598,-0.0168022720923311,0.00320987959026135,-0.0230936360892433,-0.0105109080954189,1.67935454998542e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37150,0.0553460906584655,0.0105749180923451,0.0346192511974691,0.0760729301194618,1.68786036266209e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,39980,-0.0214146438957681,0.00409389287448053,-0.0294386739297499,-0.0133906138617863,1.70900838847274e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37598,-0.0451970223364998,0.00866020255283515,-0.0621710193400567,-0.0282230253329429,1.82695840560552e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,37572,-0.0221109323866614,0.00423785488511278,-0.0304171279614825,-0.0138047368118404,1.84135325633139e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,40471,-0.0111003054905637,0.00213058685208208,-0.0152762557206446,-0.00692435526048285,1.91206731610819e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40442,-0.0137747168136115,0.00264759305638042,-0.0189639992041171,-0.00858543442310585,1.98805779712006e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,40204,-0.0254495447757426,0.00489260105233449,-0.0350390428383182,-0.015860046713167,2.00013607059541e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40341,-0.0743161983896531,0.0143101337960623,-0.102364060629935,-0.046268336149371,2.09197605162844e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,40411,-0.0353089895370676,0.0068134690488798,-0.048663388872872,-0.0219545902012632,2.21916238153384e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,37541,-0.0193047206427314,0.00372752645434055,-0.0266106724932389,-0.0119987687922239,2.26434103108994e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40042,-0.0273109986015891,0.00528173442463748,-0.0376631980738786,-0.0169587991292996,2.35928312863313e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,37598,-0.0282807748513677,0.0054723931638042,-0.039006665452424,-0.0175548842503115,2.40209108926399e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37572,-0.0212342349338074,0.00411023933743412,-0.0292903040351783,-0.0131781658324366,2.42430467219105e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,38013,0.0162758114783114,0.00315373780549172,0.0100944853795476,0.0224571375770752,2.49369688763394e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,37671,-0.03789661330314,0.00734730131604831,-0.0522973238825947,-0.0234959027236854,2.53352471058723e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37900,-0.0403380260094008,0.00783087511089452,-0.0556865412267541,-0.0249895107920475,2.62552850567566e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,40185,-0.0283810219604533,0.00551992438006303,-0.0392000737453769,-0.0175619701755298,2.75733846664366e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40457,-0.0127664579761686,0.00248530064553134,-0.0176376472414101,-0.00789526871092721,2.82758739999484e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,37900,-0.0155966214012988,0.00304100385863059,-0.0215569889642148,-0.00963625383838287,2.95690361594794e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,40433,-0.0290760305805247,0.00566998255901811,-0.0401891963962002,-0.0179628647648492,2.96158088154742e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37628,-0.0422612011886913,0.00825183418070655,-0.0584347961828761,-0.0260876061945064,3.07505242571618e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,40305,-0.0435909162138636,0.00852383210554746,-0.0602976271407366,-0.0268842052869906,3.1907541351328e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,40536,0.00826861315514972,0.00162259362318871,0.00508832965369985,0.0114488966565996,3.50976747520496e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37628,-0.0356018053121289,0.00698748389349876,-0.0492972737433864,-0.0219063368808713,3.5341241775742e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40379,-0.0161917754124857,0.00317959479164779,-0.0224237812041154,-0.00995976962085601,3.57589432115847e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,40333,-0.043817165553627,0.00860458518557991,-0.0606821525173637,-0.0269521785898904,3.57785691011463e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,40341,-0.0327064871789927,0.00642303751669227,-0.0452956407117095,-0.0201173336462758,3.58245729226331e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40359,0.0374095450768197,0.00735308485434885,0.0229974987622959,0.0518215913913434,3.6675349892709e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,39961,-0.0504896822615983,0.0099376442513282,-0.0699674649942016,-0.031011899528995,3.80516528132441e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37942,0.0293393912580933,0.00577503258662904,0.0180203273883004,0.0406584551278863,3.81702228226075e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,40354,-0.0372165370458111,0.00733676831805118,-0.0515966029491915,-0.0228364711424308,3.96821223805626e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,37598,-0.0242430173627856,0.00478341409930831,-0.0336185089974299,-0.0148675257281413,4.0717651960006e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,40502,-0.0255198474118343,0.00504823223064486,-0.0354143825838982,-0.0156253122397704,4.34660838149502e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37959,-0.0433789439553346,0.0085839669716622,-0.0602035192197925,-0.0265543686908767,4.39492023750655e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,37900,-0.0313628632106021,0.00620897513258757,-0.0435324544704737,-0.0191932719507305,4.44764033958242e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,37901,-0.0499113021079519,0.00988808228361014,-0.0692919433838278,-0.0305306608320761,4.53189164276444e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,40332,-0.0160749793018923,0.00318522560709887,-0.0223180214918061,-0.0098319371119785,4.54398496440161e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,40228,-0.048411063602674,0.00961329022892993,-0.0672531124513766,-0.0295690147539713,4.80987550547974e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,37598,-0.0169203206932479,0.0033617967908959,-0.0235094424034038,-0.0103311989830919,4.8894626474582e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40358,-0.0478029553416313,0.0095000419101742,-0.0664230374855727,-0.0291828731976898,4.91022332426056e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,37990,-0.0256667321562409,0.00510292034047414,-0.0356684560235703,-0.0156650082889116,4.97246845780773e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,40442,-0.0333735397925895,0.00664401439000292,-0.0463958079969952,-0.0203512715881838,5.13923735708254e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,40332,-0.0194202754641099,0.00387186331236149,-0.0270091275563384,-0.0118314233718814,5.33986762845918e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,37990,-0.0139108086609657,0.00277440963947604,-0.0193486515543388,-0.00847296576759269,5.39925662481451e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,40203,0.0149153017546769,0.00297600567011458,0.00908233064125234,0.0207482728681015,5.44932334470852e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37990,-0.0509902968338895,0.0101733855580443,-0.0709301325276563,-0.0310504611401227,5.45117390758689e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37990,-0.0466554418396181,0.00930924833787096,-0.0649015685818452,-0.028409315097391,5.46239560605405e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40341,-0.021494432577988,0.00429451182307669,-0.0299116757512183,-0.0130771894047577,5.6432188597127e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,40332,0.0159021228412654,0.00317740942692475,0.00967440036449285,0.0221298453180379,5.65346129720444e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,39934,-0.0296497865853769,0.00592759572384846,-0.0412678742041198,-0.0180316989666339,5.73623806875972e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,37990,-0.0167073040432491,0.00334109883623634,-0.0232558577622724,-0.0101587503242259,5.78851577331172e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,40228,-0.0343004918644271,0.0068623510661644,-0.0477506999541094,-0.0208502837747449,5.84400330872912e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37628,-0.0391000895103894,0.00783523815232537,-0.0544571562889471,-0.0237430227318317,6.10590018035977e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37598,-0.0230887968356355,0.0046416326004864,-0.0321863967325888,-0.0139911969386821,6.63167449849321e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37990,-0.0425020180469774,0.00855584700380974,-0.0592714781744445,-0.0257325579195103,6.86140614042938e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,37705,-0.0106148493988312,0.00213728841194962,-0.0148039346862524,-0.00642576411140994,6.90200712952319e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40403,-0.0198740288010397,0.0040053747377845,-0.0277245632870973,-0.0120234943149821,7.05478814286825e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,37598,0.0126347010140903,0.00254628131196346,0.0076439896426419,0.0176254123855387,7.06364670195339e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40471,0.0128550031872626,0.0025981209566861,0.00776268611215782,0.0179473202623673,7.58154932420021e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,40139,-0.0360260922214541,0.00728923427685317,-0.0503129914040864,-0.0217391930388219,7.79749404611386e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,39877,-0.0399436834465978,0.00809839472364241,-0.0558165371049369,-0.0240708297882587,8.2114591446022e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40536,0.0128805982266079,0.00261250954561447,0.00776007951720355,0.0180011169360123,8.28987156658983e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,39665,-0.0105806623000377,0.00214889655396993,-0.0147924995458187,-0.00636882505425664,8.57849211561652e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,37402,-0.0370068603298329,0.00751701763006487,-0.0517402148847601,-0.0222735057749058,8.62434280529685e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37901,-0.0410177432762359,0.00833353492322498,-0.0573514717257568,-0.0246840148267149,8.66750575261266e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40306,-0.0324176068462456,0.00659333821529626,-0.0453405497482263,-0.019494663944265,8.88862201486281e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,37572,-0.0211161175278521,0.00429719901285094,-0.0295386275930399,-0.0126936074626642,9.03483522304966e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,37987,-0.0319573011921645,0.00650490702204707,-0.0447069189553768,-0.0192076834289523,9.08350170357792e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37562,-0.0315261996989748,0.00642994845894337,-0.0441288986785038,-0.0189235007194458,9.55024010599318e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40411,-0.0285899823758247,0.00583276306566781,-0.0400221979845337,-0.0171577667671158,9.59836083053179e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40341,0.018718609184539,0.00381901439747314,0.0112333409654917,0.0262038774035864,9.60829003858741e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,40359,-0.0590139572908595,0.0120561992916162,-0.0826441079024272,-0.0353838066792917,9.93169952267941e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37951,-0.0316178172430591,0.00645935719995035,-0.0442781573549618,-0.0189574771311565,9.94996412198928e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,37959,-0.0355008898087475,0.00725501466453767,-0.0497207185512413,-0.0212810610662536,1.00308236288761e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,37959,-0.0347947421437066,0.0071184668103138,-0.0487469370919217,-0.0208425471954916,1.03059592014001e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,37622,-0.0307777675434381,0.00629816904637513,-0.0431221788743334,-0.0184333562125428,1.0370512661489e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,40516,-0.0236946846794313,0.0048507593045599,-0.0332021729163687,-0.0141871964424939,1.04564027174956e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,40516,-0.0292972495431447,0.00601002653671468,-0.0410769015551055,-0.017517597531184,1.09998809458015e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37900,-0.0499680138727387,0.0102556852776879,-0.070069157017007,-0.0298668707284704,1.11605505657378e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,40044,-0.0526528765020805,0.0108260484397199,-0.0738719314439315,-0.0314338215602296,1.16431894311712e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,40411,-0.0294830304841128,0.00606254827474307,-0.0413656251026092,-0.0176004358656164,1.16637898196777e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37950,-0.00918067260865291,0.00188919951238681,-0.0128835036529311,-0.00547784156437477,1.18971098229197e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,40044,0.0139405986830769,0.00287416046465491,0.00830724417235326,0.0195739531938005,1.24452189526646e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,37882,-0.021255840663525,0.00438566805911665,-0.0298517500593936,-0.0126599312676564,1.2696144742639e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37901,-0.0418474552213704,0.00863989711392329,-0.05878165356466,-0.0249132568780807,1.28984038892629e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37901,-0.0270871346370939,0.00559542030460795,-0.0380541584341255,-0.0161201108400623,1.30657946993438e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,40516,-0.0408215634020865,0.00843354683757249,-0.0573513152037286,-0.0242918116004444,1.30796223792311e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37901,-0.0125744325421804,0.00259808622025468,-0.0176666815338796,-0.00748218355048124,1.31358561270435e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,39947,-0.0400034613663893,0.0082675011471034,-0.056207763614712,-0.0237991591180666,1.31988765461178e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37990,-0.0133463303488201,0.00275948540181848,-0.0187549217363844,-0.00793773896125592,1.33579933082235e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,37785,0.0192558381263251,0.00398163067318388,0.0114518420068847,0.0270598342457655,1.33843943654603e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,37942,-0.032217545932675,0.0066623809282943,-0.0452758125521318,-0.0191592793132182,1.34114614384877e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,37628,-0.0239309089395383,0.00495247948877071,-0.0336377687375289,-0.0142240491415477,1.36617899018569e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40377,-0.0183159431345487,0.00379161104180724,-0.0257475007764909,-0.0108843854926065,1.37354641144972e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,40330,-0.0166731361529677,0.0034521362335836,-0.0234393231707916,-0.00990694913514387,1.37942964474743e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40411,-0.0383917218878505,0.00795139717562481,-0.0539764603520751,-0.0228069834236259,1.38980322698095e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40042,-0.0427313834375883,0.00885456299071138,-0.0600863268993826,-0.025376439975794,1.4068025436435e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,37541,-0.0252138047538374,0.00522650974571482,-0.0354577638554384,-0.0149698456522363,1.42140083847272e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,40251,-0.0265805850670394,0.00551854479472685,-0.0373969328647041,-0.0157642372693748,1.47384151243114e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,40044,-0.030364604847714,0.00631017715992303,-0.0427325520811631,-0.0179966576142648,1.50822436618215e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37628,-0.0354004552191041,0.00735720963099639,-0.049820586095857,-0.0209803243423512,1.51334218289726e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,40250,-0.0131071455708111,0.00272852618026526,-0.018455056884131,-0.00775923425749121,1.57154001779271e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40341,-0.03655359437764,0.00761341368806082,-0.0514758852062392,-0.0216313035490408,1.59146433422972e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37901,-0.0529845343128166,0.0110683681164212,-0.0746785358210022,-0.031290532804631,1.71075081857252e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37790,-0.0255321664636383,0.00533697412862547,-0.0359926357557442,-0.0150716971715324,1.73667264245927e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,37572,-0.0311993835537435,0.00652187206243491,-0.0439822527961159,-0.0184165143113711,1.73877098871539e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37900,-0.0197743457249279,0.0041366774810064,-0.0278822335877004,-0.0116664578621553,1.76932306969873e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,37987,0.011214601889788,0.00234903303625662,0.00661049713872501,0.015818706640851,1.82369917201925e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,37643,-0.0641673705222849,0.0134483471033576,-0.0905261308448658,-0.037808610199704,1.84915447117146e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,40014,-0.0180681185784189,0.00378769970187066,-0.0254920099940854,-0.0106442271627524,1.85704153047434e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,37942,-0.0379450715753619,0.00795790926804369,-0.0535425737407276,-0.0223475694099963,1.87802191415906e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37714,-0.015759287794026,0.00331152133234228,-0.0222498696054169,-0.00926870598263514,1.96678671382637e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37628,-0.0293788231922361,0.00617364371236126,-0.0414791648684641,-0.017278481516008,1.96864826314042e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,37905,-0.0435537302806966,0.0091550000294661,-0.0614975303384501,-0.025609930222943,1.98168195527191e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,39980,-0.0238333410428151,0.00501504180130781,-0.0336628229733784,-0.0140038591122518,2.02845864880557e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40305,-0.0156638452532194,0.003299211736811,-0.022130300257369,-0.00919739024906986,2.07486266974734e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37959,-0.0533298506333648,0.0112517794728084,-0.0753833384000692,-0.0312763628666603,2.16237662599308e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,37770,-0.0148229157008013,0.00312851888027721,-0.0209548127061446,-0.00869101869545798,2.18069839213585e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,40536,0.0105268053236418,0.00222320124982384,0.00616933087398706,0.0148842797732965,2.20948745897806e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,40311,-0.0395356455537614,0.00835303821272722,-0.0559076004507067,-0.023163690656816,2.23041573954865e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,37628,-0.0135079033249116,0.00285538366864676,-0.0191044553154593,-0.00791135133436398,2.26092975890882e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,40471,-0.0125850982454002,0.00266249708216394,-0.0178035925264415,-0.00736660396435889,2.30022559508158e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,40349,-0.0191163647798221,0.00405195448131225,-0.0270581955631942,-0.0111745339964501,2.40421274491237e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,40379,0.0133188121760967,0.00282420967168977,0.00778336121958481,0.0188542631326087,2.42633554717407e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39836,-0.0540604095376559,0.0114806504542359,-0.0765624844279582,-0.0315583346473536,2.51319603349812e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40044,-0.0195777443534144,0.00415962640973913,-0.0277306121165031,-0.0114248765903257,2.5403354398338e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,37714,-0.024497024146968,0.00520466564303643,-0.0346981688073194,-0.0142958794866166,2.54251213425901e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40203,0.0150453423378417,0.00319748207694483,0.00877827746702987,0.0213124072086536,2.55557472839773e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,40422,0.0279415323086784,0.00594224048964296,0.0162947409489782,0.0395883236683786,2.59540309622218e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,37900,-0.0178280323708677,0.00379122183801323,-0.0252588271733736,-0.0103972375683617,2.59612238729796e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37541,0.0128013682193752,0.00272634430598115,0.00745773337965216,0.0181450030590983,2.68742943221858e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40489,0.0144798474200886,0.00308422233018689,0.00843477165292229,0.0205249231872549,2.69059004608008e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40305,-0.0250335392699097,0.00533963088359414,-0.0354992158017542,-0.0145678627380652,2.77842099375161e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,40341,-0.0317036233320433,0.00676565359158523,-0.0449643043715504,-0.0184429422925363,2.80953101560981e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37562,-0.0301506292384932,0.0064351869933994,-0.042763595745556,-0.0175376627314304,2.82392781000555e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37598,-0.0354579252930168,0.00757082245796093,-0.0502967373106202,-0.0206191132754133,2.84844281698708e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,39961,-0.0322960354566385,0.0068997248724318,-0.0458194962066049,-0.0187725747066722,2.88215313272111e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40305,-0.0310052545564448,0.00662542010239767,-0.0439910779571442,-0.0180194311557453,2.89611810769058e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37671,-0.00943704984814055,0.00202290340950784,-0.0134019405307759,-0.00547215916550518,3.11488889297252e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,37628,-0.0186229182312313,0.0039948183554639,-0.0264527622079406,-0.0107930742545221,3.16579003677357e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40305,-0.0143652867280727,0.00308211521884884,-0.0204062325570164,-0.008324340899129,3.17464937197598e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37990,-0.0132389291566119,0.00284203583459758,-0.0188093193924232,-0.00766853892080064,3.21935594556382e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37901,-0.0206993733868256,0.0044443191642794,-0.0294102389488132,-0.0119885078248379,3.23152484103599e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,39980,-0.0214575459149413,0.0046227775865932,-0.030518189984664,-0.0123969018452186,3.48381819877103e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40042,-0.0487570758240473,0.0105196558985264,-0.0693756013851591,-0.0281385502629356,3.60082648571296e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40341,-0.0207421885793197,0.00447563442640269,-0.029514432055069,-0.0119699451035705,3.60699017631429e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37959,-0.0370155731342896,0.00799309565255511,-0.0526820406132976,-0.0213491056552816,3.67398385279384e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,40332,-0.0116549710045806,0.00252178764498484,-0.0165976747887509,-0.00671226722041034,3.83584399367234e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40310,-0.0276635107429018,0.0059972319512658,-0.0394180853673828,-0.0159089361184208,4.00554681059312e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,37562,-0.0176291093263444,0.00382208074322663,-0.0251203875830686,-0.0101378310696202,4.0173990219292e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39980,-0.0259795252758111,0.00564284941583081,-0.0370395101308395,-0.0149195404207827,4.17793126889093e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,40341,-0.0134735592968295,0.00292836313945068,-0.0192131510501528,-0.00773396754350613,4.23605820129208e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,37482,-0.0247494171281118,0.00538587819497774,-0.0353057383902682,-0.0141930958659554,4.36302851765066e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37628,-0.0230843434660837,0.00502448523768026,-0.032932334531937,-0.0132363524002304,4.38084571750845e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40305,-0.0506532049081865,0.0110263942187544,-0.0722649375769452,-0.0290414722394278,4.3856837501403e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37990,-0.0141296053618873,0.00307913423504503,-0.0201647084625756,-0.00809450226119906,4.49754324313017e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,37990,-0.0312752957908812,0.00681951445995599,-0.0446415441323949,-0.0179090474493674,4.55547810484954e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37628,0.0161198738677131,0.00351507844551817,0.0092303201144975,0.0230094276209287,4.56150720686433e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40400,-0.0226374615079985,0.00495878430907426,-0.0323566787537841,-0.012918244262213,5.02930976752886e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37628,-0.0139105557766612,0.00305054017191948,-0.0198896145136234,-0.007931497039699,5.16070861557775e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,37541,-0.0277882107094643,0.00609557369124243,-0.0397355351442995,-0.0158408862746292,5.19246761736539e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,37884,-0.0383551633858154,0.00841388417470983,-0.0548463763682466,-0.0218639504033841,5.19611606424529e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40489,-0.0273004952267716,0.00599076787199007,-0.0390424002558721,-0.015558590197671,5.22488820689221e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,37921,-0.0138178120251551,0.00303226110042036,-0.019761043781979,-0.00787458026833117,5.2362163588182e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,37998,0.0141447605112888,0.00310528782591752,0.00805839637249047,0.0202311246500871,5.28286241838302e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39961,-0.0201191701348982,0.00442377959697006,-0.0287897781449595,-0.0114485621248368,5.45788283823459e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,39980,-0.025522300604246,0.00561894433131143,-0.0365354314936164,-0.0145091697148756,5.60924846154262e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39961,-0.0278730286823279,0.00614078700064829,-0.0399089712035986,-0.0158370861610572,5.69466357545606e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,40396,-0.0372416518062816,0.00820552810514402,-0.0533244868923639,-0.0211588167201993,5.70414249389379e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37942,-0.0416544392398832,0.00918686022423373,-0.0596606852793813,-0.0236481932003851,5.83387687301164e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,37671,-0.0375894936766223,0.00829885485436073,-0.0538552491911694,-0.0213237381620753,5.96466522800797e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37978,-0.0208192526783066,0.00459735664905698,-0.0298300717104583,-0.011808433646155,5.99039530476906e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37990,-0.0108260562219562,0.00239221902851074,-0.0155148055178372,-0.00613730692607513,6.07577447798236e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,37671,-0.0297735743834092,0.00658105289789685,-0.042672438063287,-0.0168747107035314,6.11712475842916e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37900,-0.0142940694943306,0.00316009770514063,-0.0204878609964063,-0.00810027799225498,6.1403902420552e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,37598,-0.0173164448142712,0.00382924210888564,-0.024821759347687,-0.00981113028085533,6.17471945336079e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,40359,-0.0283606677735015,0.00627664999172015,-0.0406629017572729,-0.01605843378973,6.27454741125763e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,40341,-0.0290020181804479,0.0064249839649919,-0.041594986751832,-0.0164090496090638,6.4090019535932e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39980,0.0161024956376398,0.00357488555494438,0.00909571994994884,0.0231092713253308,6.7065259566247e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,40332,-0.0283097872924104,0.00630798050242111,-0.0406734290771558,-0.0159461455076651,7.24233597985411e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37671,-0.050561658721976,0.0112818413356164,-0.0726740677397842,-0.0284492497041678,7.46782846686237e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37998,0.0151895303313766,0.00339765243028894,0.00853013156801027,0.0218489290947429,7.86355438288302e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,40393,0.0118951382424208,0.00266945489362281,0.00666300665092009,0.0171272698339215,8.40649578677731e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37900,-0.0399553416930695,0.00896629497856895,-0.0575292798510647,-0.0223814035350744,8.41107654369098e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39961,-0.0223278946453573,0.00501760813220099,-0.0321624065844712,-0.0124933827062433,8.65055037392893e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,40341,0.0164692987920142,0.00370141710583956,0.00921452126456862,0.0237240763194597,8.66724658593482e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,40267,-0.0146038079846948,0.00328470550017181,-0.0210418307650315,-0.00816578520435806,8.80786159109905e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40325,0.00944879697684278,0.00212730183101882,0.00527928538804589,0.0136183085656397,8.98618400757438e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37562,0.00855772734220606,0.00192663229747298,0.00478152803915901,0.0123339266452531,8.99372361506899e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37598,-0.0238803684933966,0.00538503456208426,-0.0344350362350817,-0.0133257007517115,9.30003332681495e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,37671,-0.0240469033397435,0.00542699325933602,-0.0346838101280421,-0.0134099965514449,9.45599740509611e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,40422,-0.0182637184568326,0.00412215081823762,-0.0263431340605783,-0.0101843028530869,9.45839704298762e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40311,-0.0369150704475376,0.00833315571390685,-0.053248055646795,-0.0205820852482802,9.490673598725e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37901,-0.0214919692369652,0.00485507517010548,-0.031007916570372,-0.0119760219035585,9.64386188769709e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,37959,0.0152714517756072,0.00345339978559805,0.00850278819583501,0.0220401153553794,9.84869940604134e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40385,-0.05025062258234,0.0113706602944082,-0.0725371167593802,-0.0279641284052999,9.96642895420469e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37900,-0.0363389893958903,0.00823541606282134,-0.0524804048790201,-0.0201975739127605,1.02966415013675e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,40310,-0.0195673715616784,0.00443592003678872,-0.0282617748337843,-0.0108729682895725,1.03515184837917e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37900,-0.0275619412994963,0.00624799559570642,-0.0398080126670809,-0.0153158699319117,1.03538403389543e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,40536,-0.0369239114044149,0.00837313275382485,-0.0533352516019116,-0.0205125712069182,1.0413330265166e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37564,-0.0119713915144124,0.00271452468100526,-0.0172918598891827,-0.00665092313964206,1.04134071232867e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,40435,-0.0185568719610915,0.00420938247934738,-0.0268072616206123,-0.0103064823015706,1.04789678504894e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37901,0.0211959848653588,0.00481691440981236,0.0117548326221266,0.030637137108591,1.08921397839477e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37959,-0.03573336621625,0.00812569810696436,-0.0516597345059001,-0.0198069979265998,1.10304187072377e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,40411,-0.0122331886030993,0.00278494367217744,-0.0176916782005671,-0.00677469900563153,1.12716139307491e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39961,-0.0306145123246261,0.00697198560221825,-0.0442796041049738,-0.0169494205442783,1.13538224223195e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,37942,-0.0114103164965297,0.00260203165258928,-0.0165102985356047,-0.00631033445745473,1.16780175150718e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,37714,-0.0140341143850509,0.00320310169462726,-0.0203121937065203,-0.0077560350635815,1.18817126324352e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40359,-0.0349615262709632,0.00798079639630705,-0.050603887207725,-0.0193191653342014,1.19051712117524e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37959,-0.0289957541729207,0.00662249578672583,-0.0419758459149034,-0.0160156624309381,1.20467931670889e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,40044,-0.0204306493780995,0.00467585122344226,-0.0295953177760463,-0.0112659809801527,1.25395158179888e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37714,-0.0205148483445331,0.00469615239043592,-0.0297193070297875,-0.0113103896592787,1.26088753002946e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40332,0.0149562236525513,0.00342435125119119,0.00824449520021661,0.0216679521048861,1.26410306410031e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37628,-0.0220884475383479,0.00505971461573581,-0.0320054881851901,-0.0121714068915057,1.27768735685174e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37900,-0.0210231196840766,0.00481817706630472,-0.0304667467340339,-0.0115794926341194,1.2907396609062e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37628,-0.0129874812315528,0.00297809278870498,-0.0188245430974146,-0.00715041936569104,1.30448687840621e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37562,-0.0148272891237056,0.00340097015418824,-0.0214931906259146,-0.00816138762149668,1.31219620479885e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37901,-0.0219403148454826,0.00505032927581809,-0.0318389602260861,-0.0120416694648792,1.40723129776277e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,40489,0.0103809989828228,0.00239317724365334,0.00569037158526226,0.0150716263803834,1.44829666947897e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37562,-0.0259802729366155,0.00599579721636483,-0.0377320354806906,-0.0142285103925405,1.48132031141184e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40341,-0.025179939844706,0.00581485671236409,-0.0365770590009396,-0.0137828206884723,1.49834151842321e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40536,0.0143400142622238,0.00331524571360898,0.0078421326635502,0.0208378958608974,1.53120236762489e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40411,-0.0298523989582069,0.0069133728962532,-0.0434026098348632,-0.0163021880815506,1.58352133552557e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,37942,-0.0187967780444575,0.00435577139017651,-0.0273340899692034,-0.0102594661197115,1.60468624560658e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,40374,-0.0121266760337048,0.00281263429923822,-0.0176394392602118,-0.00661391280719793,1.63124774263463e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37910,-0.0168280667772165,0.00390523770933902,-0.0244823326875209,-0.00917380086691197,1.65082832519024e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,40332,-0.0191422894308906,0.00444542912423723,-0.0278553305143955,-0.0104292483473856,1.67184118069905e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37671,-0.0336465474626926,0.00783437133233158,-0.0490019152740625,-0.0182911796513227,1.76150633187975e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37628,-0.014907879899083,0.00348351728891736,-0.021735573785361,-0.00808018601280496,1.88596154106475e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40311,-0.00770322105672721,0.00180242146211922,-0.0112359671224809,-0.00417047499097355,1.93275599777935e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,40470,-0.0244855651898622,0.00573312954958307,-0.035722499107045,-0.0132486312726794,1.95816669098699e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40228,0.0115125115776842,0.00269637421668316,0.00622761811298525,0.0167974050423832,1.9694492382597e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,40422,-0.0144189082688734,0.00337714340177052,-0.0210381093363436,-0.00779970720140321,1.96992014023956e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37959,0.0192175169678997,0.00450214263369111,0.0103933174058652,0.0280417165299343,1.98110747660426e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37990,-0.036415762783516,0.00853905000441231,-0.0531523007921641,-0.0196792247748679,2.0160545965586e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,37671,-0.0438068592165078,0.0102774866011408,-0.0639507329547438,-0.0236629854782719,2.03636562506706e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,37998,0.0124773930678506,0.0029331447324744,0.00672842939220075,0.0182263567435004,2.1146134387286e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,39961,-0.0286513089481367,0.00673728113618854,-0.0418563799750662,-0.0154462379212072,2.12491460695295e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,37987,0.00905200980082954,0.00212958247907763,0.00487802814183737,0.0132259914598217,2.14624298333245e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,40359,-0.00979209670541164,0.00230542854985995,-0.0143107366631371,-0.00527345674768614,2.17486521763647e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40192,-0.0299359395359596,0.00704817605730247,-0.0437503646082724,-0.0161215144636467,2.17574284366388e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,37482,-0.0209048121912024,0.00493232493089895,-0.0305721690557644,-0.0112374553266405,2.26740723130282e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,37628,-0.0204669054928276,0.00483664466164972,-0.029946729029661,-0.0109870819559941,2.33570698968324e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,40044,-0.0225935176153407,0.00534590043111794,-0.0330714824603319,-0.0121155527703495,2.3888927231328e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40341,-0.0324440154812807,0.00769915197454103,-0.0475343533513811,-0.0173536776111803,2.52302978755906e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,37942,-0.0183275281254712,0.0043585547008761,-0.0268702953391884,-0.00978476091175408,2.62818452565856e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40341,-0.0134281062441807,0.00319569177142023,-0.0196916621161643,-0.00716455037219701,2.66081999666979e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37562,-0.0142722706694167,0.00340460805199272,-0.0209453024513225,-0.00759923888751101,2.78265022336587e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,37942,-0.0397270456130095,0.00948463354408618,-0.0583169273594185,-0.0211371638666006,2.82502900387603e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,37598,0.0171104238989079,0.00408899228135783,0.00909599902744656,0.0251248487703693,2.87640834501566e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37671,-0.0164982384607717,0.00394299169539473,-0.0242265021837454,-0.00876997473779807,2.88029961487533e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37901,-0.0206070003568827,0.00492901661194417,-0.0302678729162933,-0.0109461277974721,2.92384872257184e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40228,-0.0164257251242823,0.00393006111755928,-0.0241286449146985,-0.00872280533386613,2.93713721508991e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40357,0.0158129743858938,0.00378404214722165,0.00839625177733939,0.0232296969944482,2.94541765026633e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37714,-0.0289761584241853,0.00697443188224275,-0.0426460449133811,-0.0153062719349895,3.27862011294601e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37998,-0.0238473275198603,0.00574192086087802,-0.0351014924071812,-0.0125931626325394,3.29871942756079e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37714,-0.0419765072056724,0.0101133962913611,-0.0617987639367401,-0.0221542504746047,3.33698296440432e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37901,-0.0179644310096512,0.00433099324452084,-0.026453177768912,-0.00947568425039036,3.37632805452283e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39961,-0.0296668966857619,0.00717189020878691,-0.0437238014949842,-0.0156099918765395,3.54421694797526e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,40209,0.0501418373666233,0.0121272207919292,0.026372484614442,0.0739111901188046,3.57333806609566e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40293,0.0227495013182399,0.00550906130667448,0.0119517411571579,0.0335472614793218,3.65464963228798e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,37998,-0.0354201169551819,0.00858526138902111,-0.0522472292776633,-0.0185930046327005,3.71835594212202e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37990,-0.029062947080298,0.00706681581894018,-0.0429139060854208,-0.0152119880751753,3.93548650860547e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39980,-0.0206046446395591,0.00501372486606529,-0.030431545377047,-0.0107777439020711,3.98297386489672e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40228,-0.0408673669897867,0.00994765615516194,-0.0603647730539041,-0.0213699609256693,4.00696660152278e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,40332,0.00757931770465571,0.00184703565271686,0.00395912782533066,0.0111995075839807,4.08971504913964e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,39980,0.0329381279851424,0.00804600492991763,0.0171679583225038,0.048708297647781,4.26646404577855e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,40341,-0.0206733731483364,0.00505396948097508,-0.0305791533310475,-0.0107675929656252,4.32525290902875e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,40044,0.0157961132586046,0.00387117540026877,0.00820860947407787,0.0233836170431314,4.51735351538409e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37714,-0.0143718428555925,0.00352199382163713,-0.0212749507460013,-0.00746873496518375,4.51828493253436e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,40411,0.0105862381562446,0.00259619534971517,0.00549769527080285,0.0156747810416863,4.57242356446302e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39961,-0.0324929707673536,0.00797747715846815,-0.0481288259979511,-0.016857115536756,4.66243349649736e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,39980,-0.0207322238863259,0.00509345033940544,-0.0307153865515605,-0.0107490612210912,4.71710584822135e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,37990,-0.011708266984908,0.00287677847798495,-0.0173467528017585,-0.00606978116805752,4.72956901106375e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37959,-0.0264532284405534,0.00650117520427749,-0.0391955318409372,-0.0137109250401695,4.7485483912332e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,37810,0.0117501998011587,0.00288839338261392,0.00608894877123539,0.0174114508310819,4.76755113241846e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,39980,-0.0265862198367664,0.00655010961468527,-0.0394244346815495,-0.0137480049919832,4.95465688449107e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40305,-0.014372979789573,0.00354230408343224,-0.0213158957931002,-0.00743006378604579,4.9833595920824e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,40502,-0.00779178848809053,0.00192060922859493,-0.0115561825761366,-0.00402739440004446,4.99558963767429e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37562,-0.0108029738984967,0.00266528593841397,-0.0160269343377881,-0.00557901345920532,5.08104047105502e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,40028,-0.0164650402941743,0.00406884184148891,-0.0244399703034925,-0.00849011028485598,5.22142240023281e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,37942,-0.0355493560002111,0.00880264397888114,-0.0528025381988181,-0.018296173801604,5.40949033098711e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,37990,-0.0248670882386161,0.00616416828077844,-0.0369488580689418,-0.0127853184082903,5.5104655324012e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,40489,-0.0174274368532379,0.00432165561393896,-0.0258978818565583,-0.00895699184991753,5.54222598178235e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,37562,-0.0235545089908577,0.0058474318294336,-0.0350154753765475,-0.0120935426051678,5.65271918676796e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40359,-0.0254211976794645,0.00632015445673493,-0.037808700414665,-0.0130336949442641,5.79128033226294e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40434,-0.0280645639526209,0.00698737687074537,-0.0417598226192819,-0.01436930528596,5.93474386554585e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",38013,-0.00624339379757104,0.00155767995587607,-0.00929644651108814,-0.00319034108405395,6.15270723129931e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,40228,-0.0127871019733908,0.00319250350737684,-0.0190444088478494,-0.00652979509893216,6.22089252323825e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37959,-0.0166705351210794,0.00416280223417941,-0.0248296275000711,-0.00851144274208778,6.24437328956657e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37628,0.0130050294263635,0.00325696551705171,0.00662137701294211,0.0193886818397848,6.55994750129383e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,37572,-0.0185082060248733,0.00463862966586077,-0.0275999201699604,-0.00941649187978615,6.64279003826975e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40403,0.012634829933431,0.0031672713233294,0.00642697813970537,0.0188426817271566,6.65968252431087e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,40536,-0.0186351583011689,0.00467786867196559,-0.0278037808982214,-0.00946653570411634,6.81534877761721e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,37942,-0.025354575731153,0.00636615816000257,-0.037832245724758,-0.012876905737548,6.84908255481223e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,40305,-0.0311341895080148,0.00783671396869903,-0.0464941488866649,-0.0157742301293647,7.13280486580242e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40355,0.0188707586732405,0.00475261525329381,0.00955563277678461,0.0281858845696963,7.20057115867897e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37901,-0.0290577139466846,0.00731828930037878,-0.043401560975427,-0.0147138669179422,7.2076719710574e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,39961,-0.0254377144192996,0.0064089902214837,-0.0379993352534076,-0.0128760935851915,7.24795113251463e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40489,-0.0127411564718718,0.00321391939307421,-0.0190404384822973,-0.00644187446144635,7.39100699747099e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37671,-0.0230496677888762,0.00582030681150322,-0.0344574691394225,-0.0116418664383299,7.527478815048e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40516,-0.0276092156204808,0.00697293246531448,-0.0412761632524972,-0.0139422679884644,7.54355146885712e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37598,-0.0328707990711467,0.00832514722952222,-0.0491880876410103,-0.0165535105012831,7.90937413448524e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37572,-0.0232463042726641,0.00588851929235062,-0.0347878020856713,-0.0117048064596569,7.93063485117999e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,40471,-0.00979083946564355,0.00248172698325971,-0.0146550243528326,-0.00492665457845452,8.00826814907416e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39980,-0.0286549640886468,0.00727532443498944,-0.0429145999812261,-0.0143953281960675,8.22991072355888e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,37628,-0.0348906589443812,0.00886294757542515,-0.0522620361922144,-0.0175192816965479,8.30387219812408e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,37990,-0.0195771548736296,0.00497690301420793,-0.0293318847814771,-0.00982242496578205,8.40998863186054e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40044,-0.0269550946104338,0.00685606484002052,-0.040392981696874,-0.0135172075239936,8.47579381599333e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,39961,-0.019726700949077,0.00501751466191605,-0.0295610296864324,-0.0098923722117215,8.47603198428632e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37959,-0.0147789340074813,0.00377786153093698,-0.0221835426081178,-0.00737432540684486,9.19893016386434e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,37942,-0.0264914791037579,0.00677374247078067,-0.039768014346488,-0.0132149438610278,9.24004886437804e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37942,-0.0231876648933252,0.00592961120657985,-0.0348097028582218,-0.0115656269284287,9.25614306238578e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,37678,0.0117548477545589,0.00300798076582044,0.00585920545355087,0.017650490055567,9.3570852452048e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37959,-0.0367977108751013,0.00941788624210322,-0.0552567679096236,-0.018338653840579,9.38210559375107e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,39934,-0.025868837458093,0.00662119778665862,-0.0388463851199439,-0.0128912897962421,9.38571234924407e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,40341,-0.0290567959373883,0.00744954308572021,-0.0436579003854,-0.0144556914893767,9.63972146247876e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,39961,-0.0306178596742933,0.00787039082268233,-0.0460438256867507,-0.0151918936618359,0.000100555372817493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39980,-0.019050261537635,0.00489707326928552,-0.0286485251454346,-0.00945199792983537,0.000100607490840619
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,40359,-0.0254005342302156,0.00653172516030705,-0.0382027155444174,-0.0125983529160137,0.000101153086490072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,37987,0.0176146869260964,0.00453380388999472,0.0087284313017067,0.026500942550486,0.000102737058176734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37628,-0.0206679805783047,0.00532557353123075,-0.0311061046995169,-0.0102298564570924,0.000104580672046274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,40332,-0.0445351277370112,0.0114950301284969,-0.0670653867888651,-0.0220048686851573,0.00010736354433394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39980,0.0114100743988333,0.00294632796103499,0.00563527159520475,0.0171848772024619,0.000108103131913472
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37562,0.0148150983680208,0.00384364557164122,0.00728155304760403,0.0223486436884376,0.000116548623742685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,40332,-0.00909116810249977,0.00236552603222574,-0.0137275991256622,-0.00445473707933733,0.000121917919310721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40228,0.025458621196738,0.00663284471894504,0.0124582455476058,0.0384589968458703,0.000124389717259599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,37598,-0.0139690080842659,0.00364428026442955,-0.0211117974025478,-0.00682621876598397,0.000127111449422921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37562,0.00938171942567581,0.00244828218109726,0.00458308635072518,0.0141803525006264,0.000127719707156133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,40042,-0.0272320242633681,0.00710915247405108,-0.0411659631125082,-0.0132980854142279,0.000128353697438223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,37642,0.0116297965169461,0.00304226548770727,0.00566695616103988,0.0175926368728524,0.000132582420601416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37562,-0.0252732063373108,0.00662027266222802,-0.0382489407552777,-0.0122974719193439,0.00013540492327015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,40042,-0.0306807014828903,0.00804794903369663,-0.0464546815889357,-0.0149067213768449,0.000138243791851174
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,37901,-0.0164974448059938,0.00432941788703652,-0.0249831038645853,-0.00801178574740218,0.000139277958430318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40516,-0.0212283682474948,0.00557474639067584,-0.0321548711732195,-0.0103018653217702,0.000140643343171629
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37562,-0.0139459505464534,0.00366254243145139,-0.0211245337120981,-0.00676736738080869,0.000140890778541282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40044,-0.01292807613933,0.00339541392858515,-0.0195830874393569,-0.00627306483930308,0.000140910012390142
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37562,-0.0227497587775795,0.00597672430073692,-0.0344641384070239,-0.0110353791481352,0.000141650193384666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37900,-0.0104960271563007,0.00275798984113257,-0.0159016872449205,-0.00509036706768086,0.000142041928004704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39980,-0.0184619078780263,0.00486764542804872,-0.0280024929170018,-0.00892132283905085,0.000149534696289927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40489,-0.0127736714071471,0.00337258532782098,-0.0193839386496762,-0.00616340416461796,0.000152725274445814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,40270,-0.0144759282404523,0.00382256128085653,-0.0219681483509311,-0.00698370812997347,0.000153058973192568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40228,-0.0215491551236966,0.00569286608990719,-0.0327071726599147,-0.0103911375874785,0.00015409717307764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,37671,-0.0339956554127097,0.00899816279466995,-0.0516320544902627,-0.0163592563351566,0.000158744298103281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37541,-0.0358374588597183,0.00949858808634298,-0.0544546915089505,-0.017220226210486,0.000162056221399132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,37959,-0.0206576887247101,0.00547985480584702,-0.0313982041441702,-0.00991717330524989,0.000164106306511313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39925,-0.0236768052797075,0.00629159887002489,-0.0360083390649563,-0.0113452714944588,0.000168344504394255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37959,-0.0169858265531199,0.00451587670007732,-0.0258369448852715,-0.0081347082209684,0.000169707349123217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,39961,-0.0176526859209763,0.0046984720742604,-0.0268616911865267,-0.00844368065542596,0.000172514918030755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,40346,-0.0184839940991119,0.00492045027394517,-0.0281280766360445,-0.00883991156217939,0.000172876246509003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37628,0.0139645023125272,0.0037280213646952,0.0066575804377246,0.0212714241873298,0.000180570816244243
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37714,-0.0239667035474624,0.00640263962263426,-0.0365158772078256,-0.0114175298870993,0.000182419978092499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40225,-0.0207177779260814,0.00554779842547206,-0.0315914628400066,-0.00984409301215617,0.000188814620165756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39961,-0.0137249681800615,0.00367677644819235,-0.0209314500185185,-0.00651848634160449,0.000189978647074704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,39897,-0.0167047527189235,0.0044768620366832,-0.0254794023108226,-0.00793010312702445,0.000191136445336383
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,40359,-0.0119377810105752,0.00319977682416376,-0.0182093435859361,-0.00566621843521418,0.000191523553919236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39961,-0.017290881127146,0.00463539525398091,-0.0263762558249486,-0.00820550642934344,0.000192021214336865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37900,-0.0173932903226072,0.00467094148658022,-0.0265483356363045,-0.00823824500890999,0.00019710831342431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,40350,-0.0329442754854045,0.00884989260132475,-0.050290064984001,-0.0155984859868079,0.000197891646127742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,40329,-0.0344007415710854,0.00924256830551381,-0.0525161754498924,-0.0162853076922783,0.000198341674190202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,37942,-0.0132565381777774,0.0035625471845056,-0.0202391306594083,-0.00627394569614638,0.000199174681880495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40305,-0.0194440467309982,0.00523085936587025,-0.0296965310881039,-0.0091915623738925,0.000202151944328352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,40536,0.0142166914301117,0.00382485866453888,0.00671996844761552,0.0217134144126079,0.000202350459835536
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,37541,0.00987766884898006,0.00265810420179023,0.0046677846134712,0.0150875530844889,0.000203197841401832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,40192,-0.0270519127253172,0.00728033602792545,-0.0413213713400511,-0.0127824541105833,0.000203302472413666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40044,-0.0234153799369325,0.00630450797858862,-0.0357722155749662,-0.0110585442988988,0.000204664120643355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,39961,-0.0162594049726398,0.00438334433814358,-0.0248507598754012,-0.00766805006987834,0.000208508327653406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,40489,-0.010069044241166,0.00271709330226326,-0.015394547113602,-0.00474354136873001,0.000211420810223242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37541,0.0117565444664248,0.00317655921772297,0.00553048839968775,0.0179826005331618,0.000215605664000094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37628,-0.0360655457430755,0.00975265727724272,-0.0551807540064712,-0.0169503374796797,0.000218168078528442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,40396,0.0182701059729324,0.00494573897641708,0.00857645757915495,0.0279637543667099,0.000221395321181585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37990,-0.0248861589699299,0.00673921843667742,-0.0380950271058176,-0.0116772908340421,0.000222725868948962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,37942,-0.0254386912201914,0.00690276559615599,-0.0389681117886571,-0.0119092706517257,0.000229337045316659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37879,-0.0246830294519068,0.00669850671867877,-0.0378121026205172,-0.0115539562832964,0.000229732182624025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,40332,-0.0137487339186744,0.00373139809365688,-0.0210622741822419,-0.00643519365510693,0.000229817357528759
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37671,-0.0305968498419102,0.00831785404972996,-0.0468998437793809,-0.0142938559044395,0.000235582385988781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,37671,-0.0398642406467906,0.0108438330862744,-0.0611181534958884,-0.0186103277976927,0.000237659007879825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,37608,-0.0145048344317301,0.00395523782063637,-0.0222571005601774,-0.0067525683032828,0.000246142213115772
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37990,-0.0106299014173348,0.00290641037781668,-0.0163264657578555,-0.00493333707681414,0.000255754024440097
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,37959,0.0126096497177504,0.00345214536308701,0.00584344480609984,0.0193758546294009,0.000260479274348657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,37987,0.0501011508873441,0.0137624899162781,0.0231266706514391,0.0770756311232491,0.000273215244184854
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37562,-0.0243996255344449,0.00670544898234231,-0.0375423055398359,-0.011256945529054,0.000274989429732244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39980,-0.0292385136285219,0.00803876399910344,-0.0449944910667646,-0.0134825361902791,0.000276520677333466
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37959,0.011998313333398,0.00330617262809114,0.00551821498233941,0.0184784116844567,0.000285500232218304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37572,-0.0209533121361084,0.00577512962819675,-0.032272566207374,-0.00963405806484276,0.000286490266549826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,40357,0.0124287857838751,0.00342649753712282,0.00571285061111434,0.0191447209566358,0.000287344657505182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37598,-0.0139653916782918,0.00386178422762564,-0.0215344887644381,-0.00639629459214554,0.000299956126449954
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,37714,0.0126163720423324,0.00350311224382923,0.00575027204442707,0.0194824720402376,0.000317572528883183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40338,-0.0321630307190463,0.00893810787261007,-0.049681722149362,-0.0146443392887306,0.000321134338361594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,40471,0.01058000203099,0.00294160323198335,0.00481445969630261,0.0163455443656773,0.000323275829737778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,40471,-0.0183024741976134,0.00508907280393054,-0.0282770568933173,-0.0083278915019096,0.000323589666874881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40305,-0.0322652229468884,0.00899062093653101,-0.0498868399824892,-0.0146436059112877,0.000333250435975616
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40228,-0.00873204498539753,0.00243398586401173,-0.0135026572788605,-0.00396143269193453,0.000334810457264918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40042,-0.0299833575745321,0.00836355327574878,-0.0463759219949997,-0.0135907931540645,0.000338104804521324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,40359,-0.0118681328860828,0.00331720388541699,-0.0183698525015001,-0.00536641327066555,0.000347591589761473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37541,-0.0262592667849965,0.007351969777367,-0.0406691275486358,-0.0118494060213571,0.000355900584249508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37628,-0.0141204393180104,0.00395493517086631,-0.0218721122529083,-0.00636876638311242,0.000357795469989455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40411,-0.00856537373104778,0.00240050939523689,-0.0132703721457121,-0.00386037531638348,0.000360566800122879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40422,-0.0373600140747231,0.0105115204796277,-0.0579625942147934,-0.0167574339346529,0.000380229675298144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37628,-0.0169954485438579,0.00478371177633457,-0.0263715236254736,-0.00761937346224209,0.000382523341205099
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40341,-0.011107188550772,0.00313107000412617,-0.0172440857588593,-0.00497029134268476,0.00039015966456749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40471,-0.019299706526672,0.00544291063244786,-0.0299678113662698,-0.00863160168707424,0.000392475776009524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40536,0.00761910542042325,0.00214991778974967,0.0034052665525139,0.0118329442883326,0.000395364436856819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,37959,-0.027874450882722,0.00786521341680991,-0.0432902691796694,-0.0124586325857746,0.000395410647797515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40291,-0.0145570640147452,0.00410775839754888,-0.022608270473941,-0.00650585755554934,0.000395543535234683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37959,-0.0269907741417766,0.00761709317215771,-0.0419202767592057,-0.0120612715243475,0.000396264117279489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,40260,-0.00998960367856719,0.00282535382836091,-0.0155272971821546,-0.00445191017497981,0.000407859377142573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,37786,-0.0182595293348638,0.00519252132516837,-0.0284368711321938,-0.00808218753753377,0.00043872081217757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,37990,-0.0187943073736454,0.00534499310278443,-0.0292704938551029,-0.00831812089218796,0.000439128389298863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40437,-0.0271569529665889,0.00772817395691024,-0.0423041739221329,-0.0120097320110448,0.000442600672166934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,39980,-0.0251174889669114,0.00716675075846938,-0.0391643204535113,-0.0110706574803114,0.00045836738779738
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38013,0.00596513971967453,0.00170388912628205,0.0026255170321617,0.00930476240718736,0.000465185746183556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39961,-0.037402895267193,0.0106895441890633,-0.0583544018777571,-0.016451388656629,0.000468286427104138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37544,0.0134692139484696,0.00385341878749567,0.00591651312497807,0.0210219147719611,0.000474930287844978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,40517,-0.00789347048727733,0.00226006478136382,-0.0123231974587504,-0.00346374351580424,0.00047965360972014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40228,0.0119939756255156,0.00343417282706815,0.00526299688446201,0.0187249543665692,0.00047976505451285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40359,-0.024026009625912,0.00688958598138582,-0.0375295981494282,-0.0105224211023958,0.000489252508176444
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37714,-0.0256173920858072,0.00735416263189039,-0.0400315508443123,-0.011203233327302,0.000496709497284662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,39961,0.0116924851898804,0.00336031827000994,0.00510626138066092,0.0182787089990999,0.000503585742213478
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,37598,0.00942182632570441,0.00270821628632267,0.00411372240451197,0.0147299302468968,0.000504958823455024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,37911,-0.0189208433257222,0.00545089823470713,-0.0296046038657481,-0.0082370827856962,0.000519874762380785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37572,-0.0202242422591856,0.00583158653835271,-0.031654151874357,-0.00879433264401433,0.000525928053644479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37959,-0.0220247904796942,0.00635231136312221,-0.0344753207514137,-0.00957426020797466,0.000527529628144409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,40359,0.0087563312045744,0.00252784308071361,0.00380175876637572,0.0137109036427731,0.000533699752549406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,37900,-0.0124596933720474,0.00359969647325759,-0.0195150984596323,-0.00540428828446256,0.000539207477891901
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,40359,-0.0282936333575688,0.00817659923864504,-0.0443197678653131,-0.0122674988498246,0.000540952854185579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40272,0.00761636564155447,0.00220547190315262,0.00329364071137534,0.0119390905717336,0.000555026717152129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37714,-0.0229918610641054,0.00666179895769388,-0.0360489870211854,-0.00993473510702535,0.000559633076395597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37900,-0.0179529194443686,0.00520519466303341,-0.0281551009839141,-0.00775073790482309,0.000564309801108677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37539,-0.0135071796744922,0.00391803927615721,-0.0211865366557603,-0.00582782269322401,0.000567719273995508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,37628,-0.0384457668552038,0.0111522242174816,-0.0603041263214677,-0.0165874073889399,0.000567854865582429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,37598,0.0113776903977735,0.00330101964192775,0.00490769189959508,0.0178476888959518,0.000569211152158929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,39980,-0.0242516207330465,0.00703928588216219,-0.0380486210620844,-0.0104546204040086,0.000572183464877753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,40042,-0.0117710804180961,0.0034189255915709,-0.0184721745775751,-0.00506998625861716,0.000576985098634442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,40489,0.0102930250417156,0.00299393844919777,0.00442490568128797,0.0161611444021433,0.000587613856429204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,40044,-0.00966521423095597,0.00282571042613737,-0.0152036066661852,-0.00412682179572673,0.000626767750751824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40341,-0.0327102955201327,0.00956385250550062,-0.051455446430914,-0.0139651446093515,0.000627322517055096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,40184,0.0152479962985138,0.00446066020356845,0.00650510229951961,0.0239908902975079,0.000631669574220987
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37990,-0.0176090704686461,0.005152094602937,-0.0277071758904026,-0.00751096504688956,0.000633043892983933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40489,0.0191989017253384,0.00561900783817273,0.00818564636251983,0.0302121570881569,0.000635242011756617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37562,-0.0148246709904418,0.00435088173137202,-0.023352399183931,-0.00629694279695267,0.000658110062346315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,40182,0.022522975403834,0.00661580558960528,0.00955599644820767,0.0354899543594604,0.000664704223786548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,40305,0.0246554217719969,0.00724964137861294,0.0104461246699156,0.0388647188740783,0.000673261489433087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,37598,-0.0140819473778441,0.00414635431505407,-0.0222088018353501,-0.00595509292033814,0.000685247316058256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,37986,-0.0117840712531056,0.00347175968072421,-0.018588720227325,-0.00497942227888613,0.000690106040469397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37598,-0.0113545285245906,0.00334724140685469,-0.0179151216820258,-0.00479393536715544,0.000695369431612485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40465,0.0130244038102505,0.00385539608267089,0.00546782748821551,0.0205809801322854,0.000731286026566649
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,37628,-0.0169335213703454,0.00501732181450371,-0.0267674721267726,-0.00709957061391812,0.000740254759999152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39925,-0.0140767044524932,0.00417106923856957,-0.0222520001600895,-0.00590140874489682,0.000740392110324534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37562,-0.0376195249396494,0.011148278413264,-0.0594701506296469,-0.0157688992496519,0.000741724975726834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39980,-0.01857664236142,0.00550702635409204,-0.0293704140154404,-0.00778287070739961,0.000744647721700153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37628,-0.0199204689728152,0.00590769625779444,-0.0314995536380923,-0.00834138430753812,0.000748520819993921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40341,-0.017686655910478,0.00524678305808169,-0.0279703507043181,-0.00740296111663794,0.000750872339817398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,40044,-0.0276233199164306,0.00820234555893947,-0.043699917211952,-0.0115467226209093,0.000759719347685526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40357,-0.0161153480302258,0.00478827241574573,-0.0255003619650875,-0.00673033409536421,0.000765616232558111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40422,-0.00840670748540294,0.00250238592091354,-0.0133113838903935,-0.00350203108041241,0.000782729409920857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37942,-0.01529505089103,0.0045532029341435,-0.0242193286419512,-0.00637077314010869,0.000783892417564719
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,40396,0.026501443351277,0.00788965491317224,0.0110377197214594,0.0419651669810946,0.000784049987944494
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40305,-0.0143668807238801,0.00427825507167509,-0.0227522606643633,-0.00598150078339697,0.000786601306819198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,39857,0.0211988359429831,0.00632099524417164,0.00880968526440666,0.0335879866215595,0.000799257623976786
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,37819,-0.01422336404413,0.00424515946590508,-0.022543876597304,-0.00590285149095606,0.000808920732258424
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,37598,-0.016446291352262,0.00491847183584783,-0.0260864961505237,-0.00680608655400021,0.000828759573609312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40159,0.0188402458356684,0.00563614393071779,0.00779340373146158,0.0298870879398753,0.000831449764919388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37959,-0.00986259929077124,0.00295137499448979,-0.0156472942799712,-0.00407790430157125,0.000834939956513869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,37855,-0.0152711633425234,0.00457575330319426,-0.0242396398167841,-0.00630268686826261,0.00084793321419754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,37990,0.0107884892879356,0.00323536121423768,0.00444718130802972,0.0171297972678414,0.000856655061158335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37900,-0.0127339593077434,0.00384032377446823,-0.0202609939057012,-0.00520692470978571,0.00091604912068234
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37942,-0.0118356432006873,0.00357862316258493,-0.0188497445993538,-0.00482154180202086,0.000944403090365636
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,37671,-0.0177994346275068,0.00538189984737328,-0.0283479583283585,-0.00725091092665522,0.000944589593488261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40289,-0.00863179331346233,0.00261400488526507,-0.0137552428885819,-0.00350834373834279,0.000961647815012947
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37959,0.0133058559832845,0.00403035783517154,0.0054063546263483,0.0212053573402207,0.000964503781275501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40380,-0.0149119129223809,0.0045171834374213,-0.0237655924597267,-0.00605823338503518,0.000965001259426606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37482,-0.0193169810735009,0.00585453420373817,-0.0307918681128277,-0.00784209403417408,0.000971203300518346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40422,-0.0272566142698209,0.00828167485257247,-0.043488696980863,-0.0110245315587789,0.000999787546675726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40044,-0.0186373521120068,0.00567337637037821,-0.0297571697979481,-0.00751753442606552,0.00102187462247703
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40341,0.00764998317392562,0.00233044687742058,0.00308230729418129,0.01221765905367,0.00103067387421871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,40311,0.0213956414304093,0.00651938283819134,0.00861765106755427,0.0341736317932643,0.00103351022554792
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,40042,-0.0139818631186816,0.00426860816365696,-0.0223483351194493,-0.005615391117914,0.0010570206264294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,40341,-0.0196116744590331,0.00598881340980873,-0.0313497487422583,-0.00787360017580804,0.00105993823800913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,37482,-0.0111971939935165,0.00342004012110631,-0.0179004726308848,-0.00449391535614811,0.00106314975568117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,37900,-0.012820589412518,0.00391726465400239,-0.0204984281343627,-0.00514275069067333,0.00106740472739874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37562,-0.0159892716552614,0.00488885714303198,-0.0255714316556041,-0.00640711165491876,0.00107614073829445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37482,0.0178897445999825,0.00549736791244698,0.0071149034915864,0.0286645857083785,0.00113986769915104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,40032,-0.0134399456710135,0.0041329500792893,-0.0215405278264205,-0.00533936351560648,0.0011487957322942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,37714,0.00911926071048524,0.00281556549761179,0.00360075233516615,0.0146377690858043,0.00120298121791346
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,40044,-0.0257146584140172,0.00794310173733535,-0.0412831378191945,-0.0101461790088399,0.00120894365972823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40536,0.00777672823806894,0.00240371098378561,0.00306545470984914,0.0124880017662887,0.00121760193688017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40182,0.0125248720037804,0.00389835166066521,0.00488410274887655,0.0201656412586842,0.00131683393829324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,37655,0.0113463523851543,0.00353514113666532,0.0044174757572903,0.0182752290130183,0.00133242392989682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40517,-0.00830554903908731,0.00258912096207121,-0.0133802261247469,-0.00323087195342774,0.00133986723221343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,37942,0.0119265901960691,0.00372645520208694,0.00462273799997867,0.0192304423921595,0.00137498047659192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,39990,-0.0273657476945197,0.00855384785975535,-0.0441312894996402,-0.0106002058893992,0.00138070606836359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,40116,-0.020587091229956,0.0064421398020945,-0.0332136852420612,-0.00796049721785078,0.00139772812673629
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39980,-0.0182574981766291,0.00572283581796269,-0.029474256379836,-0.00704073997342227,0.00142413303973045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,40044,0.00978257566933726,0.00307520991970638,0.00375516422671275,0.0158099871119618,0.00147000185186329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,37541,0.0110068234292916,0.00346872929980498,0.00420811400167388,0.0178055328569094,0.00151139516069246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37959,-0.0377138616538191,0.0119457719327595,-0.0611275746420278,-0.0143001486656104,0.00159703309865364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37628,-0.0142165655303026,0.00450905384399197,-0.0230543110645268,-0.00537881999607829,0.00162023581759339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40522,0.0165731975341761,0.00525923935182365,0.00626508840460171,0.0268813066637504,0.00162869640543459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37562,0.0156565590759892,0.00496934113550157,0.00591665045040612,0.0253964677015723,0.00163284681564971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,39961,-0.0136047295737107,0.00432263915128419,-0.0220771023102277,-0.00513235683719372,0.0016508639362788
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,40257,-0.0199081813579886,0.00634411835045936,-0.0323426533248889,-0.00747370939108824,0.00170386545387364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37562,0.0097953627612669,0.00313065744838078,0.00365927416244058,0.0159314513600932,0.0017587558483723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,37987,-0.0157192168636201,0.00502779154752763,-0.0255736882967742,-0.0058647454304659,0.0017729586141231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,40042,-0.0113545917991786,0.003634395826209,-0.0184780076185482,-0.00423117597980892,0.00178614007090861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,40216,-0.0143669038253245,0.0046123325991251,-0.0234070757196097,-0.00532673193103927,0.00184344152218821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37598,-0.0166915793125839,0.00537171659790979,-0.027220143844487,-0.00616301478068068,0.00189201823383222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,37812,-0.0295602919274487,0.00952320287668678,-0.0482257695657548,-0.0108948142891426,0.00191303842694349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37541,0.0101578055966965,0.00327331528605754,0.00374210763602375,0.0165735035573693,0.00191837433944858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,40341,-0.0189937219509925,0.00612624568608714,-0.0310011634957233,-0.00698628040626172,0.00193607066723379
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,37942,-0.0282997505950795,0.00912966354119038,-0.0461938911358126,-0.0104056100543463,0.00194077294469016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,37598,-0.0187800278571568,0.00606001547699048,-0.0306576581920582,-0.00690239752225549,0.00194580512152073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,40456,0.0126838338667468,0.00410994146976752,0.00462834858600247,0.0207393191474911,0.00203122971793662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37482,-0.0121494574574619,0.00394039803654389,-0.0198726376090879,-0.00442627730583583,0.00205141601536432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,37572,-0.0206214238303485,0.00670087804496476,-0.0337551447984795,-0.00748770286221761,0.00209230447655094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,39961,-0.0180097996302587,0.00585673366025588,-0.0294889976043603,-0.00653060165615721,0.0021082706294195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37879,-0.0121846329923499,0.00396352765351288,-0.0199531471932351,-0.00441611879146461,0.00211499168454609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40332,0.00948749443788432,0.00309115036144838,0.0034288397294455,0.0155461491463231,0.00214963174596222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37598,0.0129469221362544,0.00422010175640932,0.00467552269369211,0.0212183215788166,0.00215994868594632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,37231,0.0203996473479844,0.00665213347059336,0.00736146574562141,0.0334378289503474,0.00216937256268777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,40305,-0.021815263552381,0.00711474204254521,-0.0357601579557696,-0.0078703691489924,0.00217158883601532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,40044,0.00999866761469781,0.00326507956600794,0.00359911166532225,0.0163982235640734,0.002200140482397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37942,-0.0134313078386335,0.00438907704000787,-0.0220338988370489,-0.0048287168402181,0.00221648161729675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37942,-0.0306628502356062,0.0100345855991474,-0.0503306380099352,-0.0109950624612772,0.00224961895614917
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",39961,-0.0145109072493781,0.00475591290600689,-0.0238324965451516,-0.00518931795360464,0.00228367244095576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40442,-0.00658776923959581,0.0021607900171531,-0.0108229176732159,-0.00235262080597573,0.00230149626185198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37987,-0.00745538796822993,0.0024454085138611,-0.0122483886553977,-0.00266238728106217,0.0023025531596567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37628,-0.0264871769820818,0.00870064746946347,-0.0435404460222302,-0.00943390794193341,0.0023370072403488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37572,-0.014354273862556,0.00472406620784131,-0.023613443629925,-0.00509510409518706,0.00238193621891178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37572,0.019117211714503,0.00629829444193133,0.00677255460831754,0.0314618688206884,0.00240767632504547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,37900,0.033932978781779,0.0111842929115424,0.0120117646751558,0.0558541928884022,0.00241806999784398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39980,-0.0221424115024343,0.00730324598011398,-0.0364567736234578,-0.00782804938141094,0.00243453524255044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37541,0.0178832425535306,0.00590312840650943,0.00631311087677208,0.029453374230289,0.00245475938572059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,40359,-0.0195309450714679,0.006449825450173,-0.032172602953807,-0.00688928718912881,0.00246462049566166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39980,-0.0116979079714872,0.00386666811431147,-0.0192765774755377,-0.00411923846743669,0.00248776582200127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37628,-0.0177800560576701,0.00588372832220947,-0.0293121635692007,-0.00624794854613956,0.00251673365678955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37959,-0.0136591190803447,0.00453113153506059,-0.0225401368890635,-0.00477810127162596,0.00257876702009935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,37598,-0.00818294575113499,0.00271484080674893,-0.0135040337323629,-0.00286185776990707,0.00258189051768144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,40522,-0.00968681633163941,0.00321431268693338,-0.0159868691980288,-0.00338676346525,0.00258526923636238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40203,-0.00694422911567177,0.00230438824728469,-0.0114608300803497,-0.00242762815099378,0.00258680198343076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37572,-0.0197958763684054,0.00657008237253756,-0.032673237818579,-0.00691851491823179,0.00259144035342226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,39961,-0.0106877651355495,0.00354856450609633,-0.0176429515674983,-0.00373257870360069,0.00260074186257301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37990,-0.0181649008728393,0.00603125029925923,-0.0299861514593874,-0.00634365028629124,0.00260185718339732
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,39802,0.00754272854223089,0.00250458027945607,0.00263375119449698,0.0124517058899648,0.00260320143858708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37598,-0.00873184361073616,0.00289937508528502,-0.0144146187778948,-0.00304906844357751,0.00260343405260855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,37942,0.00876043576612333,0.00290931035383482,0.00305818747260709,0.0144626840596396,0.00260722580812978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,40044,-0.0148568190856527,0.00494293664655376,-0.0245449749128981,-0.00516866325840734,0.0026542103410338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40359,-0.0182568326581616,0.0060830046109051,-0.0301795216955356,-0.00633414362078755,0.00269259477787493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,37942,0.0075561617472972,0.0025179305502966,0.00262101786871586,0.0124913056258785,0.00269638528528382
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,39980,-0.0100127059603739,0.00334474857765487,-0.0165684131725775,-0.00345699874817038,0.00276177195671999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40536,0.00839946987683069,0.00280926402235012,0.00289331239302446,0.0139056273606369,0.0027947424462054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,37562,-0.0347721117676599,0.0116452653319432,-0.0575968318182686,-0.0119473917170512,0.00283226491077576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37998,0.00839076846500697,0.00281046277074953,0.0028822614343379,0.013899275495676,0.00283577516095522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,37998,0.0141847691623997,0.00476562502473119,0.0048441441139266,0.0235253942108729,0.00292097034966692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,37901,-0.00956484760253837,0.00321716753500013,-0.0158704959711386,-0.00325919923393812,0.00295364775330135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40044,-0.0192836592464342,0.00649825204477753,-0.0320202332541981,-0.0065470852386702,0.00300673649011227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,37967,0.0298170898240444,0.0100699364538468,0.0100800143745047,0.0495541652735841,0.00307174042701865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39980,-0.0148155215852833,0.00500420480839036,-0.0246237630097284,-0.00500728016083819,0.0030749006379038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40276,0.0169878993459634,0.00573809544690843,0.0057412322700229,0.028234566421904,0.0030754911518247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,37714,-0.0209270866760864,0.00707542292884093,-0.0347949156166147,-0.0070592577355582,0.00310474893177076
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37900,-0.0170543335435924,0.00576930682371397,-0.0283621749180717,-0.00574649216911297,0.00312152023830359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40278,0.00718136074271909,0.00243530861439055,0.00240815585851361,0.0119545656269246,0.00319424637784887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37628,-0.0268440682414361,0.00910490546570957,-0.0446896829542269,-0.00899845352864537,0.00320078972366225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,37598,-0.0146753553661697,0.00498071404318548,-0.0244375548908133,-0.00491315584152618,0.00322022999441446
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,40024,-0.0117927573896768,0.0040307635220366,-0.0196930538928685,-0.00389246088648506,0.0034419139246359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37942,-0.0104418021917803,0.00357433525812224,-0.0174474992976999,-0.00343610508586069,0.00349121517699807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37990,-0.00946494580415812,0.00324027515343833,-0.0158158851048972,-0.003114006503419,0.00349450591838267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37562,-0.0281595609197323,0.00965444149810296,-0.047082266256014,-0.00923685558345046,0.00354302704510886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,40276,-0.00927708611295996,0.00318482141196001,-0.0155193360804016,-0.00303483614551834,0.00358582824956562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,40314,-0.0112083308920867,0.00384806198457793,-0.0187505323818594,-0.00366612940231396,0.00358794272858564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37562,0.00794289641212911,0.00272894383278308,0.00259416649987428,0.0132916263243839,0.00361328886766255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,37541,0.0209377644277793,0.00720335626002974,0.00681918615812096,0.0350563426974376,0.00365913584162292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37714,-0.0119217772258452,0.00410437890350394,-0.0199663598767129,-0.00387719457497746,0.00368273146386666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,37671,-0.00992106793309831,0.00342146177606472,-0.0166271330141852,-0.00321500285201145,0.00374185468087058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,39946,-0.0155867435877712,0.00537644003518421,-0.0261245660567323,-0.00504892111881015,0.00374781639995237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37541,0.017022176553016,0.00587194618272226,0.00551316203488039,0.0285311910711517,0.00375098086205599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,37900,-0.0149377146925996,0.00515621713709267,-0.0250439002813012,-0.00483152910389791,0.00377321655126407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40332,-0.0133820484734664,0.00462185944996761,-0.022440892995403,-0.00432320395152993,0.00379213652985298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40432,0.00769242164949596,0.00265980636786344,0.00247920116848362,0.0129056421305083,0.00383194371380454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,37482,-0.0100581946607253,0.00349433889409764,-0.0169070988931566,-0.00320929042829389,0.00400315514018362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40422,-0.0324430389446297,0.0112989884495728,-0.0545890563057923,-0.010297021583467,0.00409295906750749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37572,0.00885184357197163,0.00308327030341635,0.0028086337772756,0.0148950533666677,0.0040992504162646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37671,-0.0103744110830573,0.00362616552020877,-0.0174816955026664,-0.00326712666344806,0.00422987155625769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37746,-0.0151622633187953,0.00529980227750286,-0.0255498757827009,-0.00477465085488967,0.00423084101198549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,40332,-0.00964190588821201,0.00337509477131723,-0.0162570916399938,-0.00302672013643024,0.00428516964861941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39925,-0.0128011968994916,0.00448421124768734,-0.0215902509449588,-0.00401214285402442,0.00431311483198199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37998,-0.0168296445260193,0.00589996755950502,-0.0283935809426491,-0.00526570810938943,0.00434427831218943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,40489,0.0165017718664694,0.00578534231806333,0.00516250092306527,0.0278410428098735,0.0043453935905559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,40278,-0.0161538248699615,0.00567562078969395,-0.0272780416177617,-0.00502960812216136,0.00443043832106905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37900,-0.0129362558384313,0.00455704980555275,-0.0218680734573147,-0.00400443821954788,0.00453606566307583
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37671,-0.0338409322109287,0.0119282614136545,-0.0572203245816914,-0.0104615398401659,0.00456034437539742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37598,-0.00847181712942512,0.00298703569415764,-0.0143264070899741,-0.00261722716887615,0.00457242540841877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37621,-0.00772613992856456,0.00272659879855168,-0.0130702735737258,-0.00238200628340328,0.0046094258917705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,40250,0.013693540221638,0.00484923792265372,0.00418903389323668,0.0231980465500393,0.00475093698908162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37628,-0.00768918497495201,0.00272347817456249,-0.0130272021970945,-0.00235116775280952,0.00476039486153103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,40341,-0.0266994934028524,0.00946020247752155,-0.0452414902587947,-0.0081574965469102,0.00477403327940361
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,39923,-0.0203684079643653,0.00722276154503388,-0.0345250205926318,-0.00621179533609893,0.00480801513747503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39934,0.0143921166181767,0.00511024986699163,0.00437602687887307,0.0244082063574803,0.00486381722424316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,37562,0.0137131284824564,0.00487303722141959,0.00416197552847402,0.0232642814364388,0.0048989541181579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37901,-0.0261287514162301,0.00930463654223264,-0.0443658390390061,-0.00789166379345413,0.00498998669862876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,40471,-0.0254403925412909,0.00907480924434348,-0.0432270186602041,-0.00765376642237766,0.00506264560250296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,37998,0.00612141665421384,0.00218671952227272,0.0018354463905593,0.0104073869178684,0.00512763329069081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,40516,-0.0161905772599609,0.00579362356378334,-0.0275460794449763,-0.0048350750749456,0.00520334245042631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,37562,0.00984177436493397,0.00352505869523544,0.00293265932227251,0.0167508894075954,0.00524679028102744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39823,0.0230510179378767,0.00825776412818492,0.00686580024663424,0.0392362356291191,0.00525395184411123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37865,-0.00832412302083403,0.00298306727910564,-0.0141709348878811,-0.00247731115378698,0.00527079066825065
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37901,-0.0230973512570076,0.00830405280667396,-0.0393732947580886,-0.00682140775592668,0.00541911239917599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,37900,0.0155131942392943,0.00558106113285068,0.00457431441890697,0.0264520740596816,0.00544991760042438
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39980,-0.0125915134653342,0.00453203337147524,-0.0214742988734257,-0.00370872805724273,0.00547036203293281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37628,-0.0129400732062642,0.00466058234241066,-0.0220748145973891,-0.00380533181513933,0.00550264330243575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,37714,-0.0101369962157482,0.00366105127941616,-0.0173126567234038,-0.00296133570809249,0.00563281986915096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37714,-0.0200151710512408,0.0072305077248167,-0.0341869661918815,-0.00584337591060003,0.00564527401440681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,37714,0.00934960088149346,0.00338903030037411,0.0027071014927602,0.0159921002702267,0.00580964799516968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40044,-0.0128376717187265,0.004654632606474,-0.0219607516274156,-0.00371459181003748,0.00582164696850859
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37457,-0.0234433462193536,0.00851310134303422,-0.0401290248517007,-0.0067576675870065,0.00589902425969335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40341,-0.0222472204466449,0.00810994716412898,-0.0381427168883377,-0.00635172400495213,0.00609115102353302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39980,-0.0140327859060963,0.00512117627418632,-0.0240702914035015,-0.00399528040869113,0.00614814990133205
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37562,-0.0118676536497238,0.00433337853161933,-0.0203610755716977,-0.00337423172774989,0.00617733107498157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,40422,0.00533332664231777,0.0019503693512144,0.00151060271393755,0.00915605057069799,0.00625399236261123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40192,-0.00618103527929619,0.00226180296083404,-0.0106141690825309,-0.00174790147606148,0.00628702218097395
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39961,-0.0106261517383887,0.00390511319082699,-0.0182801735924096,-0.00297212988436782,0.0065140266082598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37541,0.0150100520820003,0.00552069986836229,0.00418948034001027,0.0258306238239904,0.00655921505437755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,37598,0.0115583443136629,0.00426164839181748,0.0032055134657006,0.0199111751616251,0.00669298489662936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,40359,-0.0196836859542549,0.00726227842927724,-0.0339177516756383,-0.0054496202328715,0.00672739891115066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,37482,0.00928135140939188,0.00342497689265463,0.0025683966997888,0.015994306118995,0.0067391160673065
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40379,0.00687103726725385,0.00253779821520794,0.00189695276544628,0.0118451217690614,0.00678685340055016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40303,-0.00574833620388392,0.00212383421934214,-0.00991105127379452,-0.00158562113397332,0.00680521184425342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37598,0.00756965578926029,0.00280236534280153,0.0020770197173693,0.0130622918611513,0.00691852759170989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,37931,-0.0165357823076509,0.00612351742064439,-0.0285378764521139,-0.00453368816318793,0.00693482284073634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37714,-0.0152382889354412,0.00564668036006075,-0.0263057824411603,-0.00417079542972216,0.00697141535641495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,37572,-0.0155220291669119,0.00575408707667755,-0.0268000398371999,-0.00424401849662392,0.00699377359178022
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,37562,0.0137313429910499,0.00509862552715113,0.00373803695783364,0.0237246490242661,0.0070871275619964
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40516,0.00935240496478481,0.00347342795069733,0.00254448618141805,0.0161603237481516,0.0070979805495206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,40312,-0.017215199642346,0.00640313112457412,-0.0297653366465113,-0.00466506263818076,0.0071835995526097
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40536,-0.0155906847231459,0.00580475637785201,-0.0269680072237359,-0.00421336222255601,0.00724205731290677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,37562,-0.0097837984410232,0.00364474553365894,-0.0169274996869947,-0.00264009719505168,0.00727607845335603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,37541,0.0112762301625636,0.00420242264788794,0.00303948177270326,0.019512978552424,0.00729979833091773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39980,-0.0173126883314256,0.00645428107978738,-0.0299630792478088,-0.0046622974150423,0.00731826872538994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,40357,0.00592394929405869,0.00221017384908549,0.00159200854985113,0.0102558900382662,0.00736299720608177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,37901,-0.0108351849423815,0.00404835388140502,-0.0187699585499354,-0.00290041133482771,0.00744986166554752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,37541,0.0243367484303905,0.00909738918491324,0.00650586562796053,0.0421676312328204,0.00747919470290242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37714,0.00741011104191845,0.00277391478993035,0.00197323805365497,0.0128469840301819,0.0075637957264189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37714,-0.00917486972052862,0.00343483981738065,-0.0159071557625947,-0.00244258367846254,0.00756908708204338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",37714,-0.0113707427684804,0.00426829444110503,-0.0197365998730463,-0.00300488566391454,0.00773105808710197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,40184,0.0167870050190633,0.00630878149232551,0.00442179329410531,0.0291522167440213,0.00780123588820326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,37541,-0.0115432366478101,0.00433851104732205,-0.0200467183005613,-0.00303975499505884,0.00780863093388345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,37901,-0.0147906940978912,0.00556360317682171,-0.0256953563244617,-0.0038860318713206,0.00785883133576147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37562,-0.0101777398080155,0.00384752872920159,-0.0177188961172506,-0.00263658349878036,0.00817238914961924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37959,-0.0182868934205002,0.00691870406056842,-0.0318475533792143,-0.0047262334617861,0.00822432440615183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39980,-0.00852296026344877,0.00323307839864031,-0.0148597939247838,-0.00218612660211377,0.00839298821891825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,40355,-0.00989996659242273,0.00376961970268926,-0.0172884212096937,-0.00251151197515178,0.00864139089322721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40330,-0.00787207868840038,0.00300072956199748,-0.0137535086299154,-0.00199064874688532,0.00871432205746693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37990,-0.0221035064334249,0.0084254281294622,-0.0386173455671708,-0.00558966729967898,0.00871473738052621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,40003,-0.0156354901322195,0.00596212949400283,-0.027321263940465,-0.00394971632397391,0.00873807187260394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,40536,0.00484168812046694,0.00184684026200976,0.00122188120692782,0.00846149503400606,0.00875988440111644
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37671,0.00623989197807888,0.00238610841722121,0.00156311948032531,0.0109166644758324,0.00893048168357624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37628,-0.0105478615627392,0.00403385089101519,-0.018454209309129,-0.00264151381634946,0.00893717594313991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40341,-0.0204674572761756,0.0078339028267888,-0.0358219068166817,-0.00511300773566958,0.00899207496337491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,37721,-0.00625378624459132,0.00240234864171745,-0.0109623895823575,-0.00154518290682512,0.00924617074767014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40365,-0.012247661683887,0.00470699164969472,-0.0214733653172887,-0.00302195805048539,0.00927637246179824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,37959,-0.0148218544038691,0.00570255211779643,-0.0259988565547501,-0.00364485225298812,0.00935533738826461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40305,0.00953340662109737,0.00367177811891366,0.00233672150802661,0.0167300917341681,0.009429311322922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37863,-0.0131403037689229,0.00506528296624478,-0.0230682583827626,-0.0032123491550831,0.00949173342484094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37919,-0.00942241422053316,0.00363400622960786,-0.0165450664305646,-0.00229976201050176,0.00952886085921431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,37598,0.0067312847896238,0.00260179660759141,0.00163176343874464,0.011830806140503,0.00968747464093596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37901,-0.0278843655248812,0.0107793472530842,-0.0490118861409263,-0.00675684490883609,0.00969666630251084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37998,0.00952690752324748,0.00368552487338164,0.00230327877141947,0.0167505362750755,0.00974958952338496
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,39801,-0.00869020687622858,0.00337022365733063,-0.0152958452445966,-0.00208456850786054,0.00993153154015017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,37714,0.0084926913105236,0.0032961739393897,0.00203219038931979,0.0149531922317274,0.00999046427163101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40359,0.00685593901840997,0.00266347314571051,0.00163553165281737,0.0120763463840026,0.0100602553988418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,39980,0.0137587968722813,0.00536473528702237,0.00324391570971748,0.0242736780348452,0.0103365931116166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37901,-0.0232350044142519,0.00906105041737009,-0.0409946632322973,-0.00547534559620655,0.0103499867302561
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40305,-0.013061928257435,0.00512331267837312,-0.0231036211070464,-0.00302023540782374,0.0107968244690378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,38013,-0.00461898430360125,0.00181610820101919,-0.00817855637759886,-0.00105941222960363,0.0109907768228313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37572,0.00914563929916283,0.00359625818987374,0.00209697324701029,0.0161943053513154,0.0109988022044029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,40471,-0.00720147988857459,0.00283516055755819,-0.0127583945813886,-0.00164456519576052,0.0110926863776269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,40171,-0.0141265371299189,0.00556835519346284,-0.025040513309106,-0.00321256095073169,0.0111924605527404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40359,0.0106130775809275,0.00420015502247795,0.00238077373687069,0.0188453814249843,0.0115193333562783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,37598,-0.0150053658651747,0.00594072034898461,-0.0266491777491845,-0.00336155398116483,0.0115535374466441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,40396,-0.00705139847414996,0.0027940022238976,-0.0125276428329893,-0.00157515411531068,0.0116202613837894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37562,-0.00903603819171814,0.00358386715843179,-0.0160604178222444,-0.00201165856119184,0.0117036541949376
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37482,0.00726928185993544,0.00288387736667618,0.00161688222125012,0.0129216814986208,0.0117252500694045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,40042,-0.00730513416305809,0.00290963022688047,-0.0130080094077438,-0.00160225891837238,0.0120601157441746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40422,-0.0063063691345969,0.00251462802852213,-0.0112350400705003,-0.00137769819869354,0.0121558502701177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,37990,-0.00652646829080763,0.00261291718149591,-0.0116477859665396,-0.00140515061507564,0.0125094688980733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40305,-0.0174145996986503,0.00698536213334206,-0.0311059094800008,-0.00372328991729987,0.0126765359150961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,37628,-0.00690655037967719,0.00277437711795322,-0.0123443295308655,-0.00146877122848887,0.0128079224381682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40359,-0.0138091946034547,0.00555144143311197,-0.0246900198123541,-0.0029283693945552,0.0128747136117757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,40309,-0.00640867023299129,0.00258323568710729,-0.0114718121797216,-0.00134552828626099,0.0131165308566442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,37562,-0.014282775494446,0.00575955636370625,-0.0255715059673102,-0.00299404502158174,0.0131566175022189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40042,-0.0148140273277024,0.00597450695447479,-0.026524060958473,-0.00310399369693181,0.0131656936702865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39925,-0.011251891174825,0.00454245739134299,-0.0201551076618572,-0.0023486746877927,0.0132579597862259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37567,-0.0140211997295713,0.00566054343382545,-0.0251158648598692,-0.00292653459927344,0.0132614785959564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40044,-0.00752449111692227,0.00303811678442322,-0.0134792000143918,-0.00156978221945277,0.0132710124038553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,40411,-0.00720236858966976,0.00290858800180152,-0.0129032010732007,-0.00150153610613877,0.0132876346819322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37562,-0.0111528566327399,0.00450524141719104,-0.0199831298104343,-0.00232258345504542,0.0133164279159529
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,40207,-0.0105609970219545,0.00427900005575126,-0.018947837131227,-0.00217415691268205,0.0135938041990151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',37562,-0.01013207948866,0.00411703304403772,-0.0182014642549739,-0.00206269472234609,0.0138672533784449
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,37942,-0.0139236412171005,0.00565924974176064,-0.0250157707109513,-0.00283151172324962,0.0138932413464835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40044,-0.00984860400234905,0.00400719189803366,-0.017702700122495,-0.00199450788220308,0.0139925466813084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37942,0.00834376672432371,0.003396121846614,0.00168736790496027,0.0150001655436871,0.0140285652860798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40042,-0.0123177088338007,0.00501384467592212,-0.0221448443986081,-0.00249057326899335,0.0140312603001341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,40471,-0.0153225477867243,0.00625030210425286,-0.0275731399110599,-0.00307195566238867,0.0142372505605761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,37628,-0.0139313302581358,0.00569428464043606,-0.0250921281533905,-0.00277053236288116,0.0144362092981817
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37541,0.0073929711124458,0.00302604058659175,0.00146193156272597,0.0133240106621656,0.0145741400500402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,37714,0.00976945332753348,0.00400012469054804,0.00192920893405932,0.0176096977210076,0.0146074971377493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37598,0.00990877900550746,0.00406786364007273,0.0019357662709649,0.01788179174005,0.0148692957606589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,37598,-0.0076231962837995,0.00314665644683337,-0.0137906429195929,-0.0014557496480061,0.0154218738608196
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37942,-0.016418014662959,0.00678679170702218,-0.0297201264087224,-0.00311590291719548,0.0155715563777191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37942,-0.00504969333015453,0.00208897502347415,-0.00914408437616387,-0.000955302284145189,0.0156490084079928
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37671,-0.00722552636609562,0.00299180117932248,-0.0130894566775677,-0.00136159605462356,0.0157439762301888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37562,0.0138068128823379,0.00571907639205788,0.00259742315390443,0.0250162026107713,0.0157847853559919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,40536,0.00608197369762771,0.00252135323475378,0.00114012135751031,0.0110238260377451,0.0158682982272631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37572,0.0103862653626831,0.00430575554055763,0.00194698450319012,0.018825546222176,0.0158710041061868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37562,-0.00947429925815334,0.00393046868510527,-0.0171780178809597,-0.00177058063534702,0.0159454068895844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37598,-0.00884124699288736,0.00366816125412457,-0.0160308430509715,-0.0016516509348032,0.0159545025818406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37562,0.00730548747715228,0.00303610443996018,0.00135472277483033,0.0132562521794742,0.0161329982606417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37562,-0.0153440445113843,0.00639511168633914,-0.027878463416609,-0.00280962560615956,0.0164385460288639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37671,-0.0083246626711253,0.00347225999223826,-0.0151302922559123,-0.00151903308633832,0.016522216519934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37900,-0.00842624287883891,0.00351572682606795,-0.0153170674579321,-0.00153541829974573,0.0165557400701562
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,37562,0.0106007073796899,0.00442732899650165,0.00192314254654666,0.0192782722128332,0.016662454785796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37959,-0.0206791627513622,0.00864301001896285,-0.0376194623885294,-0.00373886311419498,0.0167435904770811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,37482,0.00725270644829476,0.00303381734940032,0.00130642444347012,0.0131989884531194,0.0168340317672949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39980,-0.0129558467512178,0.00542139767548951,-0.0235817861951772,-0.00232990730725839,0.0168711761005413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39961,-0.0125927867833463,0.00527107112031691,-0.0229240861791675,-0.00226148738752519,0.016904454737125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37900,-0.0117257161499228,0.00492524652845732,-0.0213791993456992,-0.00207223295414647,0.0172918897966925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,37482,0.00587106611121024,0.00246985145324232,0.00103015726285529,0.0107119749595652,0.0174640487903852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,39896,-0.00693320039868604,0.00291877244072389,-0.0126539943825049,-0.0012124064148672,0.0175429160033333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,37562,0.0072651968454363,0.00305893521103915,0.00126968383179956,0.013260709859073,0.0175597418137724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,37901,-0.00794153156602108,0.00334680864200542,-0.0145012765043517,-0.00138178662769046,0.0176645986181152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40341,0.0137130720189588,0.00578017358904827,0.00238393178442423,0.0250422122534934,0.0176832257692077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,40516,0.00923144909597492,0.00389775578869496,0.00159184775013279,0.016871050441817,0.0178769223129623
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,40044,0.0329500353654753,0.0139145669692617,0.00567748410572243,0.0602225866252281,0.017895480102615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,37562,0.00927792294005822,0.00392578333599469,0.00158338760150863,0.0169724582786078,0.0181260241493314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,37598,0.00756930647515629,0.00320870269072466,0.00128024920133595,0.0138583637489766,0.0183391570092888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,40305,-0.0192533187047998,0.00817077491868953,-0.0352680375454313,-0.0032385998641683,0.0184669303962783
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40228,0.0113135927796424,0.00480665641995902,0.00189254619652275,0.0207346393627621,0.0185980806507124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37714,-0.0166280227064565,0.0070706585105618,-0.0304865133871576,-0.00276953202575532,0.0187027047081165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,40172,-0.0157363896980992,0.00669260846386856,-0.0288539022872815,-0.00261887710891677,0.018719773883445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37942,-0.0144899804223656,0.006164170804443,-0.0265717551990739,-0.00240820564565736,0.0187535617004398
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40044,-0.0134711142433459,0.00574250788088793,-0.0247264296898863,-0.00221579879680561,0.018995741956861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,37562,0.00894268080314019,0.00383332308058003,0.00142936756520334,0.016455994041077,0.0196695189907281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,38013,-0.00577912907132068,0.00247829203465656,-0.0106365814592475,-0.000921676683393831,0.0197205194280291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40516,-0.00729476712561695,0.00313462540022943,-0.0134386329100666,-0.00115090134116727,0.0199692455792489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,40471,0.0169564464903269,0.00729464611504972,0.00265894010482944,0.0312539528758244,0.0201108430167558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,40305,-0.00936809127760306,0.00404088917267657,-0.0172882340560491,-0.00144794849915698,0.0204443642343348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,40341,-0.0088556963982023,0.0038309548690616,-0.016364367941563,-0.00134702485484156,0.020811583793655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,40359,0.0172776166530494,0.00750198946144497,0.00257371730861729,0.0319815159974816,0.0212876692080253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37482,-0.0170009731782231,0.007381844971895,-0.0314693893231373,-0.00253255703330887,0.0212900630526049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,37562,-0.0136636337300089,0.00594891236538694,-0.0253235019661673,-0.00200376549385046,0.021644220809461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,37714,-0.0116960783570666,0.00510343753911024,-0.0216988159337226,-0.00169334078041051,0.0219325537423295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,40330,-0.00842405690579721,0.00367622434500278,-0.0156294566220027,-0.00121865718959176,0.0219477179732463
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37942,-0.0519908378866764,0.0227257150962012,-0.0965332394752308,-0.00744843629812204,0.0221672725116791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40283,-0.00701718113729833,0.00306940740255093,-0.0130332196462982,-0.0010011426282985,0.0222575762918694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40228,-0.00755685744395893,0.00330873198750191,-0.0140419721394627,-0.0010717427484552,0.0223898449593389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,40042,-0.0102838265836337,0.00451594724215419,-0.019135083178256,-0.00143256998901154,0.0227862945053405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37572,0.0113481779173299,0.00498986402685224,0.00156804442469955,0.0211283114099603,0.0229672791506538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,37598,-0.0255373883288712,0.0112295972747725,-0.0475473989874253,-0.00352737767031708,0.022975157119207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,40271,-0.0117359704676637,0.00516158657365404,-0.0218526801520256,-0.00161926078330183,0.0229965412416593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40178,0.009420214957103,0.00414724639507454,0.00129161202275691,0.0175488178914491,0.0231339004222451
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,37787,-0.0133322560125155,0.00587108051164998,-0.0248395738153495,-0.00182493820968152,0.0231728336075345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37541,0.0125752700425417,0.00553851019649082,0.00171979005741971,0.0234307500276637,0.0231925376165836
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,37541,0.0074901726163348,0.00330342036958096,0.00101546869195611,0.0139648765407135,0.0233820855677412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,37901,-0.00751113962613421,0.00331914602616949,-0.0140166658374264,-0.00100561341484201,0.0236531956314944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40536,0.00629822055337579,0.00279612296017161,0.000817819551439444,0.0117786215553121,0.0243051650375894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37562,-0.00856939493151384,0.00382300766022379,-0.0160624899455525,-0.00107629991747521,0.025008281655832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40471,0.00490623574892836,0.00219060186402792,0.000612656095433638,0.00919981540242309,0.0251257067624181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,39695,0.0100646466685329,0.00449501932099352,0.00125440879938556,0.0188748845376802,0.0251659645054112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,37482,0.00989849232516093,0.00442664076749884,0.00122227642086321,0.0185747082294586,0.0253608843521594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37900,0.00873740436171424,0.00390962184271888,0.00107454554998523,0.0164002631734433,0.0254437908163534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,37541,0.0195780111519158,0.00876128125922728,0.00240589988383036,0.0367501224200013,0.0254600407582726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,40341,0.0074254489142204,0.00332660643569706,0.000905300300254163,0.0139455975281866,0.0256196418936328
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37671,-0.0134419410743983,0.00602316750777452,-0.0252473493896364,-0.00163653275916029,0.0256510735626157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37671,-0.0189162651905378,0.0084769729564888,-0.0355311321852559,-0.0023013981958198,0.0256655067199626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,37671,0.0191784924777541,0.00859690143627977,0.00232856566264575,0.0360284192928625,0.0257070449579648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37901,-0.00836948161925937,0.00375277657624886,-0.0157249237087071,-0.00101403952981159,0.0257499084605688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40471,-0.00947527371615106,0.00424977972337464,-0.0178048419739653,-0.00114570545833677,0.0257883665008485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40044,-0.0135433022421053,0.00610113925970629,-0.0255015351911296,-0.00158506929308096,0.0264467498700441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,37671,-0.016529609653855,0.00746052206423423,-0.0311522328997541,-0.00190698640795595,0.026735174744725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,37352,0.00817363694042314,0.00369679018351567,0.000927928180732431,0.0154193457001138,0.0270526769727221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,37598,0.0087435749397176,0.00395781429449461,0.000986258922508165,0.016500890956927,0.0271784100244715
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37987,0.00994144172939952,0.0045192857807193,0.00108364159918969,0.0187992418596094,0.0278392356458635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,37959,-0.00767507845079004,0.00349225103697331,-0.0145198904832577,-0.000830266418322346,0.0279841693489352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37541,0.00894075064347745,0.00406867430653555,0.00096614900266777,0.0169153522842871,0.0280050380772095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,40176,0.00553797800926396,0.00253701844801557,0.00056542185115345,0.0105105341673745,0.0290602243582791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,37482,0.00780558701429697,0.00358088547182549,0.000787051489519008,0.0148241225390749,0.0292906917739308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37714,0.0153101415110197,0.00704567237748929,0.00150062365114066,0.0291196593708987,0.0297990766817189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,37562,0.0100228553573223,0.004614799432954,0.000977848468732461,0.0190678622459121,0.0298815220752015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,37900,-0.00775370474332369,0.00357187347745086,-0.0147545767591274,-0.000752832727519997,0.0299662317370075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,39980,-0.0166946216316659,0.00774096270839751,-0.031866908540125,-0.00152233472320677,0.0310474970666001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,37959,0.00437800164318584,0.00203283073328188,0.000393653405953352,0.00836234988041833,0.0312854344676028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40489,0.00518229271046312,0.00240721283083735,0.000464155562021925,0.00990042985890432,0.0313478008938975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39980,-0.015732551270624,0.00731180098362217,-0.0300636811985234,-0.00140142134272451,0.031439066594855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,39961,0.0107818095247091,0.00501398315257268,0.000954402545666663,0.0206092165037516,0.0315430938120767
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37671,-0.0137950075364679,0.00642539327028777,-0.0263887783462319,-0.00120123672670389,0.0318152807916022
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37900,-0.00580655903125453,0.0027074466605234,-0.0111131544858804,-0.000499963576628655,0.0319977139004957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,37959,-0.00615633595324251,0.00287059088256719,-0.0117826940830742,-0.000529977823410818,0.0320007683123227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,37541,0.00693466154408331,0.0032391141268705,0.000585997855417127,0.0132833252327495,0.0322994712797251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40536,0.0084579676105374,0.003955595662643,0.000705000111757118,0.0162109351093177,0.032513221229581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40498,-0.0107257302770756,0.00501740712108151,-0.0205598482343954,-0.000891612319755842,0.0325558570945241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,37541,0.0102110349256708,0.00478817253384235,0.00082621675933983,0.0195958530920018,0.0329799129672319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,40434,-0.0125131303574703,0.00587827468112922,-0.0240345487324836,-0.000991711982457065,0.0332936753198665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37714,-0.0176915024167056,0.00831643911704436,-0.0339917230861125,-0.00139128174729864,0.0334141488795422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37714,-0.0112254111365061,0.00528136275284465,-0.0215768821320816,-0.000873940140930589,0.033565322645563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40516,0.00527246530759574,0.00249008597298774,0.000391896800539773,0.0101530338146517,0.0342426926999273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37572,0.0158443850862602,0.00749769873473401,0.00114889556618149,0.0305398746063388,0.0345996518572793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,38013,0.00296262918610919,0.00140251518065089,0.000213699432033436,0.00571155894018494,0.0346730674053017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37998,-0.0118144819438347,0.00560415198119445,-0.0227986198269759,-0.000830344060693624,0.0350349616731704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37900,-0.00907556422032242,0.00431184219852938,-0.01752677492944,-0.000624353511204843,0.035327250400951
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,40173,-0.0207543410722849,0.00986795605813787,-0.0400955349462352,-0.0014131471983347,0.0354636456046206
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,37900,-0.0155893482170401,0.0074206796674869,-0.0301338803653144,-0.00104481606876577,0.0356772787547957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37541,0.00827743533863556,0.00394729870183844,0.000540729883032211,0.0160141407942389,0.0360138357398297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,40228,-0.0121281910051018,0.00579893302297,-0.023494099730123,-0.000762282280080625,0.0365035027870813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39961,-0.00549286795253582,0.00263174827830542,-0.0106510945780145,-0.000334641327057192,0.036890363536795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37572,0.00639689293195999,0.00307023162192338,0.000379238952990163,0.0124145469109298,0.037223042025663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,37766,0.00655930326766352,0.00315397597114438,0.000377510364220526,0.0127410961711065,0.0375727432157165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,38013,-0.00496679254514855,0.00239118102169435,-0.00965350734766948,-0.000280077742627621,0.0378083905758445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40305,0.00445440310746832,0.00214805189030508,0.000244221402470372,0.00866458481246627,0.0381238127701607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40044,-0.00691395010944662,0.00334015563785097,-0.0134606551596345,-0.000367245059258714,0.0384735959904713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,40262,-0.0047759626533183,0.00230864050157383,-0.009300898036403,-0.000251027270233591,0.0385872895770593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37562,0.0106779620336846,0.00516230224878949,0.000559849626057212,0.020796074441312,0.0386173260787611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37671,-0.0105539379262133,0.00510526892209353,-0.0205602650135166,-0.000547610838910011,0.0387287160681466
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,37562,0.00723609981759373,0.003513416829187,0.000349802832387221,0.0141223968028002,0.0394601310976546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37959,-0.00768666163328896,0.00373990138464567,-0.0150168683471945,-0.00035645491938345,0.0398681296377974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,37541,0.0192621811529972,0.0093867279659918,0.000864194339653297,0.0376601679663412,0.0401831390569941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,37900,-0.00998050023722039,0.00486590606513836,-0.0195176761248916,-0.000443324349549214,0.0402757346705138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,39961,-0.00889856433691683,0.00434317568563834,-0.017411188680768,-0.000385939993065687,0.0404924769423189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37901,-0.0104794490076113,0.00514781843846409,-0.0205691731470009,-0.000389724868221719,0.0417993649968576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,39961,-0.0101583791878185,0.00499780137646438,-0.0199540698856887,-0.000362688489948353,0.0421130257326327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,37990,-0.0187564813478469,0.00925466413928253,-0.0368956230608407,-0.000617339634853168,0.0427120721461739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37541,0.0137642951027118,0.00679150406643435,0.000452947132500462,0.0270756430729231,0.0427140313085754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",40489,-0.014244519360321,0.00702889991562098,-0.0280211631949381,-0.000467875525703897,0.0427234805607195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37900,-0.00790328843078305,0.00390101160031481,-0.0155492711674001,-0.000257305694166012,0.0427887194265218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,37541,0.00888593381688398,0.00439039722752447,0.00028075525093601,0.0174911123828319,0.0429958201239356
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,37562,0.00701787387076296,0.00347205382267281,0.000212648378324248,0.0138230993632017,0.0432746182976221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37921,-0.00743360413033137,0.00367792145029112,-0.014642330172902,-0.000224878087760779,0.0432847365511664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,37900,0.0110279639089291,0.00546157422092536,0.00032327843591539,0.0217326493819428,0.0434871272604199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,37671,-0.0214376072057242,0.0106355666621737,-0.0422833178635846,-0.000591896547863839,0.0438565155018248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,39951,-0.0211925424636063,0.0105479699549299,-0.0418665635752689,-0.000518521351943756,0.0445376433496172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,37998,0.0174203777151965,0.00867431015056709,0.000418729820084982,0.034422025610308,0.0446341658899288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37987,-0.0137910967222056,0.00687571270769537,-0.0272674936292885,-0.000314699815122622,0.0449006817390737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37482,0.00661114725991403,0.00329851184082912,0.000146064051888949,0.0130762304679391,0.0450605384362435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37677,-0.0125846437085227,0.00628967383096555,-0.0249124044172152,-0.000256882999830246,0.0454298183719962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40357,-0.0557607294338912,0.0278768844128905,-0.110399422883157,-0.00112203598462582,0.0454902790012938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40228,-0.00431582629084827,0.00215793288348742,-0.00854537474248361,-8.62778392129197e-05,0.0455193517746492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,37990,0.00701873871837996,0.00351098051129545,0.000137216916240883,0.013900260520519,0.0456194124689898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37990,-0.00738436213861253,0.0036940447988772,-0.0146246899444118,-0.000144034332813211,0.0456292878718762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,40042,-0.00955783542965401,0.00478395228149081,-0.018934381901376,-0.000181288957932018,0.0457453621118105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,40192,-0.005934962008685,0.00297167791250521,-0.0117594507171952,-0.000110473300174791,0.0458233181776927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37562,-0.0124961837507575,0.00629801819498463,-0.0248402994129274,-0.00015206808858766,0.0472604527567127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,40044,0.00540870453497421,0.00273450029746694,4.90839519390156e-05,0.0107683251180094,0.0479519381693311
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40400,0.0120477183918119,0.00609333184531545,0.000104787974993666,0.0239906488086302,0.0480365423608679
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40305,0.00388752840274499,0.00196637170615695,3.34398586773711e-05,0.0077416169468126,0.0480582654207478
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,40048,0.00780566830180154,0.00396038120089972,4.3321148038092e-05,0.015568015455565,0.0487485500526518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39897,-0.0107324869655383,0.00545077743627994,-0.021416010740647,-4.89631904296538e-05,0.0489729171152407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,37562,0.0105204133451052,0.00535895512088478,1.68613081710442e-05,0.0210239653820394,0.0496502765589605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,37874,0.0106258070577589,0.00542534839628504,-7.87579895978122e-06,0.0212594899144776,0.0501863844543075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,39961,-0.0104703887443583,0.0053540863469463,-0.0209643979843731,2.36204956564016e-05,0.0505315994161945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,40341,-0.0107420853942126,0.00549342717110187,-0.0215092026495722,2.5031861147079e-05,0.0505482714891696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40305,-0.00667546783024383,0.00341836703448988,-0.013375467217844,2.45315573563264e-05,0.0508580721751304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,40044,-0.0114376386802553,0.00586038443717513,-0.0229239921771185,4.87148166079827e-05,0.050993203502195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,37562,0.00883159448843938,0.00454233573518506,-7.13835525233356e-05,0.0177345725294021,0.0518824736752011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,37551,-0.0127710399034155,0.00657009050152835,-0.0256484172864111,0.000106337479580021,0.0519391601362292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,39311,0.00887287897880784,0.00459421876270831,-0.000131789796100448,0.0178775477537161,0.0534632299063528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,37901,-0.0102732624147874,0.00532659162712627,-0.0207133820039549,0.000166857174380083,0.0537922815477598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37990,0.00486435972082253,0.00252275735272167,-8.02446905119325e-05,0.009808964132157,0.053852177701873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37572,-0.00986960523190722,0.00513300661303797,-0.0199302981934616,0.000191087729647203,0.054530218422701
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37598,0.00771002376203592,0.00401070983271381,-0.000150967510083136,0.015571015034155,0.0545821976463503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,40070,-0.0100824027938566,0.00524968072576383,-0.0203717770163537,0.000206971428640519,0.054803563182579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40296,0.00874865614298649,0.00455935659036132,-0.000187682774121695,0.0176849950600947,0.0550230775738752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,37562,0.00773806084904271,0.00403460435038086,-0.00016976367770378,0.0156458853757892,0.0551424636628019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,37714,-0.0108897041127314,0.00568326739640979,-0.0220289082096946,0.000249499984231799,0.0553739437972909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37572,0.0145123103654576,0.00758599465688123,-0.000356239162029636,0.0293808598929448,0.0557646903674835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,37482,0.0062651830790532,0.00327656820667338,-0.000156890606026619,0.012687256764133,0.0558830433432422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37541,0.0147850564035223,0.00773804431544469,-0.000381510454749311,0.0299516232617939,0.0560653826682739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,37628,-0.0124398883923262,0.00652007258203563,-0.025219230653116,0.000339453868463648,0.0564210602983923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39980,0.00900912690699509,0.00473177302120314,-0.000265148214563062,0.0182834020285532,0.0569332998803239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40332,-0.0215380935439538,0.0113353664030737,-0.0437554116939782,0.000679224606070641,0.057440826810243
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,37901,-0.0193198484626037,0.0101734698438189,-0.0392598493564889,0.000620152431281409,0.0575803075051127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,40471,-0.0232146174927396,0.0122296023025623,-0.0471846380057616,0.000755403020282437,0.057683537068584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37562,0.00888379680200073,0.00469706176984425,-0.000322444266893996,0.0180900378708955,0.0585994050878803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40403,-0.00489014236170062,0.00259069793603707,-0.00996791031633329,0.000187625592932039,0.0591008700114905
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,40341,0.0088028475578156,0.00467605016506326,-0.000362210765708394,0.0179679058813396,0.0597811039772177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,40411,0.00661691014841549,0.00352552356368532,-0.000293116036407727,0.0135269363332387,0.0605556698501571
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,37598,0.0100113679163217,0.00533970452009531,-0.000454452943065078,0.0204771887757085,0.0608297709840627
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,40374,-0.0118737126291063,0.0063373722097883,-0.0242949621602914,0.000547536902078743,0.0610036180662221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40042,0.00587279534558001,0.00313889502276193,-0.000279438899033374,0.0120250295901934,0.0613672090526087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40536,0.0124953574047399,0.00668327389064088,-0.000603859420916231,0.025594574230396,0.0615511242600061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37562,0.0125868280707809,0.00673752126841634,-0.000618713615315116,0.0257923697568769,0.061760813777254
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,37598,0.00618227450480068,0.00331631144631709,-0.000317695929980821,0.0126822449395822,0.0623156116538646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,37482,0.00816943180646394,0.00438816775625424,-0.000431376995794368,0.0167702406087222,0.0626685329811678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37184,0.00867851891192567,0.00466299055212841,-0.000460942570246006,0.0178179803940973,0.0627462082172591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,37541,-0.015473343443842,0.0083263386621501,-0.0317929672216562,0.000846280333972245,0.0631401931166845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,40372,-0.00423291739343102,0.00228442639861629,-0.00871039313471895,0.00024455834785691,0.0639086766803554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,40044,-0.0157979024939678,0.00857054092418104,-0.0325961627053627,0.001000357717427,0.0653071779671251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,40183,0.0116499891967221,0.00632097699199818,-0.000739125707594376,0.0240391041010385,0.0653379124305054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37562,-0.00713609939993853,0.00388576191001676,-0.0147521927435714,0.000479993943694314,0.0663102623972658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,40042,0.00894155874699683,0.00487305723742406,-0.000609633438354322,0.018492750932348,0.0665399749302705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40465,-0.011129606590922,0.006075884627828,-0.0230383404614649,0.000779127279620911,0.0670046667523722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,37990,0.018299932721055,0.010004694417179,-0.00130926833661585,0.0379091337787258,0.0674014315597311
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,40411,0.00476430311277812,0.00260875854644103,-0.000348863638246295,0.00987746986380253,0.0678279492090253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,37900,-0.00914483230481071,0.005023803505506,-0.0189914871756025,0.000701822565981045,0.0687354639139094
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,38013,-0.00454329042222358,0.0024973057893396,-0.00943800976932919,0.000351428924882028,0.0688912561976023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37562,-0.0146503672462199,0.00805868030473887,-0.0304453806435081,0.00114464615106829,0.069092892082544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,37572,-0.00912933823290216,0.0050228518839146,-0.0189741279253748,0.000715451459570447,0.0691541002680588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,37457,0.00698279325453159,0.00387909546162667,-0.000620233850256685,0.0145858203593199,0.0718666508333015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37562,0.00657500029891025,0.00365267731494433,-0.000584247238380626,0.0137342478362011,0.0718757886511485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,40458,0.00512543056252828,0.00285141996332942,-0.000463352565597383,0.0107142136906539,0.0722749424979889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37562,-0.00812760212920169,0.0045238079268929,-0.0169942656659118,0.000739061407508399,0.0724176320749802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,40279,-0.0122635275121491,0.00683049618222711,-0.0256513000293142,0.00112424500501604,0.072607788080459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,37482,0.0106774530796572,0.00597425529678311,-0.00103208730203772,0.022386993461352,0.073921265294553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37944,0.00377241365144371,0.00211165693452327,-0.000366433940221898,0.00791126124310932,0.0740454923244304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37901,0.00934678835536434,0.00523624796326048,-0.000916257652626212,0.0196098343633549,0.0742811914032394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37628,-0.00399378657425786,0.00223993224898016,-0.00838405378225897,0.000396480633743253,0.0746102354117266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,37714,-0.00752837947675781,0.00422470930094997,-0.0158088097066198,0.00075205075310414,0.0747741319210329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,37648,-0.00971348015136161,0.0054574050199268,-0.0204099939904181,0.000983033687694916,0.0751199840219066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,40442,-0.00823887812670576,0.0046337316868514,-0.0173209922329345,0.000843235979522974,0.0754191963018757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,40316,-0.0216014152720629,0.012161737569791,-0.0454384209088533,0.00223559036472754,0.0757226837500534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37990,0.00422233660992129,0.00237853367157615,-0.000439589386367955,0.00888426260621054,0.0758898558972675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,37959,-0.00468387235377582,0.00263890816562007,-0.00985613235839115,0.000488387650839517,0.0759322700026723
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37482,-0.0112285533460122,0.00635181619196419,-0.023678113082262,0.0012210063902376,0.0771226761002425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37562,-0.0093318793950015,0.00529864622128061,-0.0197172259887115,0.00105346719870849,0.0782309425886918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37482,0.00789388042403235,0.00448889635147363,-0.000904356424855975,0.0166921172729207,0.0786800288741018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37714,0.00847593402092058,0.00483039553107203,-0.000991641219980606,0.0179435092618218,0.0793323454532075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,40516,-0.00444272458779424,0.00253308178550624,-0.00940756488738647,0.000522115711797986,0.079469929144131
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37959,-0.00811433249872073,0.0046268356211967,-0.0171829303162663,0.000954265318824808,0.0794953091347391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39961,0.00670898768907059,0.00382819412128427,-0.00079427278864659,0.0142122481667878,0.0797041513188674
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38013,0.00449939184811624,0.0025723138402351,-0.000542343278744553,0.00954112697497703,0.0802857612529962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,37998,0.0150808731181058,0.00862882279095508,-0.00183161955216616,0.0319933657883777,0.0805330334117768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,40077,-0.00569239970567892,0.00325881718994951,-0.01207968139798,0.00069488198662213,0.0806971246418546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37541,0.00563467362271294,0.00324027327970599,-0.000716262005510797,0.0119856092509367,0.0820670473404007
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40305,-0.00512900506986789,0.00295158596015552,-0.0109141135517727,0.00065610341203692,0.0822810681919786
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39961,-0.0134268984185036,0.00773128365280251,-0.0285802143779966,0.0017264175409893,0.0824604937610538
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40333,-0.0122608397196595,0.00707097463777219,-0.026119950009693,0.00159827057037402,0.0829432684590606
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37541,0.00496851838632068,0.00286781661841224,-0.000652402185767308,0.0105894389584087,0.0832065140535423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40357,0.00489113385642809,0.00282368503366036,-0.000643288809546208,0.0104255565224024,0.0832607094177534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40167,-0.00530557342263931,0.00306895843672888,-0.0113207319586279,0.000709585113349293,0.0838669822731406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,39961,-0.00723836298419436,0.00419287367811821,-0.015456395393306,0.000979669424917323,0.0843045726573625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,40228,0.0091833484912927,0.00532940040011335,-0.00126227629292947,0.0196289732755149,0.0848812630199235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37562,0.0103005888892,0.00597786174522418,-0.00141602013143937,0.0220171979098394,0.0848899303630675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37959,-0.00620425944106698,0.00360504712040445,-0.0132701517970597,0.000861632914925745,0.0852750659413124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37598,-0.00334985664543994,0.00194961561696746,-0.00717110325469617,0.000471389963816283,0.0857811546651306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37900,-0.0086482651203024,0.00504225194060602,-0.0185310789238902,0.0012345486832854,0.0863390681356319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,37541,-0.0106022855440767,0.00619340632996899,-0.0227413619508159,0.00153679086266253,0.0869449406292282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37714,-0.0112031770331285,0.00654681816569835,-0.0240349406378973,0.00162858657164026,0.0870602032487736
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37572,-0.00876958658197004,0.00514419866918917,-0.0188522159735808,0.00131304280964073,0.088264231098098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37942,-0.0045895131274576,0.00269287277993076,-0.00986754377612189,0.000688517521206689,0.0883446126995587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,37541,0.00786708567813586,0.00461952600721719,-0.00118718529600983,0.0169213566522815,0.0885904772568124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37482,-0.00892047840348052,0.00525297077466349,-0.019216301121821,0.00137534431485993,0.0894980835705774
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37998,0.00416822206376663,0.00246512320990731,-0.000663419427651709,0.00899986355518496,0.0908831527339315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,37959,-0.00702730008891039,0.00415665017043894,-0.0151743344229707,0.00111973424514993,0.0909332026487847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,40391,0.00637370807371747,0.00377138437149441,-0.00101820529441157,0.0137656214418465,0.0910440355147247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37562,0.00780379888167242,0.00462819648787172,-0.00126746623455614,0.016875063997901,0.0917921470666862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37562,0.00608835108853672,0.00361226940371412,-0.000991696942742966,0.0131683991198164,0.09192282707553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40341,0.00731247613983143,0.0043460288855578,-0.00120574047586186,0.0158306927555247,0.0924789778725722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37959,-0.0118151481867038,0.00702804834201239,-0.0255901229370481,0.0019598265636405,0.0927584299772519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,37562,0.00836242849392284,0.00498684332603401,-0.00141178442510381,0.0181366414129495,0.0935862349038239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37541,0.00800230929985865,0.00479654972085608,-0.00139892815301925,0.0174035467527366,0.0952707829400942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37959,-0.00521766794675739,0.00313119790698689,-0.0113548158444517,0.000919479950936912,0.0956671445576333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40341,-0.0193987604596618,0.0116549338740695,-0.042242430852838,0.0034449099335143,0.0960472941680799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,38013,-0.00328939151071045,0.00197698317882704,-0.00716427854121144,0.000585495519790541,0.0961667225706211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39961,-0.00606668843058464,0.00364947879012987,-0.0132196668592392,0.0010862899980699,0.0964640692860443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40359,0.00501818846222769,0.00302004575823859,-0.000901101223919946,0.0109374781483753,0.0966073653164568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37562,0.00698229180222117,0.00421342806014919,-0.00127602719567124,0.0152406108001136,0.0975126248836449
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,40203,0.00714745042686648,0.00432633023837934,-0.00133215684035704,0.01562705769409,0.0985378571403634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37572,0.00771534863659581,0.00468607824295754,-0.00146936471960097,0.0169000619927926,0.0996970674645932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,40305,-0.0293762889200996,0.0178558142630879,-0.0643736848757518,0.00562110703555259,0.0999495154464289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37998,0.00778453402218342,0.00473590136840513,-0.00149783265989063,0.0170669007042575,0.100255591658782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,37572,-0.00816480504947025,0.00496845517862862,-0.0179029771995823,0.00157336710064185,0.100338902613501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,37598,-0.00590507715575622,0.00359704464247437,-0.012955284655006,0.00114513034349355,0.100687124055166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40359,-0.00762284452423357,0.00464638012362996,-0.0167297495665483,0.00148406051808116,0.100900546163832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37598,0.00787108166383067,0.00481290195682338,-0.00156220617154316,0.0173043694992045,0.101986473208348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,37598,0.00549186896258108,0.00335849497722691,-0.00109078119278366,0.0120745191179458,0.102027452203991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,37482,0.00713676757581873,0.00436554471731296,-0.00141970007011467,0.0156932352217521,0.102116334268764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37990,-0.00421555476445758,0.00257961176055405,-0.00927159381514352,0.000840484286228366,0.102243920235378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37714,-0.0142950088712634,0.00875324388790265,-0.0314513668915526,0.00286134914902577,0.102469632664352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,39961,0.0101701187932338,0.00623502548199289,-0.00205053115147226,0.0223907687379399,0.102883816190813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37541,0.00988612840554149,0.00608803951723733,-0.00204642904824367,0.0218186858593267,0.104429611199545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40341,-0.0184206776397245,0.0113463895673425,-0.0406596011917158,0.00381824591226679,0.104505898782437
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,37628,0.00971373287184056,0.00599745777130995,-0.00204128435992695,0.0214687501036081,0.105333192322802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,37628,-0.00455481945794182,0.0028125777508767,-0.0100674718496602,0.000957832933776515,0.105375141150409
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37987,-0.00398818572274566,0.00246528018459009,-0.00882013488454225,0.000843763439050924,0.105741650153272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,37525,-0.0147142946100978,0.00911701891652738,-0.0325836516864915,0.00315506246629587,0.106565216175839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,40536,-0.010984395449776,0.00680985006719001,-0.0243317015814685,0.00236291068191638,0.106760703360806
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37714,-0.00820860024644022,0.00509068074110562,-0.0181863344990072,0.00176913400612679,0.106882204295757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,40299,-0.0121508812356342,0.00754072322926519,-0.026930698764994,0.00262893629372554,0.107119420060576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37541,0.0100487549406945,0.00623613270363508,-0.00217406515843023,0.0222715750398193,0.10712189336548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37541,0.00719111500698834,0.00446416877047926,-0.00155865578315102,0.0159408857971277,0.107236105640968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37900,-0.00772469687536102,0.00479569845891163,-0.0171242658548278,0.00167487210410577,0.10725652882345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,37714,0.0060575821918447,0.00377229640173921,-0.00133611875556415,0.0134512831392536,0.108340001289287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,37901,-0.00470007575765295,0.00293075245485912,-0.0104443505691768,0.00104419905387092,0.108801567360824
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37598,-0.00597481991754111,0.00372644588300577,-0.0132786538482324,0.0013290140131502,0.108880070423714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,40500,-0.00931595510422197,0.00581254469389682,-0.0207085427042597,0.0020766324958158,0.109013374461609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,40354,0.0059824382305544,0.00373484728825935,-0.00133786245443392,0.0133027389155427,0.109222084056746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,37959,0.00819221912399572,0.00512471698078693,-0.00185222615834667,0.0182366644063381,0.109939557388726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,37572,-0.0117288589236326,0.00735092519400022,-0.0261366723038731,0.00267895445660779,0.110610641316166
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37714,-0.0108758619745726,0.00684837443228105,-0.0242986758618434,0.00254695191269825,0.112288935828578
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37562,0.00789536428097638,0.00498363684244826,-0.00187256393022221,0.017663292492175,0.113159242315291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,40258,0.00632413279741888,0.00399433225292146,-0.00150475841830719,0.0141530240131449,0.113378440390717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,40341,-0.0103576834472411,0.00655677475874934,-0.0232089619743898,0.00249359507990759,0.114197365684887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37541,0.0137524595772041,0.00870884885513309,-0.00331688417885679,0.0308218033332649,0.114328955727006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,37763,-0.00943640748825921,0.00598724080187457,-0.0211713994599334,0.00229858448341494,0.115029707654619
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37562,0.00742540347345315,0.00472937127890754,-0.00184416423320562,0.0166949711801119,0.116424951838935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37598,0.00686830366247317,0.00437478047047807,-0.00170626605966384,0.0154428733846102,0.116444585588113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37482,0.00382503270195475,0.00244030664193834,-0.000957968316244396,0.00860803372015389,0.117036310905197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,40489,-0.00303285458577564,0.00193963450940596,-0.00683453822421132,0.000768829052660041,0.117926169842735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,37900,0.00411709720020253,0.00263778094038886,-0.00105295344295964,0.0092871478433647,0.118590120123088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,40359,0.00538366958910442,0.00346417425904232,-0.00140611195861853,0.0121734511368274,0.120180709094769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,37572,-0.00463635213299478,0.00298629424382726,-0.0104894888508962,0.00121678458490665,0.120556319501681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,39961,0.00488191844978675,0.00314460298314149,-0.00128150339717056,0.0110453402967441,0.120568943745915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,37959,-0.0094314181728161,0.00608250121431891,-0.0213531205528812,0.00249028420724897,0.12102526710042
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,40355,0.0272064298349936,0.0175543628920123,-0.0072001214333504,0.0616129811033377,0.12120015010754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37562,0.00600291519114008,0.00389795773347716,-0.00163708196647515,0.0136429123487553,0.123580718526881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,37482,0.00881561406376425,0.00575266277653567,-0.00245960497824567,0.0200908331057742,0.125438019757384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40403,-0.00666830144696264,0.00435504186324681,-0.0152041834989264,0.00186758060500111,0.125747668027567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37541,0.00836873003198432,0.00546553819433425,-0.0023437248289108,0.0190811848928794,0.125748751108013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,40305,-0.00598496266705752,0.00393347339608876,-0.0136945705233915,0.00172464518927645,0.128142696982367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40411,-0.00535100579632954,0.00351817790198483,-0.0122466344842198,0.00154462289156073,0.128289834454501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40109,-0.00299405643945813,0.00197334207902651,-0.00686180691435008,0.000873694035433823,0.129223360765781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39980,-0.00671558564332952,0.00443605449324059,-0.0154102524500811,0.00197908116342203,0.130080549332405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,40288,-0.0156393828879638,0.0103350449630935,-0.035896071015627,0.00461730523969947,0.130239168163798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,37998,0.00748606238712997,0.00496487322853821,-0.00224508914080493,0.0172172139150649,0.131627674499225
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,37998,-0.00661565344282449,0.00439610153885941,-0.0152320124589889,0.00200070557333996,0.132375429274284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,37482,0.00686637262315655,0.00456403698053232,-0.00207913985868679,0.0158118851049999,0.132489370653417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37714,0.00926598839916784,0.00616029505569289,-0.00280818990999022,0.0213401667083259,0.132567372568813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37562,-0.00698991759067331,0.00466009749027793,-0.0161237086716181,0.00214387349027144,0.133651192720796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37562,0.0102418334032389,0.00683932406853727,-0.00316324177109413,0.023646908577572,0.134289348170641
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37598,0.00422858951293116,0.00283201784924093,-0.00132216547158107,0.00977934449744338,0.135425431501827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,37572,0.0049896943044337,0.00334341989975262,-0.00156340869908143,0.0115427973079488,0.135620361988443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,40044,-0.00944732580605395,0.0063419099914406,-0.0218774693892775,0.00298281777716962,0.136332383473568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37482,-0.00717441824263693,0.00481823197007721,-0.0166181529039883,0.0022693164187144,0.136507699157546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,40536,0.00457679215408419,0.00307498709795718,-0.00145018255791188,0.0106037668660803,0.136666639743442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40042,-0.00496551169548747,0.00333720577179599,-0.0115064350082076,0.00157541161723267,0.136790915245057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,37577,0.00973072390481904,0.0065725752104281,-0.00315152350762003,0.0226129713172581,0.138762796563691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37562,0.00539508381911367,0.00364607307878893,-0.00175121941531263,0.01254138705354,0.138978123869969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40215,-0.0132725543321927,0.00897103635807901,-0.0308557855940276,0.00431067692964216,0.139029512232159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,37598,-0.00588372312249609,0.00399019530848754,-0.0137045059271317,0.00193705968213949,0.140358818348162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37482,0.00584650362516163,0.00397364016891854,-0.00194183110591872,0.013634838356242,0.141228244775402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37562,-0.00538361983990312,0.00365922289708417,-0.0125556967181881,0.00178845703838184,0.141248396650615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37562,0.00547338046890414,0.00372804729352776,-0.00183359222641027,0.0127803531642185,0.142083989075088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,37482,-0.00998647526572295,0.00681635575381517,-0.0233465325432007,0.00337358201175478,0.142924469714245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,37959,0.00455053246789687,0.00311714910713094,-0.00155907978207977,0.0106601447178735,0.144357881098368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40305,-0.00291867681560309,0.00201468761576205,-0.00686746454249672,0.00103011091129053,0.147441316044001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40470,-0.00840284189180697,0.00581026746867366,-0.0197909661304074,0.0029852823467934,0.148139083324067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,37959,-0.00654652453628721,0.00452762792989126,-0.0154206752788741,0.00232762620629966,0.148226761730963
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37942,-0.00776742961033248,0.00537960536565464,-0.0183114561270156,0.00277659690635063,0.148799877546235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37598,0.00859659343648804,0.00595816959144347,-0.00308141896274116,0.0202746058357172,0.149093723575211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,40044,-0.00680902575015797,0.00472223410973383,-0.0160646046052363,0.00244655310492034,0.149348496712646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,37714,0.0048279693292064,0.00335684605680337,-0.00175144894212819,0.011407387600541,0.150387955862628
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,37541,0.0108815403506722,0.00756605477480892,-0.00394792700795327,0.0257110077092977,0.150399709937793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37541,0.0103709193294307,0.00722767345873063,-0.00379532064968134,0.0245371593085427,0.151342221699513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,37541,0.0125059143783484,0.00871909729827281,-0.00458351632626635,0.0295953450829631,0.15150685940453
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40403,0.00580937735335792,0.00405912186549126,-0.00214650150300495,0.0137652562097208,0.152395167066708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37942,-0.00738213310199865,0.00516282446282901,-0.0175012690491435,0.00273700284514621,0.152779422458132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37598,-0.00443625711782616,0.00310825161386529,-0.0105284302810021,0.00165591604534982,0.153531134902637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37628,0.00625111030574656,0.00439903813665896,-0.00237100444210499,0.0148732250535981,0.155335328554442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,39831,-0.0080217375240979,0.00564592098743975,-0.0190877426594798,0.003044267611284,0.155394516176027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37541,0.007797478762262,0.00551017572469228,-0.00300246565813486,0.0185974231826589,0.157061420542872
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39961,-0.0191847258052314,0.0135744439483186,-0.0457906359439359,0.00742118433347303,0.157588379242313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,37987,-0.00845332244733111,0.00598723481604644,-0.0201883026867821,0.00328165779211991,0.158005071748682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,37572,0.00802560417435399,0.00570481685886809,-0.00315583686902746,0.0192070452177355,0.15950686314696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39980,-0.010734590952212,0.00763464866529906,-0.0256985023361982,0.00422932043177416,0.159733441424353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,37562,0.00463089403467393,0.00329918718846741,-0.00183551285472219,0.0110973009240701,0.160447692730413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,39961,-0.0043397082256169,0.00310792050292824,-0.0104312324113563,0.00175181596012245,0.162632649430994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,40341,-0.00744833882104832,0.00535005445766419,-0.0179344455580701,0.0030377679159735,0.163881722835712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40291,-0.00377617842834019,0.00271734762547637,-0.00910217977427387,0.00154982291759349,0.164652894347868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39980,-0.00474994145888592,0.00342498558036628,-0.0114629131964038,0.001963030278632,0.165507396094825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37714,-0.00937821504803648,0.00676845229122442,-0.0226443815388363,0.00388795144276338,0.165899260183172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,40042,-0.00803293356911955,0.00581113354275351,-0.0194227553129164,0.00335688817467733,0.166888651796357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,37671,-0.0111517596569296,0.00807954421945817,-0.0269876663270676,0.00468414701320842,0.167534214744254
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37598,-0.00386567251352377,0.00280501424852641,-0.00936350044063553,0.00163215541358799,0.168186804854407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37959,-0.0102973446545988,0.00747793202881695,-0.02495409143108,0.00435940212188243,0.168525466461828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37482,-0.0108000073088282,0.00784480150828042,-0.0261758182650578,0.00457580364740142,0.168625949288045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,40411,0.00281304583854839,0.0020479952015824,-0.00120102475655312,0.0068271164336499,0.16959738134719
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40044,0.00380882490119304,0.00278790450302892,-0.00165546792474364,0.00927311772712971,0.171897051997456
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,39992,-0.00620536174315886,0.00455291287482736,-0.0151290709778205,0.00271834749150275,0.172920153640418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,40422,-0.00422506479253522,0.00312246741346758,-0.0103451009229317,0.00189497133786124,0.176037301388943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40042,0.00439965076456647,0.00325485336455564,-0.00197986182996259,0.0107791633590955,0.176484478823117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37901,0.006298547417832,0.00466878351606026,-0.0028522682736461,0.0154493631093101,0.177335018842661
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,37562,-0.0103151706533294,0.00764990898232582,-0.025308992258688,0.00467865095202924,0.177551655256062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37541,0.00699249548427089,0.00518939486142699,-0.00317871844412601,0.0171637094126678,0.177855855547145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,39961,-0.00760357305950121,0.00565612126615188,-0.0186895707411589,0.00348242462215647,0.178868243857631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37900,-0.0108941421568428,0.00812260029804271,-0.0268144387410065,0.00502615442732096,0.179873755668118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37959,0.0034291461156712,0.00256216924850314,-0.00159270561139495,0.00845099784273735,0.180796390218237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,37572,-0.00586661990001393,0.00438717749147567,-0.0144654877833062,0.00273224798327838,0.18117413601421
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,39961,0.004797305962789,0.00359524396705058,-0.00224937221263013,0.0118439841382081,0.182109481980053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,40406,0.00511527837757255,0.00383375394751494,-0.00239887935955672,0.0126294361147018,0.182133105171202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,37598,0.00749775353182108,0.00563679832252077,-0.00355037118031963,0.0185458782439618,0.183493902457982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,37541,0.00677966185141612,0.00510625698886149,-0.00322860184675239,0.0167879255495846,0.184294922266813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37541,0.00996317613289144,0.00751537245306995,-0.00476695387512567,0.0246933061409085,0.184960156961763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,39903,-0.0144380513346139,0.0108918189570182,-0.0357860164903695,0.0069099138211417,0.184996202505377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,40305,-0.00367029041094657,0.0027863822067653,-0.00913159953620655,0.00179101871431341,0.187782481888396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,37541,0.0062324931818079,0.00473701694994603,-0.00305206004008631,0.0155170464037021,0.188297799581334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,37457,-0.00440522878795391,0.00335539880085211,-0.010981810437624,0.00217135286171623,0.189247275303935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,40044,-0.0055560125998444,0.00423230010491434,-0.0138513208054765,0.0027392956057877,0.189281695450322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37900,-0.00685556525676618,0.00522575455420909,-0.017098044183016,0.00338691366948364,0.189582867108668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37572,0.00451529561950015,0.00344724917036756,-0.00224131275442027,0.0112719039934206,0.190277734643373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,39980,-0.00550723994686545,0.00420503250760658,-0.0137491036617743,0.00273462376804344,0.190324054061171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37900,-0.00774074820143955,0.0059153506389957,-0.0193348354538711,0.00385333905099203,0.190696806995486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,37942,-0.00853258171734549,0.00655094467646478,-0.0213724332832165,0.00430726984852547,0.1927689906123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40516,-0.00858238121253237,0.00659616278204707,-0.0215108602653446,0.00434609784027989,0.193236983889266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,37572,-0.00416633695403619,0.00321249891086443,-0.0104628348193305,0.0021301609112581,0.194683356419611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40411,-0.00333443495165423,0.00258648337816881,-0.0084039423728651,0.00173507246955664,0.197355234627816
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37901,-0.0101142611273347,0.00784966730357844,-0.0254996090423485,0.005271086787679,0.197595693635129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40305,-0.00323019084174503,0.00250703328883083,-0.00814397608785345,0.00168359440436339,0.197607639408961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,37410,-0.00536692563210477,0.00418863118162333,-0.0135766427480865,0.00284279148387696,0.200108517262778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40422,0.00339414238528148,0.00265057929091377,-0.0018009930249095,0.00858927779547247,0.200377917267161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37562,0.00441929942362472,0.00345495987953522,-0.00235242194026432,0.0111910207875138,0.20087834373405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37482,0.00368064340888224,0.00288243022359035,-0.00196891982935484,0.00933020664711932,0.201651947646998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,37541,0.00444602059315419,0.00348484875390083,-0.00238428296449143,0.0112763241507998,0.202043738366291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40305,0.00290525352707171,0.00227989300425494,-0.00156333676126798,0.00737384381541139,0.202577990997558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37572,-0.0125991506580139,0.00991642602352926,-0.0320353456641313,0.00683704434810341,0.203917215552801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37900,-0.00785988218392241,0.00619078777819234,-0.0199938262291794,0.00427406186133458,0.20424577883237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,39602,-0.0033830164361878,0.002666252632085,-0.0086088715950744,0.00184283872269879,0.204521851176883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40314,-0.0131937929132908,0.0104068867714484,-0.0335912909853297,0.00720370515874815,0.204889987094878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37598,-0.00527824232610714,0.00416495975921826,-0.0134415634541749,0.00288507880196065,0.205071448341785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37598,-0.00537584819980423,0.00425459425639796,-0.0137148529423442,0.00296315654273578,0.20641774176162
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,40044,-0.00715804272078054,0.00567333855899918,-0.0182777862964189,0.00396170085485785,0.207076172929312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,40268,-0.00448965003322428,0.00355978991043916,-0.011466838257685,0.00248753819123648,0.207251050253719
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37990,-0.00354648187942187,0.00281302787196298,-0.0090600165084693,0.00196705274962557,0.20742617096413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,40359,-0.00542000011213383,0.00430390915093201,-0.0138556620479606,0.0030156618236929,0.207933146267851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40042,-0.00671736964601357,0.00533915954110024,-0.01718212234657,0.00374738305454291,0.208362717408892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,40044,-0.00389388632102122,0.00309923149518453,-0.00996838005158289,0.00218060740954046,0.208988417078394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,36179,-0.0124973889967277,0.00994883165795849,-0.0319970990463263,0.00700232105287097,0.209080635508912
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37628,0.00310859859970204,0.00248644783565924,-0.00176483915819006,0.00798203635759415,0.211242602479677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37875,0.0032212324534659,0.00258113453150894,-0.00183779122829162,0.00828025613522342,0.212056152371569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,40359,-0.00329117685816111,0.00264155977611834,-0.00846863401935306,0.00188628030303084,0.212811462885103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37572,-0.00627575411926985,0.00504527690719103,-0.0161644968573643,0.00361298861882457,0.213563395141324
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40451,0.00409736861976452,0.00329539822276233,-0.00236161189684965,0.0105563491363787,0.213753167020896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,37900,-0.00723111101752259,0.00583888387750181,-0.0186753234174261,0.00421310138238096,0.215574341262172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,37482,-0.0073631837522407,0.00595144350313115,-0.0190280130183778,0.00430164551389636,0.216031529599071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,39871,0.008239339531409,0.00666303707706136,-0.00482021313963128,0.0212988922024493,0.216264049744442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,37598,0.00685058227384455,0.0055493829988419,-0.00402620840388557,0.0177273729515747,0.217047506216185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,40341,0.00691762249584043,0.00562956400532025,-0.00411632295458726,0.0179515679462681,0.219164051264793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40042,-0.00685622688299655,0.00559894664019801,-0.0178301622977846,0.00411770853179155,0.220760843560198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40536,-0.00363521228074256,0.00296864206948588,-0.00945375073693488,0.00218332617544976,0.220767623164521
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,37572,0.00347047399707766,0.00283544758255915,-0.00208700326473827,0.00902795125889359,0.220989353057411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,37598,0.00310429309526461,0.00253712909578633,-0.00186847993247661,0.00807706612300582,0.221145629284439
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,40403,0.00678600300339723,0.00555017158720677,-0.00409233330752804,0.0176643393143225,0.221474148898482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37572,0.00430623860200467,0.00352271293610606,-0.0025982787527632,0.0112107559567726,0.221570385775473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39980,-0.00533424649825296,0.00436464601976175,-0.013888952696986,0.00322045970048006,0.221669947364492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40471,-0.00534839616769144,0.00438811366821129,-0.0139490989573856,0.00325230662200269,0.22292393819252
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40042,-0.00927887621423306,0.00764228101887174,-0.0242577470112217,0.00569999458275556,0.22470880544813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40128,0.0201650493294224,0.0166637638041413,-0.0124959277266946,0.0528260263855395,0.226253503122681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37598,0.00324599340105882,0.00268608393647781,-0.00201873111443768,0.00851071791655531,0.226896631076831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,39961,-0.00384758098176993,0.00318637660386987,-0.0100928791253549,0.00239771716181502,0.22725428690291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37714,-0.0051564573295366,0.00429561125342182,-0.0135758553862434,0.00326294072717018,0.230004965727142
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37598,-0.0106637127036452,0.00894209148413281,-0.0281902120125455,0.00686278660525506,0.233075004111127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37598,-0.00894618635821807,0.00750481458912329,-0.0236556229528997,0.00576325023646357,0.233259390452293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,40042,-0.0145655935851871,0.0122373283310497,-0.0385507571140444,0.00941956994367027,0.233962624993567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,37572,0.00427861006134521,0.00359503527035781,-0.00276765906855609,0.0113248791912465,0.234011289368403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,37959,-0.00775858854652993,0.00653919205219505,-0.0205754049688322,0.00505822787577237,0.235455597639515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40314,0.00318885455527404,0.00268799746390837,-0.00207962047398637,0.00845732958453444,0.235509401753276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37562,0.008142237501809,0.00686928588536372,-0.00532156283350388,0.0216060378371219,0.235916141142758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37714,-0.00879231817996901,0.00742357875929848,-0.023342532548194,0.00575789618825601,0.236284966694509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37572,-0.00333542008082655,0.0028192997627766,-0.00886124761586869,0.0021904074542156,0.236804092788869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37901,-0.00241668346244592,0.00204573063432499,-0.00642631550572291,0.00159294858083106,0.237492447535024
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37598,0.00659226169063276,0.00558423874818859,-0.00435284625581687,0.0175373696370824,0.237817940068345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40228,-0.00542548322479776,0.00459644214353611,-0.0144345098261285,0.00358354337653301,0.237872544645221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37482,-0.00997725242088393,0.00849733529809027,-0.0266320296051409,0.006677524763373,0.240351404263856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39530,-0.00320486962502897,0.00273125729921975,-0.00855813393149968,0.00214839468144174,0.240652165883831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,37482,0.0105042972107087,0.00900140783845696,-0.00713846215266691,0.0281470565740844,0.243247236840231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,37598,0.00478380633474821,0.00410144935246924,-0.00325503439609151,0.0128226470655879,0.243486154246441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37901,-0.0112578012221733,0.00970285948650939,-0.0302754058157317,0.00775980337138516,0.245965176752911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,37457,0.00909201954821484,0.00784467613145485,-0.00628354566943666,0.0244675847658663,0.246475391629075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37482,0.00402581456603552,0.00347892985608831,-0.00279288795189757,0.0108445170839686,0.247212230398575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37598,-0.00966550245281517,0.00836315748243737,-0.0260572911183924,0.00672628621276208,0.247815041227184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,37628,-0.00927782053239052,0.0080451654649386,-0.0250463448436702,0.00649070377888913,0.248842300567541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,37643,-0.00911601141675797,0.00791932219310166,-0.0246378829152372,0.00640586008172128,0.249707825974236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37901,-0.00523770425661015,0.00456939558954899,-0.0141937196121262,0.00371831109890587,0.251708989874269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37562,0.00569380275025489,0.0049689580047012,-0.00404535493895946,0.0154329604394692,0.251867959032121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37942,0.00432384023261453,0.00380119332093978,-0.00312649867642744,0.0117741791416565,0.255351414863438
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,40384,0.00614406773093722,0.00540309686235011,-0.004446002119269,0.0167341375811434,0.255497627383084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37714,0.00754109773242668,0.00663538927503105,-0.00546426524663417,0.0205464607114875,0.255769298959489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",37900,-0.00479133871961215,0.00423591034666722,-0.0130937229990799,0.00351104555985559,0.258023187801058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,37714,0.00334325651942072,0.0029604954285567,-0.00245931452055041,0.00914582755939185,0.258796137926233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,37541,-0.00790915189638549,0.00702309987086862,-0.021674427643288,0.005856123850517,0.260117378977323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,40044,-0.00414882317710342,0.00368980004447437,-0.0113808312642732,0.00308318491006634,0.260859301826976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,37598,0.00300711161521199,0.00267719640012651,-0.00224019332903596,0.00825441655945995,0.261359654094636
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,39961,-0.00517740629018524,0.00461125959226408,-0.0142154750910228,0.00386066251065236,0.261550510704422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37900,0.00456548875678139,0.00406742622588995,-0.00340666664596292,0.0125376441595257,0.261690548230875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37959,0.00481604740561802,0.00431103054096467,-0.00363357245467274,0.0132656672659088,0.263952085219052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,37598,-0.00228854687336367,0.00205305537459131,-0.00631253540756265,0.0017354416608353,0.264998116417411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39980,-0.00440486674425484,0.00395452973934873,-0.0121557450333784,0.00334601154486867,0.265348436932835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,37598,0.0109305811665011,0.00987257779718586,-0.00841967131598318,0.0302808336489854,0.268242479610882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,37714,-0.00312057735042346,0.00282100018584923,-0.00864973771468795,0.00240858301384103,0.268662030917757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37900,-0.00817653182933755,0.00741192732033351,-0.0227039093771912,0.00635084571851613,0.269978009435483
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,40403,0.00487479326042288,0.00443222132661585,-0.00381236053974418,0.0135619470605899,0.271412642654405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,37598,0.00503697142055678,0.00459621955205623,-0.00397161890147343,0.014045561742587,0.273145051354153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,37482,0.00544866246179583,0.00497940211089587,-0.00431096567556007,0.0152082905991517,0.273869827985217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37671,-0.00265732884325485,0.00243675728429418,-0.00743337312047145,0.00211871543396174,0.275504695930337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,40042,-0.00631235219542639,0.0058278503727103,-0.0177349389259386,0.00511023453508579,0.278764991997614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37482,0.00663621267255126,0.00613154473019959,-0.00538161499863993,0.0186540403437425,0.279136245619042
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37482,0.00986481840524733,0.00911717927603449,-0.00800485297578026,0.0277344897862749,0.279271068471737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37482,0.00272636914808186,0.00252048977161989,-0.00221379080429313,0.00766652910045685,0.27941374328208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37900,-0.00703679030935592,0.00651506675564527,-0.0198063211504206,0.00573274053170881,0.280126131438446
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37562,-0.00592681277770574,0.00549317926662687,-0.0166934441402944,0.00483981858488293,0.280634168444604
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,37562,0.00462798624140443,0.00430855031589783,-0.00381677237775531,0.0130727448605642,0.282779707875431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37562,-0.00486566287122636,0.00453081511874504,-0.0137460605039666,0.00401473476151391,0.282885239046989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,37482,0.00432779937544478,0.00403998731025051,-0.00359057575264621,0.0122461745035358,0.284080996733301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39980,0.00486730574178756,0.00455568955749991,-0.00406184579091227,0.0137964572744874,0.28535603112047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37541,0.00658966481131515,0.00617610437494145,-0.00551549976357009,0.0186948293862004,0.286008957303887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,37628,0.00181512324635141,0.00170527793433382,-0.00152722150494289,0.0051574679976457,0.287160291415482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40357,0.00268605355049822,0.00253381378460115,-0.00228022146732003,0.00765232856831647,0.289122825190811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,37598,-0.00520488006422642,0.00491546978706078,-0.0148392008468656,0.00442944071841272,0.289675055200002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,39925,-0.00344354844320007,0.00325466893880163,-0.00982269956325126,0.00293560267685112,0.290056732649459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,37572,-0.00615499339187912,0.00582456173100721,-0.0175711343846533,0.00526114760089502,0.290653951201317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39980,0.00332592579875895,0.00315277003130727,-0.0028535034626033,0.00950535506012121,0.291477509763027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,37598,-0.00475301042544304,0.00451827665166372,-0.0136088326627039,0.00410281181181786,0.292840881343899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37482,-0.00293079244750779,0.00278746218401211,-0.00839421832817152,0.00253263343315594,0.293085404322025
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37541,0.00553099203017722,0.00526660967290513,-0.00479156292871683,0.0158535469890713,0.293645685327251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,37900,0.00459031920215572,0.00437609932798631,-0.00398683548069745,0.0131674738850089,0.29421894990558
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40042,0.00302556109183579,0.0028913422295633,-0.00264146967810829,0.00869259186177986,0.295382946290252
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40453,-0.00657613688341636,0.00628933956990265,-0.0189032424404256,0.00575096867359284,0.295761292334717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,37541,0.005479336922012,0.0052420733080957,-0.00479512676185557,0.0157538006058796,0.295921472113601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37541,-0.00860055901665281,0.00823967285325583,-0.0247503178090342,0.00754919977572862,0.296597855023982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37998,-0.00275101708393241,0.00264251027536659,-0.00793033722365092,0.0024283030557861,0.297865345369043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,37541,0.00743420800021036,0.00715229387468622,-0.00658428799417463,0.0214527039945954,0.298630550546423
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37598,-0.00365763866091681,0.00351936165639587,-0.0105555875074527,0.0032403101856191,0.298688828720618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,40379,0.00237692422733869,0.00229331530904473,-0.00211797377838899,0.00687182223306636,0.300004416185242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37541,-0.00612498695531664,0.00591394763603009,-0.0177163243219356,0.00546635041130233,0.300368248342741
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37541,0.00378556879692744,0.00367182118826203,-0.00341120073206613,0.010982338325921,0.302569939599929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37572,0.00404519998482962,0.00395087670767293,-0.00369851836220932,0.0117889183318686,0.30591366404271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,37900,-0.00787500870086454,0.00769765715969764,-0.0229624167338719,0.00721239933214283,0.306307488351631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37598,-0.00602132294795456,0.00589170761768993,-0.0175690698786268,0.0055264239827177,0.30679988654121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,37900,-0.00392017555802326,0.00383778447831564,-0.0114422331355219,0.00360188201947539,0.30705094943635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37714,0.00398543627740364,0.00390497746989046,-0.00366831956358166,0.0116391921183889,0.307460631496994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37572,0.0049578320818727,0.00486372207534656,-0.00457506318580655,0.014490727349552,0.308055924571863
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37959,-0.00357897348492154,0.00351917682736455,-0.0104765600665561,0.00331861309671298,0.309175612580468
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,37562,0.00529297924505323,0.00521565584312461,-0.00492970620747102,0.0155156646975775,0.310207863369597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39980,-0.00290449671114121,0.0028766191894425,-0.0085426703224485,0.00273367690016608,0.312659054429806
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,37482,0.00403611565246574,0.00400041459149114,-0.00380469694685689,0.0118769282517884,0.31302965582858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37572,0.00346147037521101,0.00344413265294296,-0.00328902962455719,0.0102119703749792,0.314899019345565
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,37562,-0.00457625323551476,0.0045693648948955,-0.0135322084295099,0.00437970195848043,0.316599997992338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40044,-0.00441790385628653,0.00441221956973799,-0.013065854212973,0.00423004650039992,0.316702983692621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,37541,0.00428999970879295,0.00429394281204665,-0.00412612820281847,0.0127061276204044,0.317773581821728
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37572,-0.00544320834006616,0.00545450194568656,-0.0161340321536118,0.00524761547347949,0.318331955544353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37572,-0.00693745931399797,0.00695344633646973,-0.0205662141334786,0.00669129550548271,0.31844284145384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37460,0.00461859503903282,0.00465323695364264,-0.00450174939010675,0.0137389394681724,0.320945175823312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,37482,-0.00739625742688886,0.00753904268230462,-0.0221727810842059,0.00738026623042819,0.326581093725469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,37671,-0.00262938483844992,0.00268988299412143,-0.00790155550692793,0.00264278583002809,0.32833511207476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40471,-0.00670764701280726,0.00686716066129234,-0.0201672819089402,0.00675198788332573,0.328697024792585
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37598,-0.00290937279943392,0.002991555598441,-0.00877282177237827,0.00295407617351044,0.330805633728455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37541,0.00657640149633392,0.00678748254163443,-0.00672706428526956,0.0198798672779374,0.332612277946885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37714,-0.00615431595033581,0.00635300491527384,-0.0186062055842725,0.00629757368360092,0.332699982267811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40286,0.0165724334112621,0.017120921289483,-0.0169845723161246,0.0501294391386487,0.333077193251784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37714,-0.00427677230581714,0.00442901020575415,-0.0129576323090953,0.00440408769746099,0.334248414566638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,40042,-0.00447254267576818,0.00465567337488772,-0.0135976624905481,0.00465257713901176,0.336735510546515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,37598,-0.00301166217427152,0.00314023026796624,-0.00916651349948535,0.00314318915094231,0.337547291239749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39980,0.00399315284240237,0.00416709495501431,-0.00417435326942567,0.0121606589542304,0.33794750367759
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37628,-0.00753244290461228,0.00788181154543399,-0.0229807935336629,0.00791590772443835,0.339254460903554
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,37990,0.00264675636044307,0.00278228327090534,-0.00280651885053138,0.00810003157141753,0.34147450977269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37959,0.00385284185622329,0.00406381777714141,-0.00411224098697388,0.0118179246994205,0.343103498880757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,40042,-0.010650814142385,0.0112922078514604,-0.0327835415312474,0.0114819132464775,0.345593061937586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,40044,0.00458546616512662,0.00486703845053477,-0.00495392919792153,0.0141248615281748,0.346131929699002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,39961,-0.00438171480829793,0.00465396594045733,-0.0135034880515943,0.00474005843499843,0.346462707050706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,37572,-0.00629516833334445,0.00669974202132766,-0.0194266626951467,0.00683632602845775,0.347433125252865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37572,0.00351981249768722,0.00374890775003005,-0.00382804669237168,0.0108676716877461,0.347804439375411
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37541,-0.00660619057191962,0.00706143799932675,-0.0204466090506,0.00723422790676081,0.349532235662005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,37482,-0.00554161993886438,0.00595126158770445,-0.0172060926507651,0.00612285277303633,0.351784303154708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37671,0.00340750550537828,0.00366729739566656,-0.00378039739012818,0.0105954084008847,0.352823216561392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37562,0.00857181085154909,0.00927929276364551,-0.00961560296519611,0.0267592246682943,0.355629893524514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,37598,0.00781262937509389,0.00847536064399579,-0.00879907748713787,0.0244243362373256,0.356647242681758
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,37987,0.00569377572498261,0.00620504006947688,-0.00646810281119208,0.0178556542611573,0.358842055155844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37598,-0.00565098472293707,0.00615850724470887,-0.0177216589225665,0.00641968947669232,0.35885038371497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37482,0.0043210825015626,0.00473183950354693,-0.00495332292538937,0.0135954879285146,0.361157964341581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37562,0.00282747713124876,0.00310141092546548,-0.00325128828266358,0.0089062425451611,0.361956875385543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37628,-0.00673345033902222,0.00742716326183251,-0.0212906903322139,0.0078237896541695,0.364636071295237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37714,0.00324892241353382,0.00360019491516508,-0.00380745962018973,0.0103053044472574,0.366845099010534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39980,0.00503209777699983,0.00558720397780678,-0.00591882201950146,0.0159830175735011,0.367790073363534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,37572,0.00233431466010979,0.0025947252745806,-0.00275134687806819,0.00741997619828777,0.368329192165015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,37482,0.00387091622871577,0.00430698459827122,-0.00457077358389582,0.0123126060413274,0.368800735902179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,37562,0.00536048921162863,0.00599821959901275,-0.00639602120243636,0.0171169996256936,0.371509505539596
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37482,0.00480135057409716,0.00539429489301276,-0.00577146741620785,0.0153741685644022,0.373439705178812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,37998,0.00377453913257222,0.00424409336559868,-0.0045438838640012,0.0120929621291456,0.373823876673575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,37429,-0.00296359520786172,0.00333521363993367,-0.0095006139421317,0.00357342352640827,0.37424675271537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,37987,-0.00239087233459107,0.00269630766001271,-0.00767563534821598,0.00289389067903383,0.375244942009764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37482,-0.00224322406499921,0.00253101991430866,-0.00720402309704418,0.00271757496704577,0.375476265428625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37572,0.00590823942540633,0.00670279859557441,-0.00722924582191952,0.0190457246727322,0.378085803085034
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,37482,0.00479197586651779,0.00547754655023273,-0.00594401537193836,0.0155279671049739,0.381677189299444
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,37562,-0.00743352543221482,0.00850028720134426,-0.0240940883468496,0.00922703748241992,0.381860485275848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40044,-0.00299535013794854,0.00344488677288272,-0.00974732821279868,0.00375662793690159,0.384583745772289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37714,-0.00450541627301012,0.00518927068485846,-0.0146763868153327,0.00566555426931246,0.385290917391511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37598,0.00766038561094583,0.00883104237545188,-0.00964845744493984,0.0249692286668315,0.385717661628614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,39961,-0.00498958406628283,0.00576328432939952,-0.0162856213519059,0.00630645321934023,0.38663869999006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,37562,0.00536871478667628,0.00624814292967483,-0.00687764535548638,0.0176150749288389,0.39021849268749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37541,0.00405152561667394,0.00473090467610675,-0.00522104754849529,0.0133240987818432,0.391794714201973
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39961,-0.00247214168467664,0.00288897669685083,-0.00813453601050427,0.00319025264115099,0.392168471248528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,40489,-0.0048508005908125,0.00568602813932661,-0.0159954157438927,0.00629381456226765,0.393611718033542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,37671,0.0035174373189575,0.00412587072190752,-0.00456926929598124,0.0116041439338962,0.393934264317975
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,40372,-0.00204242452765716,0.00240386165302313,-0.00675399336758249,0.00266914431226817,0.395536304523972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,37598,-0.00240963690198417,0.00284176997463609,-0.00797950605227092,0.00316023224830258,0.396489476110285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40536,0.00230633024728784,0.002722341250079,-0.003029458602867,0.00764211909744268,0.396903886566673
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,40419,0.0026957879169888,0.00318638954696898,-0.0035495355950704,0.008941111429048,0.397547502279232
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37562,-0.00329121740624926,0.00389032182829383,-0.0109162481897052,0.00433381337720665,0.397567448121189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,37482,0.00340403653715044,0.00402649512513445,-0.00448789390811308,0.011295966982414,0.397897861768372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,37959,-0.0129574145269855,0.0153364657560104,-0.0430168874087658,0.0171020583547949,0.398194942626121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,37714,-0.0018505389645425,0.00219587327938644,-0.00615445059213992,0.00245337266305492,0.399391943185942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,40015,-0.00387015630876106,0.00459740265142004,-0.0128810655055443,0.00514075288802222,0.399905204961412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,40471,0.0023379448694405,0.00278624276235098,-0.00312309094476743,0.00779898068364843,0.401423992196072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40042,-0.00507073612064088,0.00605846595511499,-0.0169453293926663,0.00680385715138449,0.402623942622727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,37942,0.0075460627199759,0.00904177523825032,-0.0101758167469947,0.0252679421869465,0.403970379711371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37901,-0.00345710702647748,0.00414313650681514,-0.0115776545798352,0.0046634405268802,0.404060386745492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,37482,-0.00581365409070917,0.00701064412819632,-0.019554516581974,0.00792720840055562,0.406971898411576
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37714,0.00325777789943577,0.0039349865340701,-0.00445479570734162,0.0109703515062132,0.407741665726358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,40228,-0.00341385897488067,0.0041261797185173,-0.0115011712231746,0.00467345327341323,0.408042411806779
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37562,0.00386206517072565,0.00467916303911027,-0.00530909438593048,0.0130332247273818,0.409173623517857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37628,0.0029585150167483,0.00358731346765532,-0.00407261937985613,0.00998964941335274,0.409547743301405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,39980,-0.00319774217370752,0.00388851585725973,-0.0108192332539366,0.00442374890652155,0.41088725886518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,37541,0.00367633120360326,0.00447577828285956,-0.00509619423080149,0.012448856638008,0.411442721015911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37959,-0.00184788887002283,0.00225305155790086,-0.00626386992350851,0.00256809218346285,0.412132770536244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,37942,-0.00301926733151659,0.00368678640969996,-0.0102453686945285,0.00420683403149534,0.412833493383904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37541,0.00470902591025479,0.00577102184226408,-0.00660217690058281,0.0160202287210924,0.414527661556322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,40359,0.00349042285448944,0.00428609950303431,-0.0049103321714578,0.0118911778804367,0.415451623725141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,37900,0.00274777696931393,0.00337468812039165,-0.00386661174665369,0.00936216568528156,0.415526828529452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,39961,-0.00412454801242841,0.00506921078239232,-0.0140602011459174,0.00581110512106053,0.41585971087976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,40455,-0.00338258244364219,0.00416356680698769,-0.0115431733853381,0.00477800849805368,0.416560348253777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39961,-0.00333728515012187,0.00411202371008161,-0.0113968516218818,0.00472228132163808,0.417038294110631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,40333,0.00506605854517667,0.00626383512183149,-0.00721105829361305,0.0173431753839664,0.418654371412274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,40042,0.0082710554929769,0.0102524625952508,-0.0118237711937147,0.0283658821796685,0.419829509633485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,37998,0.00412197844834443,0.00512032939793397,-0.00591386717160616,0.014157824068295,0.420821042099381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37541,-0.0051156345298733,0.00637289657206427,-0.0176065118111193,0.00737524275137268,0.422152708051345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37959,-0.0025879773046591,0.00322559367828909,-0.00891014091410572,0.00373418630478753,0.422378588471101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37562,-0.00300517130266794,0.00375087760776879,-0.0103568914138948,0.00434654880855889,0.423035304216544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,37482,0.0054796043053267,0.00684607869961984,-0.00793870994592819,0.0188979185565816,0.423493427176145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37541,-0.00596433103402944,0.00747267921050197,-0.0206107822866133,0.00868212021855442,0.424796987988702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37942,-0.00347853826760493,0.00436557416092859,-0.012035063623025,0.0050779870878151,0.425574728207178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37482,0.00255432377467985,0.00320979535042718,-0.00373687511215743,0.00884552266151713,0.426168469167093
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,37598,-0.00223874780366085,0.00282226811523833,-0.00777039330952797,0.00329289770220627,0.427649878521729
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,37562,0.00396464267388771,0.00501098375432199,-0.00585688548458338,0.0137861708323588,0.428847155483019
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,37562,0.00256624361212096,0.00324982524090632,-0.00380341386005542,0.00893590108429734,0.429743045470595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37959,-0.00221473192571841,0.00280751525884369,-0.00771746183305203,0.00328799798161521,0.430208632044112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37225,-0.00812058909783619,0.010324629424931,-0.028356862770701,0.0121156845750286,0.431574006659235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37562,0.00251540043410989,0.00320043650686796,-0.0037574551193513,0.00878825598757109,0.431907806892269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,40044,0.00222070242169956,0.00283165146509078,-0.00332933444987836,0.00777073929327748,0.432909538845662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,37562,0.0032204906149421,0.00411101175869249,-0.00483709243209519,0.0112780736619794,0.433417260005666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,40305,-0.00209753881725814,0.0026811954950239,-0.00735268198750499,0.00315760435298871,0.434041297741297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,37598,0.00778083394943212,0.0100021856290276,-0.011823449883462,0.0273851177823263,0.436634084323054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40042,-0.00369328702332689,0.0047501897095127,-0.0130036588539718,0.005617084807318,0.436873829127597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,37714,-0.00543719081995481,0.00700153981302091,-0.0191602088534758,0.00828582721356618,0.437425931151622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39980,0.00263734268563266,0.00339653668730009,-0.00401986922147552,0.00929455459274084,0.437477473403271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,39961,-0.00289250693625217,0.00372901598785682,-0.0102013782724515,0.00441636439994719,0.437952342488946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,37697,0.00729301785763976,0.00940865900801987,-0.0111479537980792,0.0257339895133587,0.438271409208755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,39961,-0.00226581316422722,0.0029307781769634,-0.00801013839107549,0.00347851206262104,0.43946921779693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,37880,0.00377229817864089,0.0048804831898464,-0.00579344887345806,0.0133380452307398,0.43957422380201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37628,-0.00502042082396101,0.0065376124124832,-0.0178341411524281,0.00779329950450607,0.442543250744778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,39980,-0.00570619103170924,0.00743221096233527,-0.0202733245178864,0.00886094245446789,0.442638519464532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40341,-0.00670350095342655,0.00873901971387548,-0.0238319795926225,0.0104249776857694,0.443047138184165
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,37824,-0.00213323440195759,0.00278782990194602,-0.0075973810097718,0.00333091220585661,0.444168748812597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,37714,0.00328872540401652,0.00430581891964879,-0.0051506796784951,0.0117281304865281,0.445008203306957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37562,0.00384715392207054,0.00503974139993212,-0.00603073922179641,0.0137250470659375,0.445260462051426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,37572,-0.00306100301769764,0.00401349473083562,-0.0109274526901355,0.00480544665474019,0.445669331661103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,37562,0.0034545383894249,0.00453248107284482,-0.00542912451335094,0.0123382012922007,0.445969983815781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,37562,0.00539618992679498,0.00708905429638077,-0.00849835649411133,0.0192907363477013,0.446551158335853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,37541,0.0046105292999006,0.00606606314578448,-0.00727895446583698,0.0165000130656382,0.447236613496862
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40332,-0.00226816334996934,0.00299297696592823,-0.00813439820318867,0.00359807150324999,0.448564882705497
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37562,0.00485596996406738,0.0064155703114235,-0.00771854784632268,0.0174304877744574,0.449121061934468
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,37562,0.00380207559615479,0.00503009688389937,-0.00605691429628797,0.0136610654885975,0.44974355237697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,37572,0.0024039559223989,0.0031822342735417,-0.00383322325374283,0.00864113509854064,0.450004450596683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,40411,-0.00411516294466071,0.00550161997624151,-0.0148983380980941,0.00666801220877265,0.454476529446429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40470,0.00208938858198169,0.00279762654623647,-0.0033939594486418,0.00757273661260518,0.455169129729878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,37562,0.00467305917191267,0.00627246692550718,-0.00762097600208141,0.0169670943459067,0.456278202126969
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,39980,0.0119183744088738,0.0160822788167712,-0.0196028920719978,0.0434396408897454,0.458651647496509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,37959,-0.00269648773403051,0.0036428203874682,-0.00983641569346819,0.00444344022540717,0.45917950872204
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,40387,0.00213727224133664,0.00289671387023757,-0.00354028694432899,0.00781483142700227,0.460630755610262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,37482,0.00217982901958648,0.00296124712556523,-0.00362421534652136,0.00798387338569433,0.461671789693364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,39961,-0.00482544083923127,0.00656029207689657,-0.0176836133099486,0.00803273163148601,0.462014053477694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37900,0.00249517463775418,0.0033940394227602,-0.0041571426308558,0.00914749190636416,0.462252613250181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,37900,-0.00343805215959441,0.00471474470827626,-0.0126789517878159,0.00580284746862705,0.465884206181086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,37714,0.00399995319832604,0.00549305373646046,-0.00676643212513646,0.0147663385217885,0.466513887165534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,37942,0.0016009725795071,0.00221279919467728,-0.00273611384206038,0.00593805900107457,0.469381867951761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37541,0.00349427566070891,0.0048297855269738,-0.00597210397215973,0.0129606552935775,0.469395114041313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37500,0.00237267710364323,0.00328916868805883,-0.00407409352495208,0.00881944773223854,0.470700530466293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,40305,0.00603256109217687,0.00838211256224144,-0.0103963795298164,0.0224615017141701,0.471723665438016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37572,-0.005371245822953,0.0074657906811665,-0.0200041955580393,0.00926170391213333,0.471877939335643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37572,-0.00248800930320957,0.00349178354686524,-0.00933190505506544,0.0043558864486463,0.476147757016559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37755,-0.000917552565121502,0.00129388865120542,-0.00345357432148412,0.00161846919124112,0.478247935913297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40451,-0.00201422909242183,0.00284109316645553,-0.00758277169867466,0.003554313513831,0.478357952130498
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39961,-0.00468477413342865,0.00661177980203708,-0.0176438625454213,0.00827431427856402,0.478614652709454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,39980,0.00965371931058701,0.013642603031204,-0.0170857826305729,0.0363932212517469,0.47919459614765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37572,0.00585750229669872,0.00828485110550938,-0.0103808058700997,0.0220958104634971,0.479570591116375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,37934,-0.00212530930795008,0.0030064706932934,-0.00801799186680513,0.00376737325090497,0.479633570332005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37482,0.00374729870861173,0.00533359072722796,-0.00670653911675508,0.0142011365339785,0.482327213404657
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,37598,0.00389396336154018,0.00555062878153822,-0.00698526905027473,0.0147731957733551,0.482981281614524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37900,-0.00257872802630508,0.00367991235126685,-0.00979135623478811,0.00463390018217795,0.483466175966814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,40422,-0.00510211902466726,0.00729184084050719,-0.0193941270720613,0.00918988902272683,0.484123326992077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40434,-0.0022461449756658,0.00321086496959016,-0.00853944031606251,0.0040471503647309,0.484221596202575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,40332,0.00336514352691936,0.00483032460881093,-0.00610229270635007,0.0128325797601888,0.486019368734555
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,37987,0.00169665574464997,0.0024381075461817,-0.00308203504586615,0.0064753465351661,0.486509390210838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,37934,-0.00170783931609527,0.00246162309692089,-0.00653262058606021,0.00311694195386968,0.487828459694904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,37900,-0.00290233377272953,0.00425386449228206,-0.0112399081776024,0.00543524063214331,0.49507261208719
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40305,0.0037060894962716,0.00544061191566241,-0.00695750985842672,0.0143696888509699,0.495761333305292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37562,0.00253195102057067,0.00371775931876758,-0.00475485724421378,0.00981875928535512,0.495856811199929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,38013,0.00141158882432381,0.00208287119584268,-0.00267083871952784,0.00549401636817546,0.497965263302367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,40042,-0.00178408955458919,0.00263936580048561,-0.00695724652354099,0.0033890674143626,0.499079953899995
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37482,0.00584141692059597,0.0086572172317154,-0.0111267288535662,0.0228095626947581,0.499849549416505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,37598,0.00447168070238873,0.00664661412036708,-0.00855568297353075,0.0174990443783082,0.501101802389294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37692,-0.00357364761959511,0.005323160149194,-0.0140070415120153,0.00685974627282513,0.502015995264737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37990,0.00176332582537036,0.00262985753871025,-0.00339119495050174,0.00691784660124245,0.502549006427903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40203,-0.00253138038708069,0.00377652985916814,-0.00993337891105024,0.00487061813688886,0.502681048347143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37628,0.00369844644483742,0.00553195853750098,-0.00714419228866449,0.0145410851783393,0.503787879572511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,40359,0.00747332272802462,0.0112683490995103,-0.0146126415070156,0.0295592869630648,0.507203352775381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37598,0.00306356761740008,0.00462700150628493,-0.00600535533491837,0.0121324905697185,0.507914598102977
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,37942,-0.00336940694078743,0.00511593300182308,-0.0133966356243607,0.00665782174278581,0.510157190444112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,37598,0.00297168603565513,0.00451708926858184,-0.00588180893076529,0.0118251810020755,0.510629131507394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37482,0.00398240582672777,0.00606749391999086,-0.00790988225645432,0.0158746939099099,0.511609887339586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37998,0.00155377467472619,0.00237754987584192,-0.00310622308192398,0.00621377243137635,0.513432658858713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40411,-0.00149825348908243,0.00230525819320834,-0.00601655954777077,0.00302005256960592,0.515747625380018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40516,0.00215587133683886,0.00332069966797109,-0.00435270001238447,0.0086644426860622,0.516204164368726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37714,-0.0050990242138593,0.00787793887962775,-0.0205397844179297,0.0103417359902111,0.517479036399189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,37598,0.00302943143199042,0.00468164572295801,-0.00614659418500728,0.0122054570489881,0.51758702720539
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,37531,0.00539145536738836,0.00838268342713003,-0.0110386041497865,0.0218215148845632,0.520127792099769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37901,0.00160296333870314,0.00251517715697159,-0.00332678388896118,0.00653271056636746,0.52392970017013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,37714,0.00260506100258039,0.00409494064403752,-0.00542102265973315,0.0106311446648939,0.524679370029191
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,37598,0.0026313474893191,0.00414302965025525,-0.00548899062518119,0.0107516856038194,0.52535703708227
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37572,0.0025657336098451,0.00404111213839327,-0.00535484618140571,0.0104863134010959,0.52549962236593
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,40044,-0.00285166615388638,0.00450757254170418,-0.0116865083356266,0.00598317602785381,0.526978694693742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40044,0.00233990440125134,0.00370421097488111,-0.00492034910951563,0.00960015791201832,0.527600247216892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,40236,-0.0041649462711294,0.00659448293439219,-0.0170901328225381,0.0087602402802793,0.527670233712842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39980,0.00325219718329509,0.0051572912059982,-0.00685609358046139,0.0133604879470516,0.528310193680366
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,37628,-0.00170480372529681,0.00273050297817158,-0.00705658956251311,0.0036469821119195,0.532405151772057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37541,0.00510762910741359,0.00818487934931195,-0.0109347344172378,0.021149992632065,0.532617246521974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37714,-0.00324184025712908,0.0051970641790142,-0.0134280860479969,0.00694440553373876,0.532780837587292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,40044,-0.00316842218635454,0.00509576658292806,-0.0131561246888935,0.00681928031618447,0.534098670538942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40490,0.0026709728162309,0.00431425053594776,-0.00578495823422671,0.0111269038666885,0.535856176040255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,38013,-0.00192594831500961,0.00311527000719265,-0.0080318775291072,0.00417998089908798,0.536435190729365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37900,0.0026503447214831,0.00431049545268253,-0.00579822636577466,0.0110989158087409,0.538658581939292
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,37572,0.00229311122233699,0.00375628089399478,-0.00506919932989278,0.00965542177456676,0.541558541523957
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37714,-0.00308426558657528,0.00506723015434596,-0.0130160366890934,0.0068475055159428,0.542754326092998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38013,0.00113273916879214,0.00186716980810056,-0.00252691365508497,0.00479239199266924,0.544086041418217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,40305,-0.00186213094406233,0.00307798761642115,-0.00789498667224778,0.00417072478412313,0.545198787132882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37714,-0.00487092582725237,0.00807793385100224,-0.0207036761752168,0.010961824520712,0.546524623929931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40042,-0.00484467844711398,0.00807843745913885,-0.0206784158670261,0.0109890589727982,0.548711644376936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40374,-0.0032432580512862,0.00542867832967881,-0.0138834675774567,0.00739695147488427,0.550228486364018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37990,0.00189980006434894,0.00318057340249208,-0.00433412380453554,0.00813372393323342,0.550307949824375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,37482,-0.00420495435926237,0.00704945591745698,-0.018021887957478,0.00961197923895331,0.55085598348536
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,37598,0.00124487131422016,0.0020928680416526,-0.00285715004741893,0.00534689267585925,0.551976735180278
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37598,0.00205531239216677,0.00345980325518077,-0.00472590198798754,0.00883652677232109,0.55248574870073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40359,0.00554422815645746,0.00933725451411315,-0.0127567906912043,0.0238452470041192,0.552671065648268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,37572,-0.00522928063282554,0.00884713154534636,-0.0225696584617044,0.0121110971960533,0.554483202990232
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37572,-0.00242250327073515,0.00410418182505794,-0.0104666996478487,0.00562169310637841,0.55503159623369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37562,-0.00256751376419567,0.0043610955618027,-0.011115261065329,0.00598023353693762,0.5560516337613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37482,0.00182946453916498,0.0031095757364404,-0.0042653039042582,0.00792423298258816,0.55631931669373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39961,0.0022105919200798,0.00377817119549279,-0.00519462362308607,0.00961580746324567,0.55849184668226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37541,0.00315410343318786,0.00542338520712748,-0.007475731572782,0.0137839384391577,0.560863227489929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,37998,-0.00241949237275179,0.00416521579390566,-0.0105833153288069,0.00574433058330329,0.561330701507834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39980,0.00668552518684644,0.0115423186190335,-0.0159374193064592,0.0293084696801521,0.562450110157889
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39961,0.0030835841828175,0.00533728265445515,-0.00737748981991459,0.0135446581855496,0.563445209827153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,37714,-0.0093806648984044,0.0163216190294788,-0.0413710381961828,0.022609708399374,0.565477829067285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37482,0.00238792767428308,0.00416603599464469,-0.00577750287522051,0.0105533582237867,0.566526351854114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,39980,0.00462092889497923,0.00808351209536599,-0.0112227548119381,0.0204646126018966,0.567568293566514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39980,0.00270679786545116,0.00474566726360421,-0.0065947099712131,0.0120083057021154,0.568433363732031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40228,-0.00328259218384613,0.00577839476999109,-0.0146082459330287,0.00804306156533641,0.56998853471064
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37482,-0.00463908661096067,0.00822497413426166,-0.0207600359141135,0.0114818626921922,0.572747191843236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37688,0.00282733806762073,0.00501610691594669,-0.00700423148763478,0.0126589076228762,0.573000624440357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40042,-0.00145443660014908,0.00258390397490765,-0.00651888839096807,0.00361001519066991,0.573522393240557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,37572,-0.00325975310664428,0.00582596952946953,-0.0146786533844046,0.008159147171116,0.575815659863686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37628,-0.0140233286261575,0.0250680631403555,-0.0631567323812543,0.0351100751289393,0.575891353480556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37628,-0.00239211071447763,0.00431173557774647,-0.0108431124468607,0.00605889101790546,0.579047259724524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37541,0.00302794597660204,0.00547253589561664,-0.00769822437880658,0.0137541163320107,0.580068468889904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36973,-0.00264471411404353,0.00478529859316791,-0.0120238993566526,0.00673447112856557,0.580495953569635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37482,0.00335526913735876,0.00608609806241058,-0.00857348306496597,0.0152840213396835,0.581437122743087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,37572,-0.00182883025410477,0.00333147523263226,-0.008358521710064,0.00470086120185446,0.583045618846269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37562,-0.00625523561946075,0.0114086689085426,-0.0286162266802042,0.0161057554412827,0.583503540040904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,37671,0.00176403500193143,0.00322802968759567,-0.00456290318575607,0.00809097318961894,0.584749228061501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40396,-0.00458425855423875,0.00844623103895308,-0.0211388713905868,0.0119703542821093,0.587304095345937
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40136,0.00152659188698671,0.0028178050740459,-0.00399630605814326,0.00704948983211668,0.587987191578598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37714,-0.0038555174283689,0.00713632713576224,-0.0178427186144629,0.0101316837577251,0.5890224319769
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38013,0.000976855281676136,0.00181315813067289,-0.00257693465444273,0.004530645217795,0.590061993111417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,37482,-0.00275755857970261,0.00519340299841833,-0.0129366284566025,0.00742151129719732,0.595446297962931
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37714,-0.00430426049893357,0.00811113573169232,-0.0202020865330505,0.0115935655351834,0.595662849728638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37541,0.00306487053950231,0.00580129251593752,-0.00830566279173523,0.0144354038707399,0.597294382147721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,40359,0.0020051620666763,0.00381002907927739,-0.00546249492870739,0.00947281906205998,0.598697374507958
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,40341,0.00279941072352162,0.00532005145064137,-0.00762789011973546,0.0132267115667787,0.598756644114179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,37572,-0.00326486544983434,0.00624432433014621,-0.0155037411369209,0.00897401023725223,0.601085188850126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37901,-0.00163129876529552,0.00313520412526676,-0.00777629885081838,0.00451370132022733,0.6028514893795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,37562,0.00359283056919706,0.00692170114137033,-0.00997370366788879,0.0171593648062829,0.60372238650904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37598,-0.00143371472330455,0.00276662783744003,-0.00685630528468701,0.00398887583807791,0.604315307618514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40489,-0.00185126840075866,0.00360379339611095,-0.00891470345713613,0.0052121666556188,0.607468881047173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,37901,0.00552365040249657,0.0107966056112627,-0.0156376965955782,0.0266849974005714,0.608932449441668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,40489,-0.00295247867962027,0.00577563344175252,-0.0142727202254552,0.00836776286621467,0.609221103327664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37562,0.00295769529543274,0.0058051739397934,-0.00842044562656233,0.0143358362174278,0.610415302385078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37697,-0.004893107561871,0.00962657797664669,-0.0237612003960985,0.0139749852723565,0.611257409814517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,40044,-0.00215419414627503,0.00424754567064282,-0.010479383660735,0.0061709953681849,0.612048263769611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,37572,-0.0028036270554499,0.00553695717102701,-0.0136560631106628,0.00804880899976303,0.612620897375095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,37572,-0.00334283332324715,0.00666507973762221,-0.0164063896089867,0.00972072296249239,0.615996463662882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,39980,0.0042435837189721,0.00851383316878483,-0.0124435292918462,0.0209306967297904,0.618185253899826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40291,-0.00162593205627331,0.00328596021527163,-0.0080664140782057,0.00481454996565908,0.620739801498506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,37959,0.00176632564203927,0.00357078704991143,-0.00523241697578713,0.00876506825986567,0.620848163120528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,40288,0.00169570486766279,0.00343302816082383,-0.00503303032755191,0.00842444006287749,0.621356446239178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37482,0.00232720644152968,0.00471315892061424,-0.00691058504287424,0.0115649979259336,0.621478449519359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40312,0.00416436891068254,0.0084493745485813,-0.0123964052045368,0.0207251430259019,0.622117484896903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,40411,-0.00372042349989334,0.00755490995977007,-0.0185280470210427,0.011087200021256,0.622407277753459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,37942,-0.00124267723323499,0.00253597667590017,-0.00621319151799932,0.00372783705152933,0.624128289415136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40044,0.00173585545878522,0.00357987742792704,-0.00528070429995179,0.00875241521752222,0.627759465695615
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,37981,0.000678599171968927,0.00140402977622646,-0.00207329918943494,0.00343049753337279,0.628874593014006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37541,-0.00211022069318653,0.00439085032331469,-0.0107162873268833,0.00649584594051026,0.630812404984271
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40536,0.00103537767514153,0.00217983501570998,-0.00323709895565003,0.0053078543059331,0.634807795946351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,40341,-0.00269814698219114,0.00570721451424356,-0.0138842874301085,0.00848799346572622,0.636390377245614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,37562,0.00382157838924994,0.00811276801003788,-0.0120794469104243,0.0197226036889242,0.637607672576406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40471,0.00211762382381313,0.00451140209187548,-0.00672472427626281,0.0109599719238891,0.638794622942378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37541,0.00221755549694922,0.00476546192355507,-0.00712274987321872,0.0115578608671172,0.641696420299248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,37934,0.00206548144389036,0.00444924648761624,-0.00665504167183747,0.0107860045596182,0.642489218133977
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37482,0.00256599295647552,0.00553485771945907,-0.00828232817366426,0.0134143140866153,0.642937836460647
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,37901,-0.00313220080451643,0.0067713899693209,-0.0164041251443854,0.0101397235353525,0.643684446455944
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,37598,-0.00212386129802374,0.00459960671851112,-0.0111390904663055,0.00689136787025805,0.644269358877154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,40044,-0.00281120521917136,0.00609198416314097,-0.0147514941789277,0.00912908374058494,0.644475261507153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,37562,0.00486462634388718,0.0105634966307492,-0.0158398270523812,0.0255690797401556,0.645155760897989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37714,-0.00156004887517943,0.00344806615101471,-0.00831825853116826,0.00519816078080941,0.650958219791963
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37562,0.00182480572945765,0.00405061456231632,-0.00611439881268233,0.00976401027159764,0.65235671541329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37598,0.00176197050361425,0.00391241186417595,-0.00590635675017061,0.00943029775739911,0.652462602995913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,37572,-0.00295794905118024,0.00658819905762667,-0.0158708192041285,0.00995492110176803,0.65345575129211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,37572,-0.00184040760139893,0.00411511137079952,-0.009906025888166,0.00622521068536813,0.654715272838568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37572,-0.00183326419101939,0.00410121768882109,-0.00987165086110873,0.00620512247906994,0.654878937947495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,37572,0.00183575632474161,0.00410733463470221,-0.00621461955927473,0.00988613220875795,0.654921508296084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37990,-0.00311227275147632,0.00698809970325969,-0.0168089481698653,0.0105844026669127,0.656061289579086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,37562,0.00172275024288095,0.00387510156513386,-0.00587244882478141,0.00931794931054332,0.656638552965345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37457,0.00216688956410536,0.00491033855222644,-0.00745737399825846,0.0117911531264692,0.659009477505659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37687,0.002108643274059,0.00483332694801584,-0.00736467754405205,0.0115819640921701,0.662646801834897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37628,-0.00136255749240978,0.00312504163998286,-0.00748763910677618,0.00476252412195662,0.662834739894855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,40398,-0.00612325008258382,0.0142100803659598,-0.0339750075998651,0.0217285074346975,0.666540437230652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,37572,0.00190598383263883,0.00445731864651037,-0.0068303607145215,0.0106423283797992,0.668943767484289
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37714,0.00229489822372165,0.00536706389817123,-0.00822454701669396,0.0128143434641373,0.668957218182464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,37900,-0.0018118500480659,0.00424981987103858,-0.0101414969953015,0.00651779689916972,0.669870051322282
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,39878,0.00284604128745887,0.00669252162816348,-0.0102713011037416,0.0159633836786593,0.670655309759283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37482,-0.00260115382845614,0.00612615510743533,-0.0146084178390294,0.0094061101821171,0.671136687655642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,40332,0.00195060604068412,0.00459756809486149,-0.0070606274252444,0.0109618395066126,0.671375324847865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,37598,0.0021926954803562,0.00519129048763786,-0.00798223387541399,0.0123676248361264,0.672754833946924
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,40044,-0.00198356795400554,0.00470622106268559,-0.0112077612368693,0.00724062532885822,0.67341198942317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,39961,-0.00176842610786104,0.00421092711366919,-0.0100218432506527,0.00648499103493059,0.674519597890524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37572,0.00155788549524106,0.00370970752822904,-0.00571314126008786,0.00882891225056997,0.674530074312895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,37959,-0.0030728246718772,0.00736109280700624,-0.0175005665736094,0.011354917229855,0.676362234736512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37562,0.00384880903041645,0.00922716090322411,-0.0142364263399028,0.0219340444007357,0.676599394829495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37562,-0.00192117771161546,0.0046156716306142,-0.0109678941076193,0.00712553868438838,0.677249044562005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37541,-0.00172937448594614,0.0041553152484614,-0.00987379237293047,0.0064150434010382,0.67728240797321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,37572,-0.00263837876830122,0.00637344855289408,-0.0151303379319736,0.00985358039537118,0.678907179870321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37959,-0.0026854636144111,0.00658535682634264,-0.0155927629940427,0.0102218357652205,0.683431982908006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39961,-0.00191743397103009,0.00472185078696352,-0.0111722615134786,0.00733739357141841,0.684691787581632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37562,-0.00188389080031305,0.00464364338483107,-0.0109854318345819,0.00721765023395585,0.684975252445044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40330,0.00186277609056329,0.00462947395293607,-0.00721099285719141,0.010936545038318,0.687414832106415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,40042,0.00126340044793208,0.00315918272599028,-0.00492859769500888,0.00745539859087303,0.689225561448729
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37998,-0.00152604121519196,0.00382721385600055,-0.00902738037295304,0.00597529794256912,0.690095319427577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37901,-0.00487023375747893,0.0122712488878538,-0.0289218815776724,0.0191814140627145,0.691461018885046
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,40489,0.0016760186377213,0.00428163291156051,-0.00671598186893729,0.0100680191443799,0.695474426242818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37541,0.00272209977591751,0.00698529505912106,-0.0109690785399598,0.0164132780917948,0.696772116992542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37572,0.00142916971361882,0.0037085839694273,-0.00583965486645869,0.00869799429369633,0.699971009722729
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,37562,0.00184372699579636,0.00478802968295944,-0.00754081118280415,0.0112282651743969,0.700191738036603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37541,-0.00438619180054908,0.0114280962367166,-0.0267852604245137,0.0180128768234155,0.701127184323147
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,37942,0.00217716012478919,0.00568731920882601,-0.00896998552450979,0.0133243057740882,0.701867009077272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,39980,0.00112008825394605,0.00295583958602374,-0.00467335733466047,0.00691353384255257,0.70473699756823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37541,-0.00198594740154149,0.00524645819172764,-0.0122690054573277,0.00829711065424468,0.705042260926721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37901,0.00195243103472207,0.00526577826629764,-0.00836849436722131,0.0122733564366654,0.710809251661895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37901,-0.000915604880553193,0.00247880941136247,-0.00577407132682364,0.00394286156571726,0.711855652111036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,37482,0.0014768962960072,0.00399966005430548,-0.00636243741043154,0.00931623000244594,0.711943324368643
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,40013,-0.00254775145631343,0.00690065785974846,-0.0160730408614204,0.0109775379487936,0.711980593101855
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,37541,0.00227969826725381,0.00621872350713861,-0.00990899980673787,0.0144683963412455,0.713933623202323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,37714,-0.00211560100214555,0.00580749976808789,-0.0134983005475978,0.00926709854330672,0.715648957007272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,37901,-0.00209036205270833,0.00574127494361914,-0.0133432609422018,0.00916253683678518,0.715793762748821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40182,0.000995049003238142,0.00273455893778588,-0.00436468651482218,0.00635478452129846,0.715953139492544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37959,0.00127825669491958,0.00351697851627525,-0.0056150211969799,0.00817153458681906,0.716272140218794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,37572,-0.00167261043578432,0.00466493837414771,-0.0108158896491138,0.00747066877754519,0.719938042151286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40044,-0.00140791512489231,0.00399049181397368,-0.00922927908028073,0.00641344883049611,0.724230073981703
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,40044,-0.00105089983530215,0.00298904096106918,-0.00690942011899774,0.00480762044839344,0.72515480179885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37714,0.00224511851082009,0.00642169435547088,-0.0103414024259028,0.014831639447543,0.726633456109734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,40332,0.000924973649088318,0.00265447554236789,-0.00427779841395275,0.00612774571212939,0.727500753957111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,37562,0.00217403018463756,0.0062669434270118,-0.0101091789323056,0.0144572393015807,0.728668716756104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,37598,0.000555945416679291,0.0016076399506828,-0.00259502888665901,0.00370691972001759,0.729487562374549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37541,-0.00356916762921124,0.0103467568730275,-0.0238488111003452,0.0167104758419227,0.730133590577084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39980,-0.00155868426982716,0.00452456109387019,-0.0104268240138127,0.00730945547415841,0.730479452795787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37562,-0.00116384026279014,0.00339182670984738,-0.00781182061409101,0.00548414008851073,0.731505551749575
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,37714,-0.00171669207915463,0.00501427718688243,-0.0115446753654442,0.00811129120713493,0.732084790954375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37482,0.00193906018515723,0.00567662267756303,-0.00918712026286631,0.0130652406331808,0.732667273388365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,37541,-0.00317277540112616,0.00929786805952458,-0.0213965967977943,0.015051045995542,0.732930745824239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,37900,0.00109057144213952,0.00322880756809405,-0.00523789139132482,0.00741903427560386,0.735547133921601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37482,0.00131583067728209,0.00391429446780237,-0.00635618647961056,0.00898784783417473,0.736755348647894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,40044,0.00150237880611101,0.00448556548231785,-0.00728932953923198,0.010294087151454,0.73767762735648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,37572,0.00210208304536407,0.00632391499183074,-0.0102927903386242,0.0144969564293523,0.739590913086114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39980,0.00102148573979856,0.00309002456873383,-0.00503496241491976,0.00707793389451688,0.740969780451913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,38013,-0.000480030474754914,0.00145849004489788,-0.00333867096275476,0.00237861001324493,0.742063732028393
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37628,0.000835016281393308,0.00254471727830681,-0.00415262958408805,0.00582266214687467,0.742813178283489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37942,0.000811900945084532,0.00248452704129839,-0.00405777205586031,0.00568157394602938,0.743837165736927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,40417,0.00347461566206299,0.0107355782635215,-0.0175671177344392,0.0245163490585652,0.746204041325205
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39961,0.00154798832417764,0.00489782043445045,-0.00805173972734523,0.0111477163757005,0.751963824058821
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,40044,-0.00140948180265104,0.00457660797855421,-0.0103796334406173,0.00756066983531523,0.758105309640283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37482,0.00260665368166009,0.00848987159987251,-0.01403349465409,0.0192468020174102,0.758824690584509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,37598,-0.000764614786471689,0.00249512863261325,-0.00565506690639365,0.00412583733345027,0.759272200624998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37942,-0.00115812697468358,0.0038007407455059,-0.00860757883587513,0.00629132488650798,0.760591079514345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39961,0.00143469035085359,0.0047458789225948,-0.00786723233743221,0.0107366130391394,0.762425640957534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37460,-0.000721148382190435,0.00241349120371259,-0.0054515911414671,0.00400929437708623,0.765098305919338
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,37572,-0.00137321096841972,0.00462739975730011,-0.0104429144927279,0.00769649255588849,0.766657113662173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39757,-0.00183921522596477,0.00620935913064638,-0.0140095591220317,0.0103311286701021,0.767080992398601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,37900,-0.00103710912154525,0.00353780907532137,-0.00797121490917514,0.00589699666608463,0.769411938913506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,38013,-0.000556295104428954,0.00189849518129799,-0.00427734565977301,0.0031647554509151,0.769512134488427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37572,0.0023129623771167,0.00799512154147363,-0.0133574758441716,0.017983400598405,0.772358899013491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37482,-0.00153113907135058,0.00536514431296417,-0.0120468219247604,0.0089845437820592,0.775352683199992
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,39934,0.000975202223825508,0.00342336337827971,-0.00573458999760272,0.00768499444525374,0.775750080253734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39961,-0.00176501982196348,0.00625948280170754,-0.0140336061133103,0.0105035664693833,0.777966177835649
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37482,0.00120081713615215,0.00426566409754956,-0.00715988449504499,0.00956151876734929,0.778325520802832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37880,-0.00234153912597525,0.00832836861277308,-0.0186651416070105,0.01398206335506,0.778598000191003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,37937,0.000618714218702516,0.00222331668859811,-0.00373898649094978,0.00497641492835481,0.780798362601296
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37482,0.00374437452026612,0.0135236046480524,-0.0227618905899167,0.0302506396304489,0.781878977673825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,37598,0.000730220264671363,0.00265216556845221,-0.00446802424949496,0.00592846477883769,0.783067184752062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37987,0.00102500245816202,0.00375878379294088,-0.0063422137760021,0.00839221869232615,0.785091652089139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,40044,-0.001971621076862,0.00758946799606073,-0.016846978349141,0.012903736195417,0.795033953294458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,37598,0.00078636457402692,0.00304204762606596,-0.00517604877306236,0.0067487779211162,0.796026297515943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37598,0.0013417317172556,0.00523561791460985,-0.0089200793953797,0.0116035428298909,0.797746383090591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,37541,0.00141646228151126,0.00557371836129179,-0.00950802570662064,0.0123409502696432,0.799397284966774
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,37714,0.00147651753536138,0.00589127252190282,-0.0100703766075682,0.0130234116782909,0.802105655398898
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37598,-0.00142164884786944,0.00577162832229642,-0.0127340403595704,0.00989074266383154,0.805440874720482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,39953,0.00208837887291215,0.00848197156101342,-0.0145362853866742,0.0187130431324984,0.805519954893819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,37572,-0.00054930984233426,0.00223269639653622,-0.00492539477954525,0.00382677509487673,0.80566301487712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,37598,-0.00146501644742009,0.00604669655463498,-0.0133165416945047,0.0103865087996645,0.808564067049914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40273,0.000622057597823244,0.0025739833623562,-0.00442294979239492,0.0056670649880414,0.809038094419831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,40228,0.000279334492543596,0.00116187677980451,-0.00199794399587323,0.00255661298096043,0.810010416128044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40419,0.000728177771520959,0.00302920530993811,-0.00520906463595773,0.00666542017899965,0.81003431516052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40305,-0.0010046811098196,0.00428595045434249,-0.00940514400033089,0.00739578178069169,0.814667646948938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40305,0.000489606774374212,0.00209256277618665,-0.00361181626695162,0.00459102981570004,0.815007631467112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,37541,-0.00255496283446852,0.010999868966236,-0.024114706008291,0.019004780339354,0.816330300257597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,40490,-0.000590152488406236,0.00256102847385893,-0.00560976829716974,0.00442946332035727,0.817756131857756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37598,0.00234873482367971,0.0102610054356764,-0.017762835830246,0.0224603054776054,0.818950907218741
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,37981,0.000487018945855132,0.00212992891376512,-0.0036876417251245,0.00466167961683476,0.819140510667377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39961,0.00144645607785814,0.00645873721979866,-0.0112126688729472,0.0141055810286635,0.822796523482579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37482,-0.00129479210998406,0.00579352988842738,-0.0126501106913017,0.0100605264713336,0.823158190546655
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40311,0.000856493977104501,0.00386230233203809,-0.00671361859369015,0.00842660654789915,0.824505628347873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,37572,-0.00176308010221581,0.00830700371840838,-0.0180448073902962,0.0145186471858646,0.831922945692772
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37900,-0.00116226621002956,0.00548047428076035,-0.0119039958003199,0.00957946338026073,0.832052502052141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37598,-0.00135922554490022,0.00650883634395021,-0.0141165447790426,0.0113980936892422,0.83458595547506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,37541,0.00144002532050839,0.00698309087297432,-0.0122468327905213,0.0151268834315381,0.836625369276796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37779,0.000159098994605473,0.000774780496062599,-0.00135947077767722,0.00167766876688817,0.837304016666991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37572,0.000966855181190017,0.00474563606428769,-0.00833459150481385,0.0102683018671939,0.838563252597248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37562,-0.00115903947956101,0.0057264682134201,-0.0123829171778644,0.0100648382187424,0.839606853328092
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,37714,-0.000786277438100813,0.00394877417521828,-0.00852587482152864,0.00695331994532701,0.842172419665753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37900,0.000815858895350525,0.00419483065664444,-0.00740600919167258,0.00903772698237363,0.845793990635544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,37628,-0.00126117894118623,0.00650064869229477,-0.014002450378084,0.0114800924957115,0.846172477357086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,37572,-0.00117181878287849,0.00609060868017129,-0.0131094117960142,0.0107657742302572,0.847433712636177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,39903,0.000779649272928455,0.00407081922514419,-0.00719915640835415,0.00875845495421106,0.848119579621047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39980,0.0023076889866318,0.0120576614145045,-0.0213253273857969,0.0259407053590605,0.848224299713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,37482,-0.00111190640643545,0.0058294518054872,-0.0125376319451904,0.0103138191323195,0.848732704368056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,37562,-0.000878582919995615,0.00462039536137479,-0.00993455782829021,0.00817739198829897,0.849192034351441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37761,0.000807580168908172,0.00427904346431895,-0.00757934502115698,0.00919450535897332,0.850307993626871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,40044,-0.000887839577216854,0.00476084584341422,-0.0102190974303087,0.00844341827587502,0.852064686265185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37562,0.000724624280786965,0.00392988519962111,-0.00697795071047041,0.00842719927204434,0.853711813514368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,37628,0.000386616123343553,0.00214510718908008,-0.0038177939672534,0.0045910262139405,0.856973514919217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40042,0.000554403534848871,0.00315155453952387,-0.00562264336261792,0.00673145043231567,0.860363549555928
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37572,0.00119196671156449,0.00692919197758758,-0.0123892495645072,0.0147731829876361,0.86342365239302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,40044,-0.000663685017232573,0.00392677790976123,-0.00836016972036458,0.00703279968589944,0.865786905329682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37883,-0.000677765623325326,0.00401142562813212,-0.00854015985446428,0.00718462860781363,0.865831599855782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40182,0.000476564864025583,0.00283860606588693,-0.0050871030251128,0.00604023275316397,0.866674389149761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37572,0.000564827365992565,0.00338092098029152,-0.00606177775537881,0.00719143248736394,0.86732292186418
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37714,0.00107188393005304,0.00649405725869587,-0.0116564682969909,0.0138002361570969,0.868902321715843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,37959,0.000685615083521438,0.00417679488115155,-0.00750090288353559,0.00887213305057847,0.869616609845879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37959,0.00177634253613895,0.0108582192158936,-0.0195057671270126,0.0230584521992905,0.87005299690334
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37959,-0.000542321163751689,0.00335392894105624,-0.00711602188822192,0.00603137956071854,0.871546670607117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40411,0.00134932176829464,0.0083629472209123,-0.0150420547846935,0.0177406983212828,0.87182353205749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,37900,0.00165424997499255,0.0103148059579088,-0.0185627697025087,0.0218712696524938,0.872587100208778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,37714,0.00128684944326806,0.0081429959205467,-0.0146734225610035,0.0172471214475396,0.87443442351263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37901,-0.0025635931344478,0.0165282913769501,-0.0349590442332701,0.0298318579643745,0.876742179694588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,37482,0.00170015223518982,0.0111605393408366,-0.0201745048728499,0.0235748093432295,0.878924268777921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,37482,-0.000827360355952451,0.00550373938588115,-0.0116146895522795,0.00995996884037461,0.880508998324287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37562,0.000731606597717213,0.00487159443511987,-0.00881671849511773,0.0102799316905522,0.880626446048403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,37671,0.000730113854052883,0.00491698372269747,-0.00890717424243416,0.0103674019505399,0.881959796120193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40372,0.000381418306906205,0.00257741753112962,-0.00467032005410785,0.00543315666792026,0.88235673335915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,37959,0.000428595467653818,0.00290412213028281,-0.00526348390770048,0.00612067484300812,0.882675050306877
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,37598,0.000876175630360122,0.00596412142865179,-0.0108135023697974,0.0125658536305176,0.883207091333027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,37598,-0.000931403288655645,0.00639692052772067,-0.0134693675229882,0.0116065609456769,0.884237961315213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40042,0.000454679704289303,0.00321834820016173,-0.00585328276802769,0.00676264217660629,0.887652667786831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37562,0.000843006905234355,0.00600921831792195,-0.0109350609978927,0.0126210748083614,0.888436482298515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,37572,0.000792043905380978,0.00573618708208857,-0.0104508827755126,0.0120349705862746,0.890180524429454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37562,-0.000732789935492675,0.00553720690635835,-0.011585715471955,0.0101201356009697,0.894717976260054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37482,0.000518271445915849,0.00396820583235244,-0.00725941198549493,0.00829595487732663,0.89608902126305
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,37857,-0.000890115421388029,0.00681611481724046,-0.0142497004631793,0.0124694696204033,0.896101730912207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37900,-0.00114644811663423,0.00903938901856959,-0.0188636505930306,0.0165707543597622,0.899078387461651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37714,0.000756521554192153,0.00609612152476631,-0.0111918766343498,0.0127049197427341,0.901238904554718
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37541,0.000384950882005374,0.00311206312612607,-0.00571469284520173,0.00648459460921248,0.901557592839031
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37714,0.000741223398288756,0.0060285134109525,-0.0110746628871781,0.0125571096837557,0.902146233163734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37671,-0.000470014978673713,0.00385365330928758,-0.00802317546487737,0.00708314550752995,0.902927737738817
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,37714,0.000874583026012255,0.00725006464928401,-0.0133355436865844,0.0150847097386089,0.903985088969801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,37562,0.000535716970371336,0.00448277989507938,-0.00825053162398424,0.00932196556472691,0.904876693236132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,37998,0.000644515829480478,0.00544517076517473,-0.010028018870262,0.0113170505292229,0.905780474878599
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37572,-0.00045775047404912,0.00399329697767896,-0.00828461255029988,0.00736911160220164,0.908740383944389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,37482,0.000882823727456405,0.0077440076060986,-0.0142954311804968,0.0160610786354097,0.909238847590512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,39961,0.000386328431248479,0.00339716063820372,-0.00627210641963081,0.00704476328212777,0.909460454110563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,40332,-0.000472801876882648,0.00417489506561083,-0.00865559620547988,0.00770999245171458,0.909834735335709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37628,0.000439198410632009,0.00388246942526049,-0.00717044166287855,0.00804883848414256,0.90993439206178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,40453,-0.00033007777590016,0.00296512653413432,-0.00614172578280342,0.0054815702310031,0.911364021892915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,37901,-0.00273039234178119,0.0247780508776232,-0.0512953720619226,0.0458345873783602,0.912257171074798
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,40042,-0.000570144365268483,0.0051980297645462,-0.010758282703779,0.00961799397324207,0.912660842007584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40044,-0.000599332699165949,0.00547081093106648,-0.0113221221240562,0.0101234567257243,0.912766898645061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,40305,-0.000191698843780828,0.00182182455493166,-0.00376247497144689,0.00337907728388523,0.916199756958686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37482,-0.000565851502821372,0.00539464787622485,-0.0111393613402221,0.0100076583345793,0.91646369549202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39961,0.000846157991972845,0.00808743120007883,-0.0150052071601817,0.0166975231441273,0.916673698893178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,40489,-0.000290923428743975,0.00279239873666607,-0.00576402495260946,0.00518217809512151,0.917024588726942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,37482,0.000669658117967681,0.00651886692534279,-0.0121073210557042,0.0134466372916395,0.918181897554249
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37900,-0.000455145968314883,0.00444587050828255,-0.00916905216454869,0.00825876022791892,0.918460557349886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,37598,0.000293210082524313,0.00290539958581741,-0.00540137310567781,0.00598779327072644,0.919616282446871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,37562,-0.000457033949898312,0.00455495748370742,-0.00938475061796486,0.00847068271816824,0.920077763823943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40305,0.000368285964920476,0.00370045238405843,-0.00688460070783404,0.00762117263767499,0.920723032129869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,40228,-0.000334264026441736,0.00337334427187281,-0.00694601879931244,0.00627749074642897,0.921068225583233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,40044,-0.000561131458559309,0.00589105346755359,-0.0121075962549643,0.0109853333378457,0.924116318636786
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,40044,-0.000596446793200964,0.00634558541432881,-0.0130337942052854,0.0118409006188835,0.925115150999637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,37482,-0.000724969786733714,0.00772953149863729,-0.0158748515240628,0.0144249119505954,0.925275667644399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40359,-0.000313197032677541,0.00334473835960291,-0.00686888421749924,0.00624249015214416,0.925397326621816
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,37598,0.000680186192602556,0.00726830459745521,-0.0135656908184096,0.0149260632036148,0.925442229233215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,37998,0.000416861600457426,0.00447922040121009,-0.00836241038591434,0.0091961335868292,0.92585277510628
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,37541,0.000447689367015029,0.00484490468058227,-0.00904832380692623,0.00994370254095628,0.926378345297462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,40497,-0.000257369227471705,0.00284412051826536,-0.00583184544327182,0.00531710698832841,0.927897639354492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37564,0.000323929870434527,0.00364088009599853,-0.00681219511772259,0.00746005485859165,0.929106943177483
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,39980,-0.000890955288740002,0.01023643883794,-0.0209543754111024,0.0191724648336224,0.930642730235771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,37714,-0.000454466011635277,0.00527780117306204,-0.0107989563108369,0.00989002428756631,0.93138109468733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,40341,-0.000726281982482549,0.00845353064925957,-0.0172952020550313,0.0158426380900662,0.931535361672169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,40475,0.000170931513824858,0.00207128300022208,-0.00388878316661041,0.00423064619426013,0.934230698180268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37598,0.000375252075691569,0.00466515820462966,-0.00876845800538257,0.0095189621567657,0.93589079787865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37598,0.000166868363637081,0.00213284984986051,-0.00401351734208951,0.00434725406936367,0.937640501186029
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,37562,0.000272837929099499,0.0035477272904414,-0.00668070756016565,0.00722638341836465,0.938700302022441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,40017,-0.00039634151439342,0.00532574838258289,-0.0108348083442559,0.0100421253154691,0.940677253199339
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40273,0.000236217232231837,0.00320756194562955,-0.00605060418120208,0.00652303864566576,0.941294704275518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,37482,0.000375252091075313,0.00515351255656008,-0.00972563251978244,0.0104761367019331,0.941954594940775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37541,0.000267799211410302,0.00384344150951581,-0.00726534614724069,0.00780094457006129,0.944451867420179
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37572,0.00035637740948289,0.00520606265765698,-0.00984750539952479,0.0105602602184906,0.94542503590839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,37671,0.000248997635298256,0.00364171866465158,-0.00688877094741885,0.00738676621801536,0.945489222828933
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37598,-0.000605877448287187,0.00893054198995116,-0.0181097397485915,0.0168979848520171,0.945911405708322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40044,0.000776607109695645,0.0114584001544921,-0.0216818571931089,0.0232350714125002,0.945964638798482
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37901,0.000256377173423149,0.00400887837782643,-0.00760102444711665,0.00811377879396295,0.949009122641384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37628,0.000256065070954318,0.00407453368928272,-0.00773002096003981,0.00824215110194844,0.949890689444064
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,40471,-0.00016606009845122,0.00280139843543947,-0.00565680103191259,0.00532468083501015,0.952731763786109
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,37671,0.000180380928607359,0.0030482067573611,-0.0057941043158204,0.00615486617303511,0.952812755705665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40332,0.00020783877954104,0.0035273916769967,-0.0067058489073725,0.00712152646645458,0.95301547157785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40042,0.000243625803677072,0.00416425612211927,-0.0079183161956767,0.00840556780303084,0.95334789495968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,40044,0.000299960093143585,0.0052181137526303,-0.00992754286201179,0.010527463048299,0.95416007604766
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,40453,0.000281929883488775,0.00493309756047952,-0.00938694133505109,0.00995080110202864,0.95442587861623
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,37562,-0.000190773394253536,0.00347695357657834,-0.00700560240434708,0.00662405561584001,0.956244483505793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37998,-0.000713513294073513,0.0131106301270156,-0.0264103483430241,0.0249833217548771,0.95659935400319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,40471,-0.000129224925628513,0.00246865611439158,-0.00496779090983601,0.00470934105857899,0.958253442888664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40324,-0.000119542305166454,0.00231859035787194,-0.00466397940659546,0.00442489479626256,0.958881389215796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,37990,0.000232056679082144,0.00475488558869128,-0.00908751907475277,0.00955163243291706,0.961076341275537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37572,0.00022134599004651,0.00477626759003183,-0.00914013848641588,0.0095828304665089,0.96303766898899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,40227,-0.000223924716723872,0.00502641108097911,-0.0100756904354429,0.00962784100199519,0.964466861966242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37482,0.000203000163737399,0.00483375669851454,-0.00927116296535109,0.00967716329282589,0.966502247071649
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,40042,-0.000265595962447917,0.00691691024547588,-0.0138227400435806,0.0132915481186848,0.969370796184986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,37598,0.000134100523053793,0.00370156936755826,-0.0071209754373604,0.00738917648346799,0.971101095280364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37572,-0.000273866290225781,0.00970844401253022,-0.019302416554785,0.0187546839743335,0.97749582301304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40044,0.000100952846017136,0.00385727728289589,-0.0074593106284588,0.00766121632049307,0.979120445680283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37572,0.000147700179727963,0.00642105018520294,-0.0124375581832698,0.0127329585427257,0.981648631949662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,39980,0.000202055951655026,0.0089264455821545,-0.0172937773893678,0.0176978892926779,0.981941192566298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37863,-8.51730960041689e-05,0.00412601246372334,-0.00817215752490192,0.00800181133289359,0.983530780486894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,40044,-9.60860171753466e-05,0.00513927524059351,-0.0101690654887386,0.00997689345438793,0.985083528255195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37942,-4.95850134951057e-05,0.00315325367748373,-0.00622996222136321,0.006130792194373,0.987453989739217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37998,2.9216800476158e-05,0.00212865821821346,-0.00414295330722222,0.00420138690817454,0.989049218126852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37714,4.05961184390672e-05,0.00435071661949343,-0.00848680845576805,0.00856800069264619,0.992555264264232
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,37959,-1.31344905076973e-05,0.00244105783394225,-0.00479760784503451,0.00477133886401912,0.995706958472648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37987,1.52628476767982e-05,0.00333680237723124,-0.00652486981169644,0.00655539550705004,0.996350481167946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37562,-3.41584296217168e-05,0.00846739713524005,-0.0166302568146922,0.0165619399554488,0.996781314312824
